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Wound contraction is a component of normal wound healing which is
often excessive in split skin grafted wounds. This manifests as
extreme scarring which is responsible for the poor cosmetic and
functional results seen when these skin grafts are used, for
example, in the treatment of burns.
This thesis proposes to test the hypothesis that the contraction
characteristics of different types of wounds can be affected when
they are covered with an occlusive dressing. The work is divided
into several sections, each studying a different type of wound.
The first study objectively assesses whether the effect of
occlusive dressings on human open wound contraction is similar to
that in published work using open wounds in rats.
In the second section a new animal model is created using bilateral
split skin grafted wounds on a flexor and non-flexor surface of a
rat. This model allows the measurement of:
A) the moisture vapour transmission from these wounds,
B) their surface areas and
C) the underlying myofibroblast cell numbers.
The use of in-animal control wounds reduces the number of animals
required to produce data that can be analysed statistically.
The third study investigates the effect of an occlusive dressing on
the contraction of human split skin grafted wounds. Patients with
bilateral upper limb tattoos excised and split skin grafted will be
studied. The surface area of one wound (occlusively dressed) will
be compared to that of the conventionally dressed wound on the
other limb.
The final section summarises and analyses the experimental results
ii} the light of contemporary publications. Conclusions and
^itgigestions for further studies are presented.
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ABSTRACT
This thesis proposes to test the hypothesis that
wound contraction is reduced when wound healing takes
place in a moist environment.
In order to do so a series of experiments will be set up:
11 Human Study - Open Wounds
A human wound model would be set up to repeat previously
published animal experiments. This model would examine the
effect on wound contraction of dressing an open wound with
an occlusive dressing.
21 Animal Study
An animal model would be created to allow a detailed
investigation of the effects of dressing a split skin
graft with an occlusive dressing.
This model would permit :
1) the precise rapid harvesting of split-skin grafts by
a single operator
2) the application of split skin grafts to comparable
wounds on a flexor and non-flexor surface on each
side of the animal, on one side the skin grafts would
be dressed with an occlusive dressing the opposite
side would act as an in animal control. The dressings
will be removed from different animal groups at
weekly intervals up to 5 weeks to see if any effect
the dressing has on wound contraction is related to
the length of time the dressing is in situ.
3) the measurement of moisture loss from the skin
grafted wounds on both sides of the animal. This
will give an indication of the humidity of the
wound healing environment.
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4) the measurement of the surface area of the split-skin
grafted wounds on the flexor and non-flexor surfaces.
These measurements will be carried out on a regular
basis up to 15 weeks after skin grafting. The
measurement of surface area would guantify any effect
a dressing had on the various phases of wound
contraction
5) quantification of the myofibroblast cell population
under all the split-skin grafts in the study.
These cells are thought to be actively involved in
wound contraction. Their numbers therefore, may be
affected when wounds are covered with an occlusive
dressing.
3) Human Study - Skin Grafted Wounds
A study would be carried out which would investigate the
effect of covering a split skin grafted wound with an
occlusive dressing and comparing it with a similar wound
dressed conventionally. Two wounds per patient would be
skin grafted and the graft surface areas measured at
various time points up to 1 year. This would allow an
accurate evaluation of any effect the dressing had on
wound contraction.
If, by allowing split skin grafted wounds to heal in a
moist environment subsequent wound contraction is reduced,
then the cosmetic and functional results of burns therapy
may be improved. This perhaps would allow an earlier
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Introduction and Aims of the Thesis
The stimulus for this work arose from the simple question;
why does a wound covered with a split skin graft contract
and what, if anything, can be done to reduce this
phenomenon?
Split skin grafts are commonly used in burns surgery and
the resultant scarring is both disfiguring and
functionally restricting. A considerable amount of patient
and hospital staff time is spent in attempting to reduce
this unwanted complication. If, through early wound
manipulation, this contraction could be reduced then the
quality of patients lives would be enhanced and both
patient and health service resources could be saved.
(Perkins 1987)
BURNS
A burn injury is measured in terms of
a) the depth of the burn and
b) the percentage total body surface area involved.
A burn injury progressing beyond the deeper aspect of the
dermis destroys the structures capable of allowing healing
by re-epithelialisation. These wounds do not heal in a
short period of time, therefore skin grafts are used to
quickly provide an epithelialised barrier on the wound
surface. This converts an open wound into a closed wound
by providing a viable barrier to infection.
Mortality in burns is related to burn depth and the
percentage body surface area burned. Early split skin
graft coverage reduces the portal to infection and
therefore the risk of septicaemia with its associated
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mortality (Hendon 1989).
Once the burn wound is "healed" (ie covered with a viable
epithelial barrier) attention then is turned to attempting
to reduce wound contraction. The techniques employed to do
so include long term physiotherapy, long term splintage or
the wearing of cumbersome, expensive, custom made pressure
garments. Pressure garments have to be worn for up to 23
hours per day for many months and many patients find them
difficult to tolerate. Secondary surgery is often
necessary to release contractures produced by the
contraction of split skin grafted wounds.
WOUND CONTRACTION
Wound contraction is a phenomenon that occurs when open
wounds heal by secondary intention (Grabb and Smith 1979).
This phenomenon can result in complications which
depending on the nature, site and extent of the injury can
produce disfigurement, excessive scarring and impaired
function of the affected organs (Peacock and Van Winkle
1970, Montandon et al 1973).
Wound contraction is reduced, but not eliminated when the
wound is covered with a split skin graft. Covering the
wound with a full thickness skin graft markedly reduces
wound contraction (Padgett 1942) but for practical
purposes, these grafts cannot be used to cover large
defects produced for example in a burn injury.
When a split skin graft is used to cover a defect, wound
contraction is most marked over the flexor aspect of a
joint (Peacock and Van Winkle 1970, Grabb and Smith 1979)
The cells thought to play an important role in wound
contraction are myofibroblasts. These cells, described in
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1971 by Gabbiani et al, have features of fibroblasts and
smooth muscle cells. The numbers of these cells under skin
grafts is thought to be influenced by the percentage of
dermis within the graft (Rudolph 1979).
SYNTHETIC DRESSINGS
In animals, when one type of occlusive dressing is applied
to an open wound, it has exactly the same effect as a full
thickness skin graft in reducing wound contraction. This
temporary dressing (Biobrane) consists of a nylon and
silicone rubber sheet coated on one side with polypeptides
from porcine dermal collagen. The dressing adheres to the
wound in a similar manner to a skin graft by a
polypeptide-fibrin clot interaction (Frank 1984).
If a permanent "dressing" could be made consisting of a
split skin graft (instead of porcine dermal collagen)
covered with a polyurethane occlusive dressing (instead of
the nylon silicone bilayer) what effect would this have on
the subsequent short and long term wound contraction?
AIMS OF THE THESIS
This study was therefore set up to investigate several
parameters of wound healing under an occlusive dressing.
The study would be divided into two sections.
The first section would be concerned with repeating the
animal work on open wounds in humans to see if a synthetic
dressing had a similar effect in man as it had in the rat.
The second section would be concerned with:
a) a detailed animal investigation of several parameters
of wound healing. Split skin grafted wounds on a flexor
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and non-flexor surface would be covered with a
synthetic dressing. These would be compared with
conventionally dressed skin grafted wounds acting as
controls on the opposite side of the animal,
b) a study in humans investigating the effect of an
occlusive dressing on the contraction of split skin
grafted wounds.
Patients with bilateral wounds reguiring split skin
grafts would have one skin graft covered with an
occlusive dressing; the other would act as a
conventionally dressed control.
Human Study - Open Wound Contraction
This initial study was undertaken using split skin graft
donor sites to see if these wounds did contract and if
this contraction was influenced in humans as it was in
rats when the wound was dressed with a synthetic dressing.
If this were the case then the findings of the second set
of experiments could be more readily extrapolated to
clinical practice.
Animal Study - Split Skin Grafts
This study was set up to observe, in the rat, the
behaviour of split skin grafted wounds covered with an
occlusive dressing. Different groups of rats would have
split skin grafts occlusively dressed for different
periods of time up to 5 weeks. These wounds would be
compared with similar, conventionally dressed wounds on
the opposite side of the animal.
The following parameters would then be measured:
Moisture Vapour Transmission
Moisture vapour transmission, measured with an
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evaporimeter, would give an accurate tabulation of how the
humidity of the split skin grafted wound was affected when
covered with an occlusive dressing.
Surface Area
The surface areas of all wounds in the study would be
measured. The areas of the grafts covered with a synthetic
dressing would be compared with in animal control wounds,
dressed conventionally.
Myofibroblast Cell Population
The split skin grafts would be covered with a synthetic
dressing for periods up to 5 weeks. This time period was
chosen for several reasons:
a) this is the active contraction phase of skin grafted
wounds in rats, therefore if the dressing was to have an
effect on wound contraction it should do so during this
time.
b) Rudolph (1979) has shown, in rats, that myofibroblast
numbers are present in very small numbers after this time.
If these cells are responsible for wound contraction it
can be assumed that any influence on their numbers would
take place during this time.
c) the anti-actin antibody used to identify the
myofibroblasts has been shown to be most successful during
the phase of active wound contraction (Darby and Gabbiani
1990). The antibody allows light microscopy to be used,
thus allowing larger tissue sections to be studied, giving
a more accurate estimation of myofibroblast numbers in the
tissue (McGrath 1982).
All the above measurements would be compared with
in-animal control wounds which would be covered with a
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split skin graft and then dressed conventionally.
Human Study - Split Skin Grafts
Patients who had bilateral upper limb defects requiring
split skin grafts would be studied. The split skin graft
on one limb would be covered with an occlusive dressing,
the other would be dressed conventionally. Surface area
measurements would be taken at operation and at various
time points up to one year following surgery. The
contraction of the skin grafted wounds on both limbs would
then be compared.
Summary
This thesis proposes to study the effect a synthetic
dressing has on several parameters of wound healing.
Firstly, the original animal work will be repeated in
humans to ensure the synthetic dressing effect is not
species specific. Secondly, detailed studies will be
carried out to see the effect, if any, synthetic dressings
have on moisture vapour transmission, surface areas, and
myofibroblast cell count under split skin grafts on a
flexor and non-flexor surface of a rat.
A study in humans would then be carried out where the
contraction of wounds covered with occlusively dressed
split skin grafts would be compared with that of
conventionally dressed identical grafts. Two wounds per
patient would be studied to allow paired statistical
comparisons. The length of time the skin graft was covered
with the occlusive dressing would be influenced by the
results of the animal study.
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Statistics
The studies were designed to allow paired comparisons
between wounds covered with an occlusive dressing and
control wounds using Student "t" tests (Armitage and Berry
1987). Crude data would be collected using a
microcomputer's spreadsheet facility. This software
package would calculate the percentage change in all
wounds with the original wound surface area acting as the
100% reference point.
Data would then be transferred to a statistics package
where mean values, 95% confidence limits and paired or












Wound healing takes place in an orderly manner with
several phases occurring in a chronological seguence
(Pessa et al 1987).
The first phase is one which occurs as an immediate
non-specific reaction to wounding and is characterized by
an acute inflammatory response. This usually lasts between
3-5 days (Peacock and Van Winkle 1970) if no wound
contamination occurs (Clark 1988).
The phase following the acute inflammatory phase is the
phase of fibroplasia - this term is used to denote the
fibroblast and neomatrix components of the forming
granulation tissue (Clark 1988). The phase of fibroplasia
then progresses to the phase of collagen remodelling as
the wound matures (Ross 1968).
Wound contraction takes place mainly during the phase of
fibroplasia (Clark 1988) which lasts between 2-4 weeks in
a rat and up to 1 year in a human (Baur, Parks and Larson
1977).
The time scale and magnitude of the latter two phases
varies according to the species of animal studied and to
the extent of the inflammatory response created by the
initial tissue damage (Narayanan et al 1989).
Wound Healing - The Inflammatory Response
When an open wound is created the epidermal and dermal
layers of the skin are disrupted. Tsuboi (1990) argued
that this initial mechanical cell damage must be converted
into chemical signals in order to cause cell
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proliferation. He demonstrated that contents released from
damaged cells, may, by increasing local fibroblast mRNA
levels, act as initiating factors triggering the
proliferation of surrounding undamaged cells.
Bleeding takes place from severed vessels and so the wound
surface is covered initially with cells originating from
the circulating blood. The local microvasculature becomes
leaky to plasma proteins either as a result of the initial
trauma or in reaction to local mediators (Dvorak, Kaplan,
and Clark 1988).
Plasma constituents then extravasate into the interstitial
tissue and clotting is initiated as a result of the
activation of 3 systems;
1) the Extrinsic Pathway which is the main source of
clotting
2) the Intrinsic Pathway which also activates bradykinin,
therefore increasing vascular permeability
3) platelet activation which plays an important role
especially when blood vessel disruption occurs
(Dvorak, Kaplan, and Clark 1988).
The fibrin clot produced subsequently becomes the vascular
collagenous matrix known as granulation tissue
(Dvorak, Kaplan, and Clark 1988).
Many factors including;
bacterial endotoxin (Wahl et al 1974)
the products of the coagulation pathway (Kay 1974,
Grotendorst 1984),
the presence of platelets covered with fibronectin (Wagner
1985),
various platelet derived cytokines (Deuel 1982 Wahl 1987)
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the products of the fibrinolysis and kallikrein\kinin
systems (Kaplan 1973 and 1972),
the activation of the complement cascade with the
formation of C5a (Snyderman et al 1970),
and the presence of surface bacteria (Ward et al 1968,
Schiffman et al 1975)
stimulate the migration of neutrophils and monocytes into
the wound thus initiating the cellular aspect of the acute
inflammatory response.
There are several cell types playing important roles in
the inflammatory phase of wound healing
Platelets
Morphology
Platelets are anucleate discoid fragments approximately 2
micrometres in diameter, derived from bone marrow
megakaryocytes as fragments budding off from the
peripheral cytoplasm (Terkeltaub and Ginsberg 1988).
They contain at least three types of organelles involved
in wound healing (Terkeltaub and Ginsberg 1988).
Alpha-granules store several platelet specific proteins
and glycoproteins which will be discussed later.
Dense bodies are less numerous than alpha-granules, they
contain serotonin, adenine nucleotides, calcium and
pyrophosphate.
Lvsosvmes contain neutral and acid hydrolases.
Activation
Platelets can be activated by a variety of factors present
in the wound environment. These include thrombin, A.D.P.,
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arachidonic derivatives, exposed subendothelial collagen,
immune aggregates, microorganisms, double and single
stranded D.N.A., Complement and some bacterial
lipopolysaccharides (reviewed by Terkeltaub and Ginsberg
1988).
Actions
Once activated, platelets release substances which have a
profound influence on their environment.
Thromboxanes and prostaglandins affect local vascular tone
and neutrophil adherence and function (Terkeltaub and
Ginsberg 1988). Serotonin, released from the platelet
dense bodies, acts as a vasoconstrictor, increases
vascular permeability and is fibrogenic in nature (daPrada
et al 1981). Thrombospondin, released from the
alpha-granules, inhibits fibrinolysis and binds to matrix
constituents (Leung 1984).
The alpha-granules also contain platelet derived growth
factor, transforming growth factors alpha and beta,
epidermal growth factor, and platelet factor 4 (a protein
that neutralizes heparin in vivo). These factors have been
found to have a significant influence on vascular
permeability, leucocyte accumulation, fibroplasia,
collagen synthesis and angiogenesis (Terkeltaub and
Ginsberg 1988).
Polymorphonuclear Leukocytes
The polymorphonuclear leucocyte responds to inflammatory
stimuli in hours to days, whereas the macrophage response
takes days to weeks. This is because large reserves of
leukocytes are stored in the bone marrow and are released
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as a response to the trauma of wounding whereas a lag
phase occurs because new pools of monocytes are generated
as a response to these stimuli (Rappolee and Werb 1988).
Therefore, the predominant cell in the wound environment
in the initial phase of healing is the polymorphonuclear
leucocyte. It marginates on capillary and venular
endothelium and then migrates into the wound space
(Knighton 1989). This process (diapedesis) was first
observed in tadpole tails by Dutrochet in 1824 and in 1893
Metchnikoff proposed that this action was a response to
chemotactic attraction from outside the vessel wall
(Tonnesen, Worthen and Johnston 1988). The
polymorphonuclear leucocyte is responsible for the initial
destruction of contaminating bacteria and early wound
debridement (Ross 1972, Falcone 1990).
It's response is relatively simple:
Inflammatory signals induce cell adhesion and
chemoattraction, phagocytosis and bacterial killing occurs
following the activation of an intracellular respiratory
burst. Degranulation then occurs which releases hydrolytic
enzymes and antimicrobial polypeptides (Tonnesen, Worthen
and Johnston 1988). These products include PMN elastase,
Myeloperoxidase, Lysosomal acid hydrolases, PMN
collagenase, Lactoferrin, Defensins, Plasminogen
activator, Reactive oxygen metabolites, active lipid
metabolites and fibronectin (Rappolee and Werb 1988).
These chemicals also destroy bacteria and may potentiate
tissue injury and prolong the acute inflammatory response
(Tonnesen, Worthen and Johnston 1988).
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The acute inflammatory response wains probably when the
balance of inhibitory mediators is greater than the
stimulator ones. It is probable that the cessation of
neutrophil influx varies with the initial wounding
stimulus and injury site. Intact senescent neutrophils are
probably phagocytosed by activated macrophages so reducing
the cellular aspect of the acute inflammatory response by
removing neutrophils from the wound without disrupting
their cell membrane and causing further tissue damage
(Haslett and Henson 1988).
Masure and Opdenakker (1989) state that, as leucocytes
invade an area of inflammation they, like macrophages,
lymphocytes and platelets, release cytokines.
Cytokines
Since their discovery there has been over 12,000
publications, numerous reviews and several books written
about cytokines (Leutz and Graf 1990).
Coverage of the whole topic is not the remit of this
thesis therefore a brief review of the articles relevant
to wound contraction follows.
Cytokines are glycopeptide signal mediators which
generally act at the site of production and influence cell
migration (McGrath 1990) and proliferation (Masure 1989).
Recent advances in biochemical and analytical technology
have allowed the purification of these growth factors.
Recombinant DNA technigues have meant that sufficient
guantities of cytokines can be produced for
experimentation so expanding the data on such peptides,
indicating they are involved in tumour and fetal growth
processes as well as wound healing (McGrath 1990).
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Cytokines can regulate the release of microbicidal and
cytocidal proteases by either the down- or up- regulation
of the genes responsible for their production (Stanley
1988).
The effects of cytokines are not totally confined to the
immediate wound environment. They can act on distant
tissues inducing fever, endocrine changes, leucocytosis
and synthesis of the acute phase proteins (Whicher and
Evans 1990).
There are several ways in which cytokines or growth
factors can get to a wound
Some growth factors (eg. insulin like growth factor I) are
transported attached to a large molecular weight carrier
protein in plasma and thus are delivered in an endocrine
fashion.
Other cytokines (eg. platelet derived growth factor) are
secreted by one cell and used by another local cell. This
is a paracrine delivery. An autocrine system is when the
cell secretes and uses the same growth factor (eg
fibroblast somatomedin - Sm-C ). Autocrine factors
regulate local homeostasis by acting in positive and
negative feedback mechanisms (McGrath 1990).
Growth factors are classified as either competence or
progression factors. A competence factor (eg PDGF)
accelerates the cell to the first growth arrest point,
whereas a progression factor (eg Sm-C) stimulates the cell
through the growth cycle committing it to DNA synthesis.
Both types of factors are strongly synergistic (McGrath
1990).
Target cell membrane receptors show specific and high
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affinity binding properties. Activation of these receptors
elicits a rapid sequence of biochemical events within the
cell. Among these are the activation of tyrosine kinase
activity and the transcription of the proto-oncogenes
c-fos and c-myc (Leutz and Graf 1990). The increased
expression of these two proto-oncogenes is necessary for
the mitogenic response of target cells to growth factors
(Coughlin, Escobedo and Williams 1988)
Cytokines have also been found to regulate the movement
(Postlethwaite 1976), and metabolic activities
(Postlethwaite 1988) of fibroblasts. This will be further
discussed in later sections.
Lastly, recent studies showing the beneficial wound
healing effects of platelet derived fluid (Knighton et al
1990) and a purified growth factor (Brown et al 1989)
indicate that wound manipulation with cytokines may become
a recognised method of treating some wounds in the near
future (Hunt and La Van 1989).
The Macrophage
As wound healing progresses the mononuclear phagocyte
becomes the predominant cell. After 2-3 days, macrophages
begin to appear in the wound and become the predominant
phagocytic cell of the inflammatory tissue. They appear in
the wound from several sources; from the resident tissue,
from the circulating blood shed at the time of the
original injury (Remensnyder 1982), and (mainly) from the
bone marrow as a response to factors released during the
wound healing process (Stewart et al 1981). When the
circulating monocyte leaves the blood it differentiates
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into a specialized tissue monocyte or macrophage (Clark
1988).
Macrophage Activation
Macrophage accumulation and activation is probably
stimulated by various chemoattractants found in the wound.
These include inflammatory reactants such as leukotrienes
and complement split products (Rappolee and Werb 1988)
collagen fragments - especially type I (dermal) collagen,
elastin, fibronectin and enzymactically active thrombin
(Clark 1988), bacterial derived factors (Riches 1988) as
well as the cytokines previously mentioned.
The migration of the macrophage (and several days later
the lymphocyte) is probably regulated in part by dermal
vascular endothelium in the wound locality. Cai et al
(1990) found that mononuclear cell-vascular endothelial
adhesion (the precursor to diapedesis) was maximal several
days after polymorphonuclear adhesion.
Macrophage Function
Recent studies have shown that macrophages occupy a
central position in the transition between wound
inflammation and fibroplasia (Clark 1988) and the
regulation of wound repair (Diegelmann 1981).
Firstly, they carry out phagocytosis, so assisting
neutrophils in the defence against bacteria. Secondly, it
has been shown that macrophages release vasoactive
mediators, chemotactic factors, enzymes (Clark 1988) and
cytokines which influence the formation and maintenance of
granulation tissue (Knighton and Fiegel 1989).
Macrophage function is related to its state of
differentiation and\or activation (Fukasawa et al 1988).
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The phagocytosing of cell constituents (eg. lipid) by
macrophages results in the subsequent release of
transforming growth factor-alpha and interleukin-1. These
cytokines stimulate angiogenesis, epidermal regrowth and
granulation tissue formation. Transforming growth
factor-beta, produced by activated macrophages, is itself
a macrophage and fibroblast chemoattractant (Rappolee and
Werb 1988) .
Johnson (1976), Postlethwaite (1976), Littman (1977) and
Wahl (1978) have all described numerous soluble factors
produced by lymphocytes (lymphokines) that can activate
macrophages.
Other factors with macrophage stimulating effects include
immune complexes and the complement cleavage products C3b
(Allison 1978), C5a (Grotendorst 1984) and C567 (Cederna
1988) .
Secretory Products
The macrophage, through its secreted products, can have a
profound influence on the behaviour of surrounding cells
(Korn 1980). Nathan in 1987, listed some 87 macrophage
secretory products which had known effects on T and B
lymphocytes, natural killer cells, macrophages,
neutrophils, fibroblasts, eosinophils, endothelial cells,
synoviocytes, chondrocytes, osteoblasts, osteoclasts,
adipocytes, skeletal myocytes and various other mesodermal
cell types present in a healing wound.
The macrophage can carry out a variety of specialized
responses to surrounding stimuli.
These include:
increased lysosomal activity (Morland 1977),
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increased secretion of proteinases (Wahl 1974),
the releasing of complement components (Littman 1977),
increased capacity to inhibit cell proliferation
(Baird 1977),
increased production of interferon (Machara 1977),
secretion of endogenous pyrogen (Bodel 1977),
formation of tissue thromboplastin (Allison 1978)
and increased prostaglandin synthesis (Humes 1977).
Indeed, Rappolee and Werb (1988) state that macrophages
have the potential to mediate the five temporal segment
responses to immunological challenge (inflammation,
killing, immunity, debridement and wound healing).
Activated macrophages can also secrete a factor that
stimulates fibroblast proliferation and fibroblast D.N.A.
synthesis at low levels and inhibits these functions at
high concentrations (Diegelmann 1979). Turck (1987)
described the effects on fibroblast function of 10
cytokines secreted by macrophages indicating perhaps the
influence this cell has on fibroplasia. The secretion of
collagenase by fibroblasts, for example, appears to be an
inducible de novo protein synthesis tightly controlled by
factors secreted by activated macrophages (Riches 1988).
Leibovich and Ross (1975) have shown that, without this
cell subseguent wound debridement and fibrosis is
retarded.
Lymphocytes
In addition to the highly specific (single cell type
target) factors produced by macrophages, fibroblasts are
also stimulated by less specific factors produced by
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T-lymphocytes (Schreiber 1985) present in the environment
of a healing wound.
Efron et al (1990) suggest from their studies using
monoclonal antibodies that a specific subset of
T-lymphocytes stimulates wound fibrosis in mice. It would
seem that T-lymphocytes are recruited into the healing
wound several days later than monocytes, possibly
attracted there by factors in the dermis remaining in or
around the wound after the initial injury (Cai et al
1990). Johnson and Ziff (1976) and Wahl et al (1978)
found that stimulated T-lymphocytes produce factors which
increase fibroblast proliferation and collagen production.
Fibroblast prostaglandin synthesis was also increased
which Wahl et at postulated served as a negative feedback
mechanism.
Although lacking an objective method of accurately
counting cell numbers Martin and Muir (1990), looked at
human wounds and found that T-lymphocytes were present in
scars up to three years old. This indicated that perhaps
the T-lymphocyte influences the late phase of normal and
abnormal scar remodelling perhaps more so than the
macrophage.
Wound Healing - Fibroplasia and Collagen Remodelling
Following the initial acute inflammatory response, the
original fibrin clot matures into granulation tissue
(Clark 1988).
This can be regarded as having two zones (Remensnyder
1982), a superficial zone of red inflammatory tissue and a
deeper zone of fibrotic tissue.
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The superficial zone is produced as a result of the
initial and continuing inflammatory response. Initially,
it consists of cells which have been shed into the area of
injury and this area becomes predominantly populated by
neutrophils. It has a high concentration of very permeable
vascular channels which allow fluid to leak into the wound
so providing a dessication barrier to the outside
environment.
As the granulating wound matures the deeper zone becomes
more defined. This fibrotic zone provides wound strength
and is associated with collagen metabolism and wound
contraction. Endothelial cells, macrophages and various
types of fibroblasts are the predominant cells present in
this compartment. Endothelial cells appear within 24-48
hours after wounding as vascular buds. Fibroblasts appear
4-5 days after wounding and appear to synthesize the
molecules of the extracellular matrix in the same order as
they do in embryonic development and tissue culture
(Nicoletis 1977). Glycosaminoglycans are manufactured
first, followed by collagen synthesis. It is interesting
to note that proteoglycans are intimately connected with
the tips of growing capillary buds, probably linking
migrating endothelial cells to the extracellular matrix
and helping to organize the capillary basal lamina
(Ausprunk 1981).
Collagen synthesis is concentrated in this zone with the
fibroblasts producing procollagen elements
intracellularly. These elements are secreted and aggregate
into fibrils of mature collagen in the extracellular
matrix. In the early stages of wound healing the embryonic
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type III collagen predominates but this is almost
completely replaced by type I collagen as the wound enters
the later phases of healing. (Remensnyder 1982)
The collagen continues to undergo remodeling as wound
healing progresses. Collagen degradation is carried out by
macrophages (Wahl 1974). Baur et al (1979) have described
"fibroclasts" and "myofibroclasts". These cell types were
found in human granulation tissue and scars. They were
identical to fibroblasts and/or myofibroblasts with
respect to size, shape, orientation and distribution but
they also contained collagen fibrils within cytoplasmic
vacuoles. This indicated that external collagen had been
phagocytosed as newly formed collagen in fibroblast
cytoplasmic vesicles is in the form of procollagen prior
to its exocytosis. Baur further postulated that these cell
types were responsible for collagen remodeling.
As the wound matures collagen metabolism continues and
this results in a strong supportive base providing
structural integrity to the wound.
The open wound is also contracting and when the deeper
zone is covered by the superficial zone (ie.the wound is
open) the stimulus to wound contraction exists. This
stimulus is reduced when the superficial zone is finally
covered with epithelium ie. the wound is said to be healed
(Remensnyder 1982) .
When the superficial zone is excised and the deeper zone
is covered with a skin graft this stimulus may still be
present but it is probably influenced by the type of skin
graft used. Covering a wound with a full thickness skin
graft reduces water loss from the wound (Lamke 1971) and
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may reduce its contraction by altering the numbers of
myofibroblasts within the wound (Rudolph 1979).
Epithelialisation
Epithelial repair begins shortly after clot formation when
an open wound is created. Migration of residual epithelium
over viable tissue and under formed scab takes place after
a lag period (Stenn and Depalma 1988). Epithelium covers
the wound by a process of active horizontal movement
rather than growth pressure from behind the advancing edge
(Pang et al 1978). The lowest cells of the stratum
spinosum are the first cells to begin migration. They
loose desmosomal and hemidesmosomal contacts, the basement
membrane zone loses definition and the cells become less
firmly attached (Stenn and Depalma 1988). Microfilament
bundles, staining with antiactin and antimyosin
antibodies, appear in the periphery of these cells. This
coincides with an increase in the proportion of the cell
surface occupied by gap junctions, suggesting a mechanism
of synchronized locomotion (Rungger-Brandle and Gabbiani
1983). The leading edge cells become actively phagocytotic
which may help cell migration which may be enhanced by the
presence of fibronectin (Takashima and Grinnell 1984).
Mitosis takes place approximately 1 mm behind the
advancing edge and appears to be diurnal in nature with
the greatest mitotic rates occurring during rest and sleep
(Baur, Parks and Larson 1977).
Behind the zone of mitosis the epithelium is undergoing
stratification as cell division increases the thickness of
this structure (Peacock and Van Winkle 1970).
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The cell sheets continue to advance until the microvillus
processes from opposing epithelial cells touch each other
and contact inhibition of movement occurs. This results in
the cells losing the phagocytic vacuoles and the actin and
myosin cytoplasmic microfilaments. The numbers of
desmosomes and hemidesmosomes increase, tonofilament
bundles reattach to the cell periphery and the basement
membrane reforms (Stenn and Depalma 1988).
Following the restoration of epithelial continuity,
mitosis commences at the junction of the two epithelial
sheets so thickening the newly formed epidermal layer
(Krawczyk 1971).
The rate of epithelialisation is enhanced if the wound is
allowed to heal in a moist environment (Winter 1972,
Alvarez 1983, Eaglstein 1988 ).
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1.2 Wound Contraction
Wound contraction has been defined as "diminution in size
of an open wound which is the result of the centripetal
movement of the whole thickness of the surrounding skin".
(Van Winkle 1967)
It has been known for some time that granulation tissue is
responsible for wound contraction (Pollock, Editorial,
Lancet 1870). Abercrombie (1956) reported that the
collagen fibres within the granulation tissue cannot
themselves contract so attention was turned to the
fibroblast (James D.W. 1969).
Fibroblasts
The Stimulation of Fibroblasts
The polymorphonuclear neutrophil was thought to play an
important role in wound repair with many authors noting
its presence in the early phases of wound healing (Page
1958, Ward 1970). Carrel (1924) assumed that these cells
produced "trephones" which regulated subseguent
fibroplasia. However, Ross and Benditt (1961) found that
fibroblasts appeared in wounds some 4 days after
neutrophils indicating that the latter cells did not have
an immediate effect on fibrosis. This theory was further
substantiated by studies from Simpson and Ross (1972)
which showed that wounds in neutropenic animals healed
normally. It would seem that neutrophils are necessary for
the removal of bacteria and foreign debris but are not
directly responsible for the regulation of fibroplasia and
wound repair.
Ross and Benditt also observed that macrophage
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infiltration always precedes fibroplasia. Animals made
monocytopenia by the administration of hydrocortisone and
anti-monocyte serum exhibited significant delays in the
appearance of fibroblasts and the deposition of collagen
in open wounds. Observations since then by several authors
suggest that mononuclear cells and macrophages play an
important role in the removal of tissue debris (Martin et
al 1988) and the regulation of collagen metabolism
(Viljanto and Raekallio 1976, Wahl 1978, Diegelman et al
1981, Hibbs 1983, Dohlman 1985). Turck (1987) reviewed the
regulation of fibroplasia and found that many polypeptides
stimulate the migration, proliferation and synthetic
functions of fibroblasts. These factors are different to
the macrophage and neutrophil chemoattractants
(Grotendorst 1984). It would seem that specific surface
receptors on the fibroblast bind the attractant molecules
which, in some way, stimulate the cell to move towards the
chemoattractant (Schiffmann 1979).
Princolo et al (1990) have found that as a wound matures
the fluid produced has a declining ability to stimulate
fibroblast proliferation. They found that after 10 days,
fluid from a rat wound reduced fibroblast proliferation
without altering collagen production. Stimulatory activity
of the wound fluid was found in the >300 kDa. molecular
weight fraction whereas the inhibitory activities of the
wound fluid were confined to the <10 kDa. molecular weight
band. In this study the possibility of a carrier
macromolecule artificially increasing the molecular
weights could not be excluded but these findings are
similar to other studies where factors were identified in
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wound fluid that influenced the behaviour of specific
cells (Roberts 1987).
Cytokines
Platelets are one of the first cell types to arrive at the
wound site. These cells contain a potent chemoattractant
for fibroblasts (Seppa 1982). Platelet derived growth
factor (PDGF) stimulates the migration of fibroblasts at
low concentrations and, at higher concentrations
stimulates fibroblast proliferation (Grotendorst 1984).
PDGF also has a synergistic effect with insulin-like
growth factor and epidermal growth factor which may be
important in the modulation of the wound healing process
(Lynch et al 1987).
Platelets also release transforming growth factor beta
(TGF-beta)(so called because of its ability to induce
phenotypic transformation in normal rat fibroblasts) which
is stored in the alpha granules in similar concentrations
to PDGF. It is released during platelet degranulation at
the time of injury in an inactive form. It is then
activated by enzyme activity or by the acidic environment
associated with acute inflammation (Ksander et al 1990).
The actions of TGF-beta are synergistic with PDGF and
Epidermal Growth Factor (EGF) - two cytokines also found
in platelets (Assoian 1988).
TGF-beta is also found in activated macrophages,
lymphocytes and fibroblasts (Pierce et al 1989).
Its actions include:
monocyte chemotaxis (Wahl S.M.et al 1987)
the stimulation of monocyte production of interleukin-1
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(Wahl S.M. et al 1987) ,
fibroblast chemotaxis (Ksander et al 1990)
the alteration of fibroblast phenotype (Roberts et al
1988)
the induction of fibrosis in the adult and fetal wound
(Krummel et al 1988),
increased collagen (Narayanan et al 1989, Pierce et al
1989), fibronectin (Roberts et al 1988) and
glycosaminoglycan (Hebda 1988) production,
the enhancement of connective tissue formation and open
wound strength (Ksander et al 1990)
accelerated tensile strength of incisional wounds (Brown
et al 1988)
the stimulation of protease inhibitors and the inhibition
of fibroblast protease production (Sporn et al 1987)
increased epidermal migration (Hebda 1988)
regulation of local vascular tone (Kurihara 1989).
the stimulation of collagen matrix contraction by
fibroblasts (Montesano and Orci 1988)
The above strongly suggest that TGF-beta has an important
role as an endogenous mediator of wound repair and
fibrosis (Assoian 1988, Ksander et al 1990).
In 1983 Postlethwaite and Kang found that polypeptides
between 10,000 and 60,000 daltons produced by human
monocytes enhanced the proliferation of cultured
fibroblasts as assessed by the uptake of H3thymidine.
Since then factors identified as originating from
monocytes which activate fibroblasts include interleukin 1
(IL-1)(Schmidt 1984), tumour necrosis factor (Vilcek 1986)
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and platelet derived growth factor-like factor (Martinet
1986). Macrophages also release factors with similar
activities to IL-1, tumour necrosis factor and fibroblast
growth factor. (Dohlman 1984, 1985)
Interactions between fibroblasts and mediators may be
selective, for example the CI component of complement is
mitogenic to a sub population of fibroblasts and
prostaglandin E2 and some products of activated
macrophages affect growth and collagen synthesis of only
some fibroblasts (Narayanan et al 1989). Russell et al
(1988) have shown that fibroblasts from keloid scars can
respond to lower growth factor concentrations than normal
fibroblasts indicating the variety of target cell
responses to these polypeptides.
It would seem that the concentrations (Narayana et al
1989) and interactions (Lynch et al 1987) of different
cytokines at differing stages of wound repair are likely
to determine the length and intensity of the various
phases of wound healing. This theory is supported by
Broadley et al (1989) who found that the reduction of
cytokine concentrations by a specific neutralizing
antibody can have a significant reduction on subsequent
wound healing indices.
McGrath (1990) aptly describes growth factors and their
receptor cells as individual symbols which have little
meaning by themselves. The meaning of each individual
cytokine can only be understood within the total context
of all the other signals operating on the cell. The
effective integration of the many different cell types and
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cytokines results in coordinated wound repair whereas the
loss of this integration results in activities not
dissimilar to carcinogenesis (McGrath 1990).
Summary
It is possible that fibroblast migration and proliferation
is stimulated by the many cells present in the initial
phases of wound healing. Platelets (Pierce et at 1989),
macrophages (Knighton 1989) and lymphocytes (Wahl 1978)
all release products that stimulate fibroblast numbers and
function until a certain cell density is reached (Tsubio
1990). At that point, proliferation is reduced possibly by
paracrine or autocrine mediators (Korn 1980, Sharma 1986,




Eosinophilic stellate cells in healing wounds had been
noted by pathologists for many years. Their size and shape
indicated that they were fibroblasts but they lacked the
cytoplasmic basophilia associated with collagen synthesis
(Anonymous, Lancet 1978). In 1971 Gabbiani noted that
these cells had contractile properties and histological
features similar to smooth muscle cells and fibroblasts
respectively, he therefore called them myofibroblasts.
Since then evidence has continued to accumulate indicating
that these cells are actively involved in wound
contraction.
Morphology
The electron microscopic appearance of myofibroblasts is
characteristic (Gabbiani 1971, Rudolph 1978, Ghadially
1982). They have some of the features of fibroblasts and
smooth muscle cells combined. Under the electron micro¬
scope fibroblasts are long, flat cells surrounded by
collagen.
Fibroblasts produce protein (collagen), therefore they
have a prominence of rough endoplasmic reticulum as well
as large numbers of mitochondria both within the cell body
and in the long peripheral processes.
Myofibroblasts have three additional features more in
keeping with smooth muscle cells (Montandon and Gabbiani
1973) .
1) Cytoplasmic Microfilaments
Cytoplasmic microfilaments are classified according to
their width (Ghadially 1982).
Thin filaments (4-7nm thick) contain actin,
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intermediate filaments (6-12nm thick) of which their are 5
types are generally thought to be cytoskeletal in nature,
and thick filaments (ll-16nm thick) contain myosin.
Filaments found in myofibroblasts are the same thickness
as filaments in smooth muscle cells. They are 4 to 8 nm
thick and are usually arranged in a manner parallel to the
longitudinal axis of the cell. They fill much of the cyto¬
plasmic space and have many electron-dense areas scattered
within the microfilament bundles or beneath the
plasmalemma (Rungger-Brandle 1983). This is similar to the
attachment sites in smooth muscle cells (Guber 1978).
These fibres contain the same proteins (actin, myosin,
alpha-actinin and tropomyosin) arranged in a pattern
similar to that seen in sarcomeres (Burridge 1981). They
are predominant in non-motile fibroblasts and
myofibroblasts (Rungger-Brandle 1983). Burridge (1981) has
observed that these microfilaments or stress fibres are
formed when a cell becomes adherent to the surrounding
structures. Large microfilament bundles form parallel to
the direction of cell contraction. Although some
shortening occurs, the contraction of the filaments is
mainly isometric in nature, since once the cell contracts
its shape remains unchanged for long periods of time. When
the adhesion to the surrounding substrate is released the
fibres and the cells relax (Burridge 1981).
Repeated work by Gabbiani and his co-workers (most recent
1990) has shown that the microfilaments within
myofibroblasts can be stained with the anti-actin
monoclonal antibody anti-alpha-sm-1, the stain used in one
section of this thesis.
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21 Nuclear Membrane Deformities
When smooth muscle cells contract their nuclei become
distorted. Fibroblasts have smooth, usually oval, nuclei
whereas myofibroblasts have nuclei with multiple deep in¬
dentations similar to the nuclei of contracting cells
(Majno et al 1971).
31 Surface Differentiations
Fibroblasts do not attach themselves to each other or the
surrounding stroma but myofibroblasts do (Guber 1978,
Doillon 1987). There are two types of surface
differentiations which allow this attachment (Gabbiani
1971):
a) macula adherens or desmosomes are dense plates on the
cell membrane, allowing intercellular connections
b) hemidesmosomes on the cell membrane enable the cell to
attach itself to the surrounding stroma.
Doillon et al (1987) postulate that there could be three
ways in which the myofibroblast could induce wound
contraction. Cell to cell adhesions, cell to extracellular
matrix adhesions possibly by an anchoring strand (Baur and
Parks 1983) or a combination of both would allow these
cells to become anchored to the wound substance. This
anchoring may trigger the isotonic and isometric
contraction (Burridge 1981) of the intracellular, actin
based microfilaments (Gabbiani 1990), inducing cell
contraction resulting in overall wound contraction.
Distribution
Healing Wounds
Myofibroblasts were first identified in the granulation
tissue of healing wounds (Majno et al 1971). As early as
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six days post wounding, fibroblasts with the electron
microscopic characteristics of myofibroblasts were
identified (Darby 1990) in rat open wounds. These
fibroblasts stained positive with anti-alpha-sm-1 antibody
indicating the presence of microfilaments containing actin
in their cytoplasm.
Other Sites
Myofibroblasts have also been reported in many different
pathological and physiological situations (Guber 1978).
Ghadially in 1982 reviewed the literature and found
evidence of the identification of myofibroblasts in the
palmar nodules of Dupuytren's contracture, intrinsic
fibrosis of muscle, ganglia, fibrous capsules around
breast prostheses, atherosclerotic lesions, cirrhotic
liver, injured human menisci, pseudointima of dacron
vascular prostheses, desmoid fibromatosis, plexiform
tumour of the uterus, nodular fasciitis, tendon sheath and
infantile digital fibromas, congenital generalized
fibromatosis, non-ossifying fibroma of bone, giant cell
granuloma of the jaw, malignant fibrous histiocytoma,
Hodgkins lymphoma, epitheliod sarcoma, and the stroma of
various carcinomata including breast carcinoma, follicular
carcinoma of the thyroid, colonic carcinoma and basal cell
carcinoma.
Myofibroblasts have also been identified in
non-pathological tissues. In the gut, they are thought to
regulate the vascular and stromal spaces in the villus
(Guldner 1972), in the lung they have been implicated in
the control of ventilation (Kapanci 1990). They have been
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identified in the seminiferous tubules of the human
testis, the testicular capsule of the rat, the theca
externa of ovarian follicles, the adrenal capsule, the
renal capsule of mammals, mesenteric lymph nodes and human
fetal spleen. Myofibroblasts have been shown to be
virtually the only cell present in Wharton's jelly in the
umbilical cord indicating that these cells have a dual
function of secretion and contraction in this particular
tissue (Ghadially 1982).
They have been found in areas where active contraction is
occurring eg. hypertrophic scars (Baur 1975, Eddy 1988),
fibromatic lesions (particularly the nodules in
Dupuytren's disease)(Vande Berg 1984, Shum and McFarlane
1988), liver cirrhosis (Rungger-Brandle 1983), tumours
(Schurch 1982), capsules around breast implants (Ryan
1974) as well as in normal wound healing.
Origin
The origin of these cells remains undecided. There is
evidence to support the theory that these cells are
modified fibroblasts, modified smooth muscle cells or a
modification of some other cell type such as a macrophage
(Reviewed by Ghadially 1982 and Skalli and Gabbiani 1988).
Modified Fibroblasts
In 1990, Darby, Skalli and Gabbiani used alpha-smooth
muscle actin, smooth muscle myosin and desmin markers to
label the cytoskeletal features of fibroblasts in healing
rat wounds. They noted that, as wound healing progressed
myofibroblasts expressed alpha-smooth muscle actin but not
desmin or myosin (two markers strongly expressed in
pericytes and/or smooth muscle cells). This lead them to
42
conclude that wound myofibroblasts were a partial smooth
muscle differentiation of local fibroblasts. This
confirmed other workers conclusions (Eddy et al 1988, Oda
et al 1988, Vande Berg 1984, Hirschel 1971, Rudolph 1979,
Ryan 1974, Madden 1974 ). The smooth muscle phenotypic
change may have been induced by the action of Transforming
Growth Factor beta-1 present in the wound environment
(Roberts et al 1988).
Also, electron microscopic studies by Ghadially (1982)
show that there are no myofibroblasts in normal human
meniscal cartilage. However, when this structure is torn,
myofibroblasts can be identified in the adjacent tissue.
It is likely that these cells are derived from the local
fibroblast population as the only other cell type present
is the chondrocyte.
Modified Smooth Muscle Cells
Myofibroblasts in atheromatous plagues contain the
alpha isoform of actin which occurs only in smooth muscle
cells7 and they contain desmin which does not occur in
wound fibroblasts (Darby and Gabbiani 1990). It is
therefore possible that these cells are derived from local
smooth muscle cells whose rough endoplasmic reticulum has
hypertrophied (Ghadially 1988). Indeed Ross (1968) noted
that such a change can be produced in an oestrogen
stimulated rat uterus.
Other Cell Type
Ryan et al (1973) found that intraperitoneal blood clots
in rats do not become attached to adjacent surfaces but
become covered by layers of myofibroblasts and mesothelial
cells. The likelihood of macrophages transforming into
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myofibroblasts was raised in this paper but this theory
has not been substantiated by other authors (Ghadially
1982) until recently when Gown (1990) presented evidence
that either of the above two cell types could have
modified their phenotypes and acquired smooth muscle cell
characteristics.
It therefore would seem reasonable to presume that cells
with the electron microscopic characteristics of
myofibroblasts can be derived from smooth muscle cells,
fibroblasts or a variety of other cell types (Ghadially
1982, Gown 1990 ). The cell of origin probably depends on
the predominant cell in the local cell population. In a
recent review Gown (1990) suggested that the smooth muscle
phenotype can be turned on in different environments.
Assoian and colleagues (1984) have shown that the
synergistic action of three cytokines from the
alpha-granules of platelets can induce smooth muscle
phenotypic transformation of fibroblasts. Darby et al
(1990) found that smooth muscle phenotype induction can
also be reversed, the timing of which, in the healing
wound coincides with the cessation of wound contraction.
Immunofluorescent Evidence
In 1965 Johnson found that patients with autoimmune
hepatitis produced an antibody to smooth muscle cells
(Guber 1978).
Hirschel et al, in 1971, used human anti-smooth muscle
serum to identify myofibroblasts in granulation tissue.
Serum from a patient with chronic biliary cirrhosis was
diluted 1:6 and applied to sections of various tissues.
Sheep antihuman IgG fluorescent serum was used as a
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counter staining reagent. Sections of rat stomach, caecum,
kidney, urethra, bladder, all reacted with the anti-smooth
muscle serum. The distribution coinciding with areas of
smooth muscle cells stained, in similar sections, with
haemotoxylin and eosin. This antibody also bound to the
contractile fibroblasts in healing granulation tissue,
normal fibroblasts were never stained. Human smooth muscle
autoantibody was then shown to be an anti-actin antibody
binding to the intracytoplasmic actin micro-filaments in
smooth muscle cytoplasm (Gabbiani 1973). In 1986, Skalli
and Gabbiani produced a monoclonal antibody against a
synthetic decapeptide having the same NH2 terminal end as
alpha-smooth muscle actin.
The use of a monoclonal antibody enables myofibroblasts to
be clearly identified (McGrath 1982) by light microscopy.
This means that larger biopsy specimens can be assayed so
increasing the likelihood of the sample giving an accurate
representation of the numbers of myofibroblasts in the
wound (Guber 1978). Also, the considerable amount of time
and experience needed to prepare the tissue for electron
microscopy and to identify and count the myofibroblasts
is not necessary when immunocytochemistry is used.
Activities
When strips of open wound granulation tissue
(microscopically shown to be rich in myofibroblasts) are
stimulated with substances that cause smooth muscle
contraction (angiotensin, vasopressin, norepinephrine,
bradykinin, epinephrine, and prostaglandin F-l-alpha)
contraction occurs. These agents have a similar effect on
avascular repair tissue which forms around intraperitoneal
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haematomas in the rat, indicating that the vascular smooth
muscle present in granulation tissue is not totally
responsible for wound contraction (Ghadially 1982). Agents
such as papaverine, and prostaglandins El and E2 (smooth
muscle relaxants) provoke granulation tissue relaxation.
Also, the distribution and numbers of myofibroblasts have
been shown by some authors to correlate with the rate of
open wound contraction (McGrath 1982, Baur 1978). This
indicates that myofibroblasts, if not directly responsible
for the contraction of granulation tissue in vitro and in
vivo, are at least strongly associated with it.
Darby and Gabbiani (1990) further noted that during the
phase of active wound contraction, alpha-smooth muscle
actin was always present in the microfilament bundles of
myofibroblasts.
When wound contraction diminished, the microfilament
bundles did not stain with anti-alpha-sm-1 monoclonal
antibody. This indicates that, as wound contraction slows
down, actin is removed from the contractile fibres
probably by the process of apoptosis (Darby 1990).
Rudolph (1979) has reported that similar cells are present
in skin grafted wounds in rats and that their life span
and numbers are influenced by the type of graft covering
the wound. The wounds covered with full thickness skin
grafts have fewer fibroblasts with a myofibroblast like
appearance than split skin grafted wounds. These cells,
also, are present for a longer period of time in wounds
covered with split skin grafts.
Although this study lacked a truly objective assessment of
myofibroblast numbers it did seem to show that
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myofibroblasts were more numerous during the phase when
the skin grafted wounds maximally contracted, a result
similar to that of Guber (1978), McGrath (1982), Baur
(1983) and Darby and Gabbiani (1990) who studied open
wound contraction in various mammals. It would seem that
during the phase of maximal wound contraction
myofibroblasts are at their most numerous and they can be
stained with anti-alpha-sm-1 monoclonal antibody.
Myofibroblast Numbers during Wound Contraction
If myofibroblasts are solely responsible for wound
contraction then their numbers should correlate with the
velocity of wound contraction. McGrath (1982) like
Gabbiani (1973), Rudolph (1979) and Van de Berg (1984)
believe that this is the case. Doillon et al (1987),
looking at actin filaments in normal dermis and during
various stages of healing of various different wound types
did not find a direct correlation between wound
contraction and the presence of actin staining
fibroblasts.
However, the wounds made in this study did not include the
panniculus carnosus, therefore this highly contractile
structure was left behind and may have influenced the
results. Other workers remove this structure as its
presence results in confusion identifying the source of
subseguent contraction. Doillon et al (1987) believed that
actin containing fibroblasts were related to zones of
trauma resulting from the skin grafting process used in
their study. They report a total failure rate of 30%
relating to the grafting process which perhaps indicates
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that they were not familiar with this technique. This
feeling is further substantiated when they report
histological features of necrosis in several layers of the
surviving skin grafts. This must cast doubt on their
findings.
McGrath, Gabbiani, Rudolph and Van de Berg believe that
animal open wound contraction begins after 4 days (when
myofibroblasts begin to be identified) whereas Baur (1984)
believes that wounds have already contracted by 25% by
this time. Baur (1984) has suggested that in the early
phase of wound contraction, the contraction force is
generated by the circumferential edge of the surrounding
skin. Specialized myoepithelial cells (Baur 1984) at the
wound edge are strongly stained by antibodies to actin
(Franke et al 1980) and are thought to be responsible for
the initial wound contraction before 4 days. Peacock and
Van Winkle (1970) and McGrath (1982) however, feel that
all wounds initially increase in size following wounding
and during the first 3-4 days the wound is in a
preexponential phase of wound contraction. It only begins
to contract after 4 days.
Most authors agree that after 4 days myofibroblasts can be
seen in increasing numbers as wound contraction proceeds.
In open wounds these numbers reach a maximum at 3-4 weeks.
This corresponds to the phase of maximal wound contraction
(McGrath 1982). When contraction stabilizes the
myofibroblast numbers fall (McGrath 1982). In humans it
has been demonstrated that myofibroblasts exist in
hypertrophic scars (Baur 1975). They adhere to the
surrounding structures by means of extracellular
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fibronectin microfilaments (Baur 1983) and it is possible
that these structures are disrupted when current splintage
regimens are used to reduce scarring (Baur 1978).
Summary - Wound Contraction
Wound contraction occurs during the phase of fibroplasia
(Clark 1988). Fibroblast migration and proliferation
during this phase is probably influenced by the
interaction between the many factors released from the
cells present in the wound (Assoian 1988, McGrath 1990).
It is probable these factors also influence the phenotypic
metamorphosis of fibroblasts to myofibroblasts (Clark
1988).
Myofibroblasts are difficult cells to identify even with
the help of monoclonal antibody reagents. They clump
together and are sometimes associated with blood vessels
(Baur et al 1978) making individual cell identification
difficult. However they are present in many situations
where active non-muscular contraction is taking place and
have been identified by various authors in healing,
contracting wounds. Recent studies (Darby et al 1990, Gown
1990) raise the possibility that actin is only present in
the microfilaments of myofibroblasts when wounds are
actively contracting.
Quantification therefore, of myofibroblast numbers with an
anti-actin monoclonal antibody may give a numeric




The care of open wounds is probable as old as man
himself. Skulls found by archaeologists have evidence of
bone healing associated with either trauma or trephining
indicating that the patient survived the procedure for
guite some time (Knight 1985). The mortality associated
with open wounds was probably very high but it may not
have been as common as we might expect.
Two factors reducing mortality (Knight 1985) from trauma
may have been;
1) the considerable infant mortality (two thirds of all
births) which probably left the fittest for adulthood,
2) the sparsity of the population meant that cross
infection with pathogenic organisms was less than today.
The aims of wound dressings in those days were probably
to arrest bleeding, to cover the wound, and to attempt to
splint any flail part. A multitude of agents was used to
achieve these objectives.
The first documented medical and surgical technigues used
for wound dressing dates from about 1500 B.C. as both the
Ebers and the Edwin Smith papyri contain references to
wound dressings. Up to the time of Christ the most
advanced surgeons were probably the Hindus with Susrata
being the most famous. Their favoured way of treatment
was the application of bandages and poultices to a wound
without further physically traumatising its surface.
In Europe, the Greeks dominated medical society even to
the extent of forming the majority of Rome's medical
fraternity. Hippocrates advised simple regimes in wound
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healing, teaching that the wound edges should be kept dry
and brought as closely together as possible to allow
healing "by primary intention" which meant at that time
without sepsis. Roman dressing procedures were based to
some extent in science as they used metal salts as
astringents and bound ulcers with figs which contain
papain, an enzyme which dissolves slough.
Galen wrote of "laudable pus" in late Roman times and it
would seem that these writings were misinterpreted
following the fall of the Roman empire. Billroth in 1866
mentioned "laudable pus" and regarded it as beneficial.
He noted that underneath it were healthy granulations
which were essential for the subsequent healing process.
Billroth felt these granulations were induced by the
presence of pus. He felt that without the pus the
granulation tissue would not appear so he assumed that
pus was necessary for a wound to heal normally. The
Church used its considerable influence to encourage this
practice and many surgeons tried to incite sepsis in a
wound believing that this was the natural way of healing
(Knight 1985). Therefore wounds were traumatised with
various mixtures, procedures and instruments to produce
pus. Interestingly, it is documented that soldiers
carried boxes of spiders webs with them into the Battle
of Crecy, this believed to be the treatment for bleeding.
Shakespeare also refers to the use of flax and egg white
as treatment for a bleeding face wound in Midsummer
night's dream and in King Lear. The scientific
discoveries made by Pasteur and Lister in the 19th
century changed peoples thoughts about wound healing.
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The Twentieth Century
The discoveries of Louis Pasteur paved the way towards
antiseptic surgery. This was further aided by Lister's
carbolic spray. With the coming of aseptic surgery,
dressings became sterile and the purpose of such
dressings was to remove infected, necrotic debris and
eliminate sepsis. Lumiere introduced "tulle gras", a
type of paraffin impregnated gauze designed to reduce
dressing adhesion, during the First World War and this
type of dressing is still used today.
The aims of wound dressings since then have been
primarily to remove infection and wound exudate,
believing both to be linked. All substances in the wound
environment were believed to be either detrimental or
potentially detrimental to wound healing. The
incorporation of antiseptics in the dressings emphasized
that the destruction of infection (sometimes at the
expense of the healing wound) was the prime concern.
Occlusive Dressings
For clarity the definition of an occlusive dressing is
taken as
"a synthetic membrane that permits moist wound healing"
Eaglstein 1987
In 1958 it was observed that a blister healed guicker if
it was left unbroken (Alvarez 1984). This finding
stimulated research into the use of plastic films
designed to mimic this natural situation. Winter (1962)
noted that by covering a wound with an occlusive membrane
and creating a moist wound environment there was almost a
50% increase in the speed of wound healing. Hinman et al
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(1963) found that occlusive dressings had a similar
effect on epidermal repair in incised wounds made on
human skin. The fear that these dressings, by creating a
pool of wound exudate, would increase the risk of
infection has meant that they were slow to be used
generally. Studies have shown that when these dressings
are used judiciously the infection rate is lower than
treatment with conventional dressings
(Mertz P.M. et al 1984, 1985).
Occlusive Dressings and Wound Contraction
Alvarez (1983) found that when occlusive dressings were
used to dress superficial wounds, epithelialisation and
underlying collagen synthesis were increased.
These findings indicated that a wound dressing can
influence the healing process in those parts of the wound
not in direct contact with the dressing.
Frank, in 1985, observed that an occlusive dressing
(Biobrane) had the same effect in reducing wound con¬
traction as a full thickness skin graft. This finding was
endorsed by Forseman (1986). Both authors stated that, in
order for this particular dressing to reduce contraction
it must adhere to the underlying wound. Biobrane adheres
to the wound in a manner similar to that of a skin graft
(Frank 1984). It is possible that the outer layer of the
dressing reduces water loss and the inner layer mimics
dermal collagen. If these two conditions are met then
early wound contraction (in rats) is reduced.
Winter (1972) showed that connective tissue regeneration
began 3 days earlier when a wound was synthetically
dressed. Linsky (1981) found that when synthetically
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dressed wounds were compared with air exposed wounds
there was a reduced number of inflammatory cells,
fibroblasts and a reduced breaking strength. Dyson (1988)
found that not only did synthetic dressings reduce the
numbers of neutrophils and macrophages in a wound they
also accelerated the inflammatory phase of wound healing.
This resulted in the wound entering the collagen
remodeling phase at an earlier stage.
Alvarez et al (1983) established that, when superficial
wounds were covered with an occlusive dressing, their
effect on wound healing was not influenced by the oxygen
concentration at the wound surface. However, some studies
(Silver 1972, Winter 1978) report increased wound oxygen
tensions when occlusive dressings were used so the role
of gaseous transfer by these dressings in wound healing
is yet to be fully evaluated.
Eaglstein et al (1988) noted that there was a critical
period in the wound healing process when the application
of an occlusive dressing would produce optimal benefits
in wound reepithelialisation. This period (between 2 and
24 hours after wounding) may be important in determining
the subsequent course the wound follows.
It is possible that;
a) the composition of the fluid that accumulates under an
occlusive dressing may be influenced by the dressing
if it is applied early enough (Eaglstein 1984, 1988)
b) this altered fluid further influences the healing
process in the wound.
Madden et al (1989) showed that when wound fluid taken
from under an occlusive dressing was applied to a
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keratinocyte culture there was an increase in cell
proliferation. This increase was most marked when exudate
from a burn wound was used. Other workers have noted an
increase in cultured fibroblast cell division and growth
when fluid from an occlusively dressed human full
thickness wound was added to the culture medium
(Alper 1985).
In summary it would seem that these dressings may reduce
the early acute inflammatory response (Linsky 1981),
accelerate the wound repair process (Dyson 1988) and may
do so by localizing beneficial cytokines to the area of
the wound (Brown 1986, Jonkman 1989,1990) so having a
profound influence on the wound's subseguent behaviour.
Other postulated reasons for the beneficial effects of
occlusive dressings include:
the fluid (Eaglstein 1987), or semi-fluid (Jonkman 1990)
environment created increasing cell migration (Madden
1989) and proliferation (Alper 1985),
the beneficial effect on the bacterial microenvironment
(Spira and Hall 1973, Buchan et al 1981, Holland et al
1984, Mertz 1984),
and the maintenance of the electrical potential between
the wounded and intact skin (Alvarez 1983).
Clinically, these dressings have been shown to be
beneficial to wound healing (Spira 1973, James J.H.1975,
Chvapil 1982, Ramirez 1984, Moserova 1987, Phillips 1989,
Yang 1989). In a long term human study Hien (1988) found
that full thickness wounds covered with an occlusive
dressing healed guicker and left scars that were
cosmetically superior to the conventionally dressed
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control wounds. However, microorganisms can multiply and
survive beneath occlusive dressings (Buchan 1981, Mertz
1984). Although one dressing (Opsite) has been shown to
activate complement C3 giving it some bacteriocidal as
well as leucocyte chemotactic properties (Holland et al
1984), care must be taken to choose the wounds which will
benefit most from occlusive dressings.
The initial belief that these dressings would be a
permanent substitute for skin has not been substantiated
(Spira and Hall 1973) but their effects when used in




A skin graft is a portion of epidermis and dermis which
has been completely severed from its original site and
transferred to some other part of the body. Subsequent
graft survival depends on the vascularity of the
recipient area.
Skin grafts can be classified as;
Autografts... a graft coming from another area of the
same individual
Allografts...a graft coming from genetically dissimilar
individuals of the same species
Xenograft.... a graft coming from a member of another
species
Skin grafts can also be classified by their physical
characteristics.
Full-thickness skin grafts
These grafts contain all the epidermis and all the
dermis. Full-thickness skin grafts, by definition, con¬
tain all the dermal structures which provide a source of
epithelial cells.
This means that;
a) the graft, once transferred, will not contract and
will exhibit the characteristics of normal skin (texture,
colour, and secretions)
b) the donor defect left when the graft is transferred
will heal by secondary intention unless otherwise
treated. This factor usually determines the size of the
graft (Grabb and Smith 1979).
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Split-skin grafts
These grafts contain all the epidermis and a varying por¬
tion of the dermis. Split-skin grafts leave a portion of
the dermis behind after transfer and it is from
structures within this remnant that epithelialisation
takes place, usually within 14 days. Further skin grafts
can then be harvested from this area.
Split skin grafts can be subdivided depending on the
proportion of dermis in the graft into thin, intermediate
and thick grafts. The thicker the graft the less the
underlying wound contracts but the resulting donor site
takes longer to re-epithelialise.
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History of Skin Grafts
In India, as early as 2500 B.C., Susrata treated defects
with the use of composite free fat and skin grafts
(Chick 1988). The skin of the buttock was marked ( around
a leaf cut to a pattern of the defect) and was then
slapped with a wooden paddle until it became quite
congested. The skin and underlying fat was then excised
and transplanted onto the defect, its edges sewn to the
freshened edges of the wound.
These techniques, carried out by the Brahmin Koomes
Caste, (who made tiles and bricks and considered the
repair of skin defects their province) were lost to time
(Chick 1988) .
In 1804 Guiseppe Baronio transplanted skin grafts in
sheep and in 1817 Leroux, in Paris, performed skin graft
transplantation according to the ancient Hindu
techniques. Brock (1952) described how Sir Astley Cooper
performed a human skin autograft in 1817. He cut a piece
of skin from an amputated thumb and applied it to the
amputation stump. In 1818 Bunger in Marburg (Germany)
performed a skin grafting operation in the presence of
three visiting doctors, one of which recorded details of
the operation and the subsequent clinical events (Deelman
1925, Rudolph 1973). Full thickness grafts were
successfully transplanted from the arm to the face by
American surgeons in the early 1840's but little notice
was taken of this breakthrough in Europe (Chick 1988).
Jacques-Louis Reverdin, an assistant in the Hospital
Necker in Paris, presented his technique of transplanting
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skin islands to aid the healing of ulcers in 1869
(Rudolph 1973). It was not until some time later that
Reverdin's technique became known to the medical
establishment outside France as Paris had become isolated
due to the Franco-Prussian War (1870-1871).
These techniques were taken up in London by Pollock with
great success (Editorial B.M.J.1870) before being
accepted in France because Le Fort and Blot had
publicized their fears that the secondary defects caused
by harvesting skin grafts may become portals for other
disease processes (Chick 1988).
Reverdin's grafts accelerated wound healing but only
partially reduced wound contraction. In 1872 Reverdin
published his last work on skin grafting and in it he
suggested that the technique could be used to improve the
management of large burns (which usually took at least
six months to heal) by speeding up epithelialisation and
reducing wound contraction. In an attempt to reduce wound
contraction even further, Oilier in 1871 used strips of
epidermis harvested with a sharp knife and laid together
to totally cover the wound. This method produced less
contraction and scar formation, resulting in a better
quality of skin. Thiersch in 1886 reported his method of
harvesting strips of epidermis with a little dermis and
applying these strips to a wound whose granulation tissue
had been shaved with a sharp razor. He suggested that
this method improved ultimate healing.
One year earlier Wolfe, an ophthalmologist in Glasgow,
wrote of the use of a full thickness skin graft in the
successful treatment of ectropion. His name became
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synonymous with this type of graft.
In the last two decades of the nineteenth century Von
Esmarch and Krause popularized the use of the full
thickness skin graft and showed that it could be used to
reconstruct a variety of defects.
It was not until the 1920's that the techniques and
equipment were introduced to allow the reliable and
accurate harvesting of split skin grafts. Finochietto
designed a knife which could control graft thickness and
10 years later Humby produced his knife, a modification
of which, is used in many plastic surgery units today.
Healing Processes in Skin Grafts
When a skin graft is harvested all connections between it
and the donor site are severed. It's survival depends on
the establishment of a stable attachment by an
elastin-fibrin bond (Burleson 1972) to the recipient area
which will then allow neo-vascularisation to occur.
During the first 24-48 hours the graft survives without a
circulation (Rudolph 1973). Fluid from vessels in the
underlying wound (Kikuchi 1970) moves in and out of the
vascular channels in the graft (Converse 1957), but
probably provides no nutritional role (Clemmesen 1962).
Clemmesen suggests that the graft is held to the
underlying wound by a fibrin meshwork. This mesh allows
fluid to pass to and from the graft in the first 24-48
hours. The fluid keeps the graft moist and prevents the
vascular channels in the graft from closing. Thereafter
the interstices of the mesh become lined with vascular
endothelium from the underlying wound which then links
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with the vascular channels in the graft (Rudolph 1973).
Haller and Billingham (1967) believed that the original
graft vessels were reused but evidence from Zarem (1967)
suggests the intrinsic graft vessels merely act as
non-living conduits. This work has been substantiated by
enzymatic studies carried out by Converse (1962) and
Wolff (1965).
As the wound matures the fibrin-collagen bond which
originally held the graft to the wound is degraded.
Fibrin degradation products, acting competitively with
thrombin, reduce the further deposition of fibrin so
acting as a negative feedback system. The collagen on the
dermal side of the graft now is intimately associated
with the newly forming fibrotic part of the wound. The
graft is now (after 6-10 days) firmly attached to the
wound. Clinically, it is deemed to be healed and has a
pink appearance indicative of the amount of patent blood
vessels in the graft. In humans the graft wound interface
continues to remain active for many months, this
manifests as graft, or wound contraction (Perkins 1987).
Studies in rats have shown massive turnover of collagen
in skin grafts with significant differences between full
thickness and split skin grafts (Klein 1974).
Contraction of Skin Grafts - Definition
Primary Contraction
When a skin graft is harvested it undergoes immediate
shrinkage (Davis and Kitlowski 1932). This is often
termed primary contraction (Grabb and Smith 1979) and is
probably due to the unopposed recoil of the dermal
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elastic fibres (Rudolph 1973). It can be reversed when
the initial tension on the graft is re-established.
Secondary Contraction
This is synonymous with the term "underlying wound con¬
traction" as it is the underlying wound that contracts,
not the skin graft. (Brown and McDowell 1958) The amount
and rate of contraction is influenced by the type of
graft covering the wound, full thickness skin grafts
reducing wound contraction more than split skin grafts of
similar thickness (Corps 1969).
Skin Grafts and Wound Contraction
Padgett in 1942 noted that thin split skin grafts "took"
very well but the underlying wound contracted by as much
as 60% especially over the flexor aspect of a joint. When
thicker skin grafts were used the resultant wound
contraction was much less (30%). The concept then, was
that the thicker the split skin graft the less the
underlying wound would contract. The Padgett dermatome
was developed to harvest as thick a split skin graft as
possible to reduce the subsequent recipient area con¬
traction and still leave a self healing donor site.
In 1969, Corps stated that there was a great variation of
contraction at various times during the healing process.
Studies by Ragnell (1952), Corps (1969) and Sawhney
(1971,1977) all showed that all skin grafted wounds
contracted in the first 3-4 weeks following application.
Wounds covered with full thickness skin grafts contracted
less than those covered with split skin grafts. After 4
weeks all wounds increased in size, the ones covered with
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a full thickness skin graft enlarging more than those
covered with a split skin graft. In Corps's study (1969)
full thickness skin grafts did not immediately stop wound
contraction. In the first 4 weeks wounds covered with a
full thickness skin graft contracted to 65-80% their
original size, split skin grafted wounds contracting to
25-45% their original size during the same time. The time
of maximal contraction in animal skin grafted wounds
coincides with the early phases of wound healing
characterized by inflammation and collagen deposition
(Pessa et al 1987).
The phase of collagen remodeling is the phase when the
contrast between wounds covered with different skin
grafts manifests most markedly. The full thickness skin
grafted wounds increasing to about twice the size of
those wounds covered with split skin grafts (Corps 1969).
This phase coincides with the phase of scar widening in
animals indicating that during this time the collagen
remodeling is associated with a reduction in the force of
wound contraction so allowing the wounds to increase in
size (Corps 1969).
Skin grafted burn wounds go through similar phases of
wound healing before a stable result occurs (Baur, Parks
and Larson 1977). The time taken for the wound to go
through the various phases of wound healing is however
longer in the human. The phase of scar formation is
associated with an inflamed appearance of the tissues and
may last from 3 to 6 months in a non-burn wound (Ketchum
1979) and from 3 months to 3 years in a burn wound
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(Larson et al 1974, Baur, Parks and Larson 1977).
The above studies indicate that the dermal component of a
skin graft has some function in influencing underlying
wound contraction, the thinner the skin graft the more
the underlying wound will contract (Blair and Brown
1929). How it does this is unclear.
1.5 Present Clinical Situation
Large, open wounds are routinely produced in surgery as a
result of trauma, tumour excision and most commonly fol¬
lowing a burn involving the full thickness of the skin.
Covering these wounds with a skin graft allows rapid
epithelialisation to take place which provides a barrier
to infection and reduces pain.
In the clinical situation a thin split skin graft will
revascularise more readily (Grabb and Smith 1979) and
leave a donor site that heals guicker than a thick split
skin graft. Thin split skin grafts also survive with
greater certainty in contaminated wounds than thicker
split skin grafts (Peacock and Van Winkle 1970).
The main objective in the early part of wound healing is
to achieve rapid epithelialisation and to concentrate on
the reduction of wound contraction at a later stage.
Unfortunately, the present regimes are not 100%
successful in reducing wound contraction (Perkins 1987)
and the resultant scarring can be cosmetically (Fig.l) or




This picture illustrates the cosmetic deformities
resulting from the contraction of wounds produced when
full thickness burns of the knees, legs and ankles are
excised and covered with split skin grafts.
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Fig. 2
The contraction of the split skin grafted wounds over the
dorsum of the fingers, thumb and wrist has resulted in a
fixed deformity of these areas which has considerably
reduced the functional capacity of the hand.
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Burns
Split skin grafting is commonly carried out in the
treatment of burns. The timing of the grafting procedure
is influenced by the systemic effect of the burn and the
likely systemic effects of sometimes guite extensive
surgery.
The following gives an indication of how skin grafting
fits into the general management of the thermally injured
patient.
By convention burn management can be broken down into
several phases.
Initial Care
The aim in this part of the treatment programme is to
stabilize the patient from the systemic effects of the
burn therefore reducing the risks of subseguent surgery.
Burn injured patients are usually assessed in
non-specialist hospitals. Those reguiring specialist care
due to the depth and extent of their burns are
transferred to a regional burns unit. On arrival at the
burns unit specialized investigations are carried out and
treatment is commenced.
The objectives are:
a) to assess the amount of fluid needed to replace that
lost as a result of the burn injury and
b) to prevent or detect and treat the associated
complications.
To this end various intravenous fluid regimens have been
devised (Settle 1986), all depend on an assessment of the
extent and depth of the burn. The amount given varies
with the type of fluid used but the aim is to replace the
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fluid lost from the intravascular space as a result of
the burn injury. This fluid resuscitation takes place
during the first 36-48 hours following injury.
Burn Dressings
A variety of burn dressings are used either with or
without systemic antibiotics in an attempt to reduce
wound infection and septicaemia (Jackson, Lowbery and
Topley 1951, Peacock and Van Winkle 1970).
Surgery
Once the patient finishes the resuscitation phase of
treatment, surgery to replace the burned skin is
considered. Such surgery takes place either at an early
stage, between 3 and 9 days post burn or at a late stage
after 14 days post burn.
The aim of surgery at this stage is to provide a viable
epithelial barrier to cover the burn wound. This reduces
fluid loss and the likelihood of septicaemia (Baur, Parks
and Larson 1977), as bacterial numbers in granulation
tissue are reduced following skin grafting (Eade 1958,
Zietkiewicz 1967).
Recent evidence (Jackson and Stone 1972, Lawrence and
Stone 1973, Burke et al 1974, Engrave et al 1983,
Scott-Conner 1990) suggests that skin grafting results in
rapid wound closure and minimizes tissue loss. This leads
to a reduction in the risks of septicaemia, reduced
morbidity, reduced nitrogen loss, a shorter hospital
stay, a reduction of wound contraction and subsequent
hypertrophic scarring in full thickness burn wounds.
Split skin autografts also promote the maturation of
collagen fibres in burn wounds (Takayanigi et al 1989),
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and, if grafting is carried out at an early stage,
mortality may be reduced (Hendon et al 1989).
The harvesting of split skin grafts has been made easier
with the introduction of powered dermatomes that can be
set to harvest grafts of specific thickness.
Different techniques of graft preparation including
meshing (Tanner, Vandeput and Olley 1964, MacMillan 1970)
and perforating help reduce the incidence of post
operative failures resulting from haematoma and seroma
formation.
Skin grafts can be stored and applied (within 21 days)
when the wound conditions permit so increasing graft
survival. (James and McGrouther 1985)
Wound Contraction
In burns surgery split skin autografts are used routinely
to cover the excised burned area. Although split skin
grafts do reduce wound contraction (Takayanigi et al
1989) the pathophysiology of a burn wound results in
excessive apparently disorganised collagen formation
which often manifests in the formation of hypertrophic
scars and contractures (Larson et al 1974).
Usually 2 to 3 months after the burn wound has healed it
becomes elevated and hard. It is characterized by a
marked increase in vascularity, fibroblasts,
myofibroblasts, interstitial material and oedema (Larson
et al 1979). This phase of healing can last from 3 months
to 3 years and if the associated wound contraction is not
treated scar and joint contractures result (Larson et al
1974) .
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Myofibroblasts are first noted in burn wounds 3-5 days
after trauma. They usually contain large amounts of rough
endoplasmic reticulum indicating that they are actively
engaged in protein synthesis (Baur, Parks and Larson
1977). As wound healing progresses myofibroblasts become
more numerous but their rough endoplasmic reticulum
content falls. Indeed, at the peak of the contraction
phase, almost all scar fibroblasts have a myofibroblast
appearance (Baur et al 1978).
The role of these cells at this stage is likely to be
contractile rather than secretory. Myofibroblast
contraction results in a bending of the collagen fibres
which may produce the microscopic sinusoids seen in
hypertrophic scars (Baur, Parks and Larson 1977).
Attention is focussed on reducing wound contraction
following surgery when the skin grafts are stable (Larson
et al 1974). Regimens are implemented incorporating
physiotherapy, pressure garment use (Harris and Pegg
1989), splintage (Cronin 1961, Willis 1970) and possibly
secondary surgery (Evans, Larson and Yates 1968, Dobbs
and Curreri 1972). These regimens often continue for many
months or years after the initial skin graft operation
(Larson et al 1974).
This is consuming in terms of time, for the patient and
the staff, and money in terms of lost patient earnings
and resources allocated to these regimens (Perkins 1987).
In the Regional Plastic Surgery Unit at St.Andrew's
Hospital, Billericay, Essex the annual budget for
Paramedical staff and resources allocated to treating the
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effects of wound contraction is £80-90,000. A similar sum
is spent in the Welsh Regional Burns and Plastic Surgery
Centre in Chepstow.
These regimens are considered to be successful if flat,
supple, stable scars are produced. When this is achieved
many scars are still cosmetically unattractive and
functionally disabling (Baur, Parks and Larson 1977).
Chapter Summary
Wound contraction has beneficial effects but it often
leads to disappointing results following skin grafting
surgery for burn injuries.
Many post operative regimens exist to attempt to reduce
this phenomenon but this late wound manipulation often
produces poor cosmetic and functional results. A regime
involving early wound manipulation therefore may have
better results.
Wound Contraction
The definition of wound contraction by Van Winkle (1967)
as "the diminution in size of an open wound which is the
result of the centripetal movement of the whole thickness
of the surrounding skin" indicates that it has been
assumed that wound contraction occurs only in open, full
thickness wounds. Literature concerned with wound
contraction commonly refers to open wounds with attention
being given to the role of granulation tissue in this
process (Skalli and Gabbiani 1988). However contraction
can occur in wounds devoid of granulation tissue such as
skin grafted wounds (eg.Corps 1969) and incisional wounds
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(Peacock and Van Winkle 1970, Ketchum 1979) indicating
that this phenomenon may be an integral part of the
normal healing process of all wounds (Frank 1985).
Factors affecting the complicated process of wound
contraction are probably present from the very initiation
of the wound healing process (Tsuboi 1990). The initial
cellular influx releases factors which stimulate the
migration, proliferation and the likely phenotypic
transformation of fibroblasts (Clark 1988). Collagen
formation and wound contraction are probably so
fundamentally linked that it is not unusual therefore to
find that wounds contract maximally during the
fibroplastic phase of wound healing (Clark 1988). The
time this phase occupies varies with the type of wound
and the animal species studied. It lasts approximately
3-4 weeks in the rat and up to at least 6 months in
humans (Grabb 1979). Its cessation coincides with the
commencement of the final phase of wound healing where
collagen metabolism stabilizes and the wound (or scar)
enlarges (Corps 1969).
Factors affecting Wound Contraction
An argument could be proposed stating that factors
influencing wound contraction are:
a) released as a result the creation of the wound and
b) influenced by the environment of the newly formed
wound.
Factors such as wound depth and subsequent dessication
may be influential in establishing this environment.
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Wound Depth
The anatomy of the cutaneous tissue remaining following
wounding may influence the subsequent physiological
responses to the wound environment.
Epidermal Loss
Epidermal stripping experiments indicate that epidermal
loss is replaced by regeneration of cells mainly from the
basal layer adjacent to the dermal-epidermal junction.
Healing by contraction is not reported to take place
(Peacock and Van Winkle 1970)
Dermal Loss
When the superficial layers of the dermis are removed,
for example in the harvesting of a split skin graft, the
resultant wound heals mainly by re-epithelialisation from
the remnants of the dermal adnexal glands. It would seem
logical to assume that the role wound contraction plays
in wound healing becomes more apparent as more of the
dermis is removed.
When the number of epidermal remnants (eg. sweat glands
and hair follicles) falls below a certain figure wound
healing mainly by re-epithelialisation is no longer
possible and healing by wound contraction occurs. The
above occurs when burns penetrate to the deeper aspect of
the dermis.
When no dermal epithelial remnants exist ie a full
thickness defect, wound contraction is maximal.
Therefore, it would seem that wound contraction is
inversely related to the amount of dermis left in the
wound. The greater the percentage of intact dermis left
the less the wound will contract.
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Tissue Replacement
When the tissue lost during the creation of a full
thickness defect is replaced, subsequent wound
contraction is reduced. This reduction is again related
to the amount of dermis present in the replacement tissue
(skin graft). Grafts containing only the epidermal aspect
of the skin (Padgett 1942) do not affect wound
contraction. When thin split skin grafts (with a small
amount of dermis) are used, wound contraction is
minimally reduced. The thicker the split skin graft used,
the more it reduces underlying wound contraction.
Full thickness skin grafts (with the full complement of
dermis in situ) are the most effective grafts in reducing
wound contraction. Wounds covered with full thickness
skin grafts however, still contract and in rats this can
be up to 40% during the first 4 weeks after wounding
(Corps 1969). The full thickness skin grafted wounds then
enlarge during the remodeling phase of wound healing.
Wound contraction therefore still persists even when all
the elements of the dermis removed during wounding are
replaced. When all the elements of the skin (epidermis,
dermis and subcutaneous fat) are surgically replaced and
accurately approximated (the situation in an incisional
wound) (Gillman, Penn et al 1952, Grabb and Smith 1979),
wound contraction still manifests.
Three to four weeks after wounding, a normally healing
human scar is hyperaemic and ridged (the major clinical
sign of active scar formation - Baur et al 1977) and has
approximately 30-40% the strength of normal skin (Ketchum
1979). The linear scar will then undergo contraction
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(Peacock and Van Winkle 1970) and over the following 3-4
months the hyperaemia will fade and the scar will widen
as the collagen remodels. Although the contraction of
incisional wounds has not been accurately quantified it
is known from clinical practice that it manifests during
the first 6 months following surgery - the time span of
the fibroplasia phase (Ketchum 1979).
If all the elements of the skin are replaced the stimulus
to contraction still exists and continues to manifest
until the end of the fibroplastic phase of healing. To
reduce this contraction even further, measures which
influence wound healing at a more fundemental level may
be required.
Burns
If a burn destroys the dermis which includes the sweat
glands and hair follicles spontaneous reepithelialisation
is no longer possible (Jackson and Stone 1972). The main
aim of burn treatment is initially to preserve life and
then to reduce the loss of function associated with post
treatment scarring. The problem of infection in the burn
wound requiring skin grafts is reduced either by removing
the necrotic tissue surgically (Jackson and Stone 1972),
or conservatively, with regular dressing changes (Wallace
1952, Lynch 1979). Split skin grafts are then applied to
speed up epethelialisation and reduce scarring
(Takayanigi, Hatano and Aoyama 1989). They also reduce
the bacterial count of the contaminated wounds (Eade
1958, Allen et al 1973) so reducing the risk of systemic
sepsis (Takayanigi, Hatano and Aoyama 1989).
Thin split skin grafts are used for 2 reasons.
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Firstly their donor sites heal quickly so reducing that
portal to infection and allowing further harvesting to be
carried out (Peacock and Van Winkle 1970).
Secondly thin split skin grafts are associated with a
higher percentage of complete take in the presence of
excessive exudation or moderate infection (Allen et al
1973).
"Nearly every severe burn wound results in the formation
of a scar" -Baur, Parks and Larson (1977), so once
complete epithelialisation has occurred and the skin
grafts are stable, attention is turned to the reduction
of the contractures induced by the contraction of the
skin grafted wounds (Peacock and Van Winkle 1970).
This wound contraction occurs in the phase following
successful skin grafting and may last up to 3 years
(Larson et al 1974). The skin grafted wounds have an
inflamed appearance and a tremendous amount of collagen
is deposited in the form of mats laid down in
omidirectional arrays (Baur, Parks and Larson 1977).
It would seem therefore that the burn wound remains in
the inflammatory phase of wound healing for an excessive
length of time. This is probably because damaged, viable
tissue is (purposely) left when burns are surgically
excised (Jackson and Stone 1972) or the deeper aspect of
granulation tissue is skin grafted when burns are managed
conservatively (Grabb and Smith 1979).
These tissues may continue to stimulate the inflammatory
response and one manifestation of this is the excessive
wound contraction and scarring associated with these
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injuries.
Wounds covered with thin split skin grafts contract more
than those covered with thick split skin grafts or full
thickness skin grafts (Padgett 1942, Corps 1969). They do
so by contracting to a greater degree during the
fibroplastic phase of healing and subsequently expanding
to a lesser extent during the collagen remodeling phase
(Corps 1969 ) .
The conventional methods or reducing such scarring is the
application of splints, pressure garments, the use of
physiotherapy and occupational therapy with the prospect
of secondary surgery if these regimens are not
successful. Even if these regimens are successful the
cosmetic results are often less than satisfactory (Baur,
Parks and Larson 1977).
Could the early manipulation of the wound environment
reduce this contraction?
Wound Dressings
The main principles of wound dressings until the late
1950's were solely concerned with the eradication of
infection (Wallace 1952). Winter (1962) noted that when a
wound was allowed to heal in a moist environment wound
healing was increased. Dyson (1988) found that this
effect manifested even in full thickness wounds. She
noted that the wounds spent less time in the inflammatory
phase of wound healing when they were covered with an
occlusive dressing (Opsite - Smith and Nephew U.K.Ltd.).
If an occlusive dressing reduced the time and intensity
of the inflammatory phase of wound healing could it
reduce wound contraction? Initial reports (Frank
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1984,1985, Foresman 1986) suggest that the application of
synthetic occlusive dressings can reduce initial wound
contraction when used to cover open wounds in animals. A
subjective review of burns treated with synthetic
dressings indicated that these dressings could reduce
hypertrophic scarring associated with deep dermal
injuries (Grisolia et al 1991).
The exact manner in which they do so remains unknown
although several theories have been proposed (see earlier
section).
The occlusive dressing used in the above studies
(Biobrane) consisted of an ultrathin semipermeable
membrane bonded to a nylon fabric. This is coated with
polypeptides from porcine dermal collagen. It adheres to
a wound in a manner similar to that of a split skin graft
(Frank 1984). This adherence is temporary in nature
lasting for only a few weeks.
The two fractions of Biobrane could be mimicked by more
permanent substitutes. The porcine dermal collagen could
be replaced with a split skin graft. This would provide a
source of collagen which was covered with a viable host
epithelial layer which would be permanent in nature. The
occlusive properties of the nylon/silicone outer bilayer
of Biobrane could be copied with another synthetic
dressing which would adhere to the surface of the skin
graft (Opsite). If this newly created "permanent
dressing" has an effect similar to Biobrane on wound
contraction then it may reduce the contraction of wounds
covered with split skin grafts to that of those covered
with full thickness skin grafts.
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CHAPTER TWO
A Study of the Effect of an Occlusive Dressing




This study was set up to see if synthetic dressings
altered human open wound contraction in the same way as
they altered wound contraction in rats.
Materials and Methods
Split skin graft donor sites are made in a repeatable
controlled procedure, can be treated in a similar manner,
and healing is independent of the primary defect for which
the skin graft is being used.
The dressing used in this study (Transigen, Smith and
Nephew Ltd.) is a synthetic wound dressing designed to al¬
low excess moisture to evaporate in a controlled manner
ensuring the wound is always kept moist.
Fifty five donor sites on fifty five patients were stud¬
ied. All donor sites were on the thigh as large donor
sites (at least 10x5 cm )were used to minimize experimen¬
tal error. Patients with more than one donor site per
thigh were excluded so that all wounds studied were sur¬
rounded by normal skin.
Donor site size was assessed in theatre by compressing a
sterile paper towel to the area after allowing capillary
bleeding to take place. The mark made was carefully cut
out and re-applied to ensure accuracy. An acetate sheet
tracing was later taken and the initial towel discarded.
The dressing regimen was then chosen by a randomizing
technigue allocating the donor site to be dressed conven¬
tionally or with Transigen.
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Conventional dressing consisted of covering the wound with
paraffin impregnated gauze then dressing swabs covered by
cotton wool held in place with a crepe bandage.
Transigen dressing regimen consisted of drying the sur¬
rounding skin with a gauze swab and then applying the
dressing and loosely covering this with a crepe bandage.
Both dressings were left undisturbed for two weeks. The
dressings were taken down in either the outpatient or ward
environment. Tracings were taken of the epithelialised
areas on acetate sheets and the surface areas calculated
and compared.




Infection occurred in two donor sites covered with
Transigen and three conventionally dressed donor sites.
These were excluded from the study and responded to local
dressings treatment.


















C = Conventional Dressing
T = Transigen Dressing
The mean time from graft harvesting to dressing removal
was 15.3 days (standard error of the mean 1.9 days )in the
conventionally dressed group and 17 days (standard error
of the mean 1.5 days) in the Transigen group.
Mean wound contraction was 20% in the conventionally





PERCENTAGE TOTAL SURFACE AREA
DAYS
1= 95% Confidence Limits
An unpaired "t" test comparing the differences in




It is accepted that split skin graft donor sites are not
full thickness wounds but this study showed that these
wounds do, in fact, contract in the short term and this
contraction can be altered by the wound dressing.
In order to minimize patient discomfort the trial was
designed, with a professional statisticians advice, so
that skin graft thickness would not be measured and the
underlying dermis would not be biopsied. All wounds
studied would be from the same anatomical area (thigh) and
would be randomly allocated to each dressing group
(unknown to the same surgeon harvesting all the grafts).
This, coupled with the fact that there would be 25 donor
sites in each group meant that both groups could be
considered statistically comparable. Maximum wound
contraction occurs in rats at 2-4 weeks. This coincided
with the clinical practice of removing donor site dress¬
ings so measurements were taken at that time.
It would seem that partial thickness wounds, in humans, do
contract. This contraction can be measured as early as
14-17 days after wounding and can be influenced in humans
as it is in rats if the wound is dressed with a synthetic
dressing.
Summary
Since humans respond in a similar manner to rats when open
wounds are synthetically dressed then the results of a
study in rats on the effect a synthetic dressing has on
the contraction of wounds covered with split skin grafts
may be extrapolated into the human population with more
confidence.
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A Study of the Effect of Covering a Split Skin Graft







3.4 Skin Graft Harvesting
3.5 Moisture Vapour Transmission




This work would be carried out in the rat as this animal
has been used as a successful wound healing model by other
workers investigating wound contraction (reviewed by
Richey K.J. et al 1989).
General advantages of using the rat are:
a) many animals can be studied simultaneously at a low
cost
b) the size of the animal means experiments could be
carried out with one operator
c) individual housing of all the animals in a single room
allows accurate standardization of each animals
environmental temperature and humidity levels during
the study.
d) Though the histology and morphology of rat skin is
very different from that of human skin, rat wounds
share the ability to contract, albeit in a more intense
manner during normal healing. This exaggerated
response is advantageous since this work proposes to
study wound contraction rather than other aspects of
wound healing (Frank 1985).
Particular advantages of the rat model are:
a) the effect of synthetic dressings on open wound
contraction (Frank 1984, 1985, Foresman 1986),
b) the contraction of skin grafted wounds (Corps 1969) and
c) myofibroblast cell populations in healing wounds with
(Rudolph 1979) and without (Gabbiani 1972) skin grafts
have been studied in this animal.




The main aim of these experiments was to gather data which
could be statistically analysed which would show the
effect, if any, a synthetic dressing had on several
factors of wound healing. All three experiments (Moisture
Vapour Transmission, Surface Area Estimation and
Myofibroblast Cell Population) would be carried out by one
investigator on one population of rats. The aim was to
compare the dressing's effect on all of the above
parameters so a model was created which would allow
in-animal control wounds to be studied. With a
statistician's help a protocol was designed to allow the
rapid repeatable formation of two wounds on a non-flexor
aspect and two wounds on a flexor aspect of a rat. These
wounds would be covered with a split skin graft fashioned
from the tissue excised in the creation of the original
wounds.
Animals would be grouped to allow:
A) the controlled application and removal of dressings at
predetermined intervals,
B) measurements of moisture vapour transmission from and
surface areas of the skin grafts at regular intervals
throughout the study,
C) whole wound biopsies to be carried out. This would
allow myofibroblast cell estimation to be undertaken
without influencing the surface area experimental data.
Using 4 wounds per animal a total of 200 rats grouped into
25 groups of 8 would be studied. This would be the minimum
number of animals which would allow the collection of data
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that could be evaluated using paired statistical analysis,
allowing for a 25% animal interference rate.
3.2 General Layout
The animal experiments were carried out in the Research
Division of SMITH AND NEPHEW U.K. Ltd. This establishment
has been designated by the Home Office as an approved
place to carry out animal work.
I was allocated three rooms in this modern animal house.
The temperature, humidity and light in these rooms could
be individually controlled (see Appendix 1) thus stand¬
ardising several important aspects of the study.
One room was used as an operating theatre so this room was
used when the initial wounding and grafting procedure was
carried out. It was also used when dressings were changed
and measurements and biopsies were taken. The second room
was used as a recovery area. This room was eguipped with a
separate heat source which was used to keep the animal's
temperature stable. This post operative support resulted
in a very low operative and post operative mortality rate.
The largest of the three rooms was used as the
residential area. In this room all the rats were indi¬
vidually caged after the initial operation until the end
of the study.
Pre-operatively rat weights were checked on a weekly basis
and they were only entered into the study when rat weight
approached 350 grammes. Immediately post skin grafting, as
intra-muscular and intra-peritoneal drugs were used, the
rats were checked on a half hourly basis usually for about
three hours or until they had fully recovered from the
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anaesthetic. Thereafter, the rats were checked three times
a day to make sure the dressings were intact and weighed
on a weekly basis (see Appendix 3.)
Following subsequent dressing changes and measurements
(done under gaseous anaesthesia with a recovery time in
seconds in this animal) the rat was monitored in the
operating room and then returned to the residential room
where routine checks were made.
3.3 Animal Model
Previous authors had used genetically similar rats with
some rats being used as donor animals, taking no further
part in the study (Millington 1968, Rudolph 1971,
Smahel 1986). We decided to use a population of ge¬
netically dissimilar rats, all of which would take part in
the experiments. The results of which, could be more
plausibly extrapolated to the (genetically dissimilar) hu¬
man population.
This meant that an animal model had to be designed which
would allow,
a) the formation of bilateral wounds on a flexor
(hip crease) and non-flexor (flank) surface and
b) the harvesting of split-skin grafts from the skin
excised in the creation of these wounds. The benefit of
this would be to reduce the overall assault on the animal.
The project licence issued under the home office
regulations [ANIMALS(Scientific Procedures) Act 1986
Chapter 14 Section 5] permitted up to 5% of the animal's
surface area to be used for this purpose. The animal model
was therefore designed to allow a 2x2 cm. wound to be ex-
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cised on the flank and hip flexor area of both sides of
the rat.
Skin Graft Harvesting
The skin from the excised tissue would be used to harvest
a split-skin graft which would be used to cover the newly
fashioned open wound. This technique, specifically
designed for this thesis, would utilize between 3 and 4
percent of the rat's surface area, depending on the weight
of the individual animal. Skin graft thickness was
measured to ensure similarly thick skin grafts were
studied. (Appendix 2)
The skin grafts on one side of the rat would be covered
with a synthetic dressing and the skin grafts on the other
side would act as an in animal control.
Wound Biopsies
Studies have been published where surface area estimations
have been carried out on skin grafts which have been
regularity biopsied. It was felt that even the smallest
biopsies would leave open wounds which would heal by
secondary intention. This would affect the surface area of
the skin graft so the study was designed to allow whole
wound biopsies to be taken. This meant that whole groups
of rats were sacrificed at regular intervals throughout
the study to provide biopsy data which could be analysed
statistically, still leaving enough animals in the study
to allow the other observations to be carried out through¬
out the 15 week period.
Animal Groups
Individual groups of eight rats per group were studied as
this allowed for a 25% failure rate (not uncommon in
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studies with these animals) and would still produce
statistically valid data.
Split-skin grafts were covered with a synthetic dressing
for periods of time up to 5 weeks. This time period was
chosen as Rudolph (1979) had noted that myofibroblasts
were not identified in open wounds covered with split-skin
grafts in any significant numbers 35 days after grafting.
If synthetic dressings were to have an effect on myofibro¬
blast numbers then it would seem logical that this effect
would take place in the first five weeks. The study was
therefore designed to collect data over fifteen weeks,
with the majority of measurements being made in the first
5 weeks.
The groups were identified by a letter and a number.
Group Identification Letter
The letter corresponded to the length of time the split
skin graft was covered with the synthetic dressing, thus








The number corresponded to the time (in weeks) following
grafting, when the animal was sacrificed.
The following table shows that the study plan allows skin
grafts on the flank and hip flexor crease to be covered
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with a synthetic dressing and compared with in animal
controls for specific periods of time up to fifteen weeks
following operation. During this time regular detailed ob¬
servations would be made of moisture vapour transmission,
surface area and myofibroblast cell populations to see if
these parameters are affected when the split skin graft is
dressed synthetically and to see if the length of time the
split skin graft is covered with the dressing influences
surface area or myofibroblast measurements.
The table below illustrates how the title of the
individual sub groups indicates how long the wound was
covered with Opsite and when the biopsy was taken.
Main Groups
A B C D E
A1
A2 B2
Sub A3 B3 C3
Groups A4 B4 C4 D4
A5 B5 C5 D5 E5
A10 BIO CIO D10 E10
A15 B15 C15 D15 E15
For example:
Group A (Dressing covering the skin graft for one week)
A1 - Grafts measured and biopsied after 1 week.
A2 - Grafts measured and biopsied after 2 weeks.
A3 - Grafts measured and biopsied after 3 weeks.
A4 - Grafts measured and biopsied after 4 weeks.
A5 - Grafts measured and biopsied after 5 weeks.
A10 - Grafts measured and biopsied after 10 weeks.
A15 - Grafts measured and biopsied after 15 weeks.
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Groups B,C,D, and E were similarly sub-divided.
Whole sub-groups would be sacrificed when wounds were
biopsied. This would eliminate the situation where
biopsies and surface area measurements were regularly
carried out on the same skin graft.
3.4 Skin Graft Harvesting
The presence of a panniculus carnosus in the rat allows
considerable skin mobility which makes split skin graft
harvesting difficult. The use of an electric or battery
powered dermatome allows repeatable precise harvesting but
this must be used with an anchoring device (Rudolph 1971).
Techniques reported have suggested the use of a clamp but
they require either an assistant or the use of genetically
identical donor rats or both (Gustavson 1971, Hansen 1956,
Millington 1968, Smahel 1986, Woodruff 1955).
A new method was therefore devised which:
a) required no assistant
b) used the skin to be excised for the formation of the
open wound as donor skin thus eliminating the need for
donor animals or separate wounds on the same rat
c) required only one custom made metal sheet which took a
few seconds to position to allow easier graft
harvesting
d) allowed rapid graft harvesting, on average the
harvesting and application of 4 split skin grafts on




The rat was anaesthetized with intra-muscular Hypnorm
(fentanyl/fluanisone) 0.3mg/kg. and intra-peritoneal
diazepam l.Omg/kg. The skin from behind the front legs to
the tail was shaved with powered vetinary hair clippers
and depillated with depilatory gel (Smith and Nephew
Research Ltd.).
The areas on both flanks and hip flexor creases were
marked by tracing around a 2x2 cm. sguare of perspex
placed over these areas. Two incisions were made through
the skin on opposite sides of the sguare, through the
panniculus carnosus.
The plane under the panniculus carnosus was dissected with
scissors and the flat steel plate was inserted.
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If the metal block was 1 cm. larger all round (3cm.x 3cm.)
than the wound area (2cm.x 2cm.) the tension applied al¬
lowed rapid, precise graft harvesting. If necessary the
incisions were minimally lengthened to allow easier plate
insertion.
If the skin immediately caudal and cranial to the metal
plate was grasped between the index finger and the thumb
of the non-dominant hand, sufficient tension could be ap¬
plied to flatten the skin against the metal plate by ap¬
proximating these two digits. This tension usually re¬
sulted in the two uncut, marked edges of the sguare moving
to thts edge of the plate.
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The skin was then lubricated with a little mineral oil and
the graft was harvested with an electric dermatome.
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Once the predetermined amount of skin had been harvested
(to the previously marked fourth side of the square ), the
dermatome was stopped and withdrawn. This manoeuvre
allowed the skin to reverse over the cutting edge of the
dermatome so reducing the risk of the cutter damaging the
newly harvested graft. When the skin was removed from the
dermatome the attached edge was cut with scissors, freeing
the graft.
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The underlying tissue was excised to the metal plate and
this was removed revealing an open wound ready for skin
grafting.
The skin graft thickness was measured with an electric
microtome (Model Mitutoyo Digimatic Indicator) and sample
biopsies were taken for histological evaluation to confirm
graft thickness and the similarity of both sides
(Appendix 2).
The increase in size produced by stretching the skin was
lost when the skin underwent primary, physiological con¬
traction immediately after harvesting, returning to its
original size. (Grabb and Smith 1968)
The split skin grafts were sutured in situ with one 4/0
black silk suture (Ethicon U.K.) at each corner and three
6/0 nylon sutures (Ethicon U.K.) on each side of the
square
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The protocol was then checked and the grafts on one side
of the rat were covered with the synthetic dressing
(Opsite Smith and Nephew U.K.) cut exactly to size.
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The relevant measurements were taken at this stage and the
grafts on both sides of the animal were then dressed iden¬
tically. Using the tie-over technique a small ball of
cotton wool was held over the graft with the long ends of
the corner silk sutures.(Brown and McDowell 1958)
The rat was then covered with a protective vest and a
thoracic "waistcoat" applied to prevent the animal inter¬
fering with the dressings.
The rat was then taken to a recovery area and given an in¬
jection of 10 mis of 0.9% sterile saline solution into the
dorsal aspect of the neck to compensate for any
per-operative fluid loss.
When the rat had sufficiently recovered, it was taken to
the main housing room and placed in an individual cage.
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3.5 Moisture Vapour Transmission
Water loss or moisture vapour transmission from a wound is
the factor most obviously influenced by a synthetic
dressing. In open wounds water loss is in the region of 60
grammes of water per meter squared per hour (Foresman
1986). The application of a synthetic dressing markedly
reduces the water loss and thus increases the humidity in
the wound healing environment (Foresman 1986).
An evaluation of the water loss from a wound covered with
a split skin graft dressed with a synthetic dressing com¬
pared with a similar wound without the synthetic dressing
would be of interest.
The moisture vapour transmission rate (M.V.T.) from the
surface of the control skin graft could also be compared
with the M.V.T. rate from the surface of the skin graft
covered with Opsite before and after its removal. When the
dressing was removed the M.V.T. would be measured for 30
minutes post removal. This period was deemed the longest
safe period to ensure animal survival. This would give an
idea of the degree of humidity of the wound healing
environment.
These measurements would be carried out on all sub-groups
to see if the values were affected by how long the skin
graft was covered with the synthetic dressing.
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Procedure
The M.V.T. rate was measured with an EP1 evaporimeter




The probe was positioned over a clean dry petri dish for
one minute to standardize the instrument at zero prior to
beginning measurements.
When measurements were being taken the probe was held over
the area in guestion for one minute before a stable read¬
ing was recorded.
Readings were taken when the open wounds were made, prior
to the application of the skin graft, and from normal
shaved skin to compare with published data (Foresman
1986).
On removal of the synthetic dressings the probe was held
over the skin grafts to record the m.v.t. rates at 1, 10
and 20 minutes following dressing removal. This procedure
was repeated 4 times on each animal to record the m.v.t.
from each of the 4 grafts. The anaesthetic time for this
procedure was therefore increased. If the anaesthetic time
(to measure the m.v.t.) was greater than 30 minutes a
significant number of rats reguired ventilatory assistance
following the procedure. Thereafter no readings were taken
beyond 20 minutes.
Readings
Readings were taken at weekly intervals in sub-groups A15,
B15, C15, D15, and E15. This meant that the M.V.T. would
be measured from skin grafts covered with a synthetic
dressing for periods up to 5 weeks before its removal and
thereafter up to the end of the study.
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3.6 Surface Area Measurement
Accurate surface area measurements would permit wound
contraction to be calculated, allowing comparison between
synthetically dressed and conventionally dressed skin
grafted wounds. In order to minimize error a standardized
technique was used to measure the surface area.
This technique involved tracing the skin graft margins on
to an acetate sheet and transferring this shape to a com¬
puter. A pilot study was carried out to gain familiarity
with the equipment and thus reduce errors.
Pilot Study
Fifty 2x2 centimetre shapes were traced on to acetate
sheets and photographed with a video camera. The image of
the shape was transferred to a screen and this was traced
with an electronic mouse. Surface areas were then
calculated by the computer. The original shapes were then
photographed and the surface areas calculated using the
same technique. The surface areas of the tracings were
compared to the surface areas of the shapes to assess the
accuracy and repeatability of the technique.
The mean surface area of the acetate tracing was 372.4 mm2
giving an accuracy of 6.9%. The mean surface area of the
shape, found when it was photographed and directly traced
by the computer mouse was 396.3 mm2. This gave an accuracy
of 0.9%. This figure compares well with the accuracy
(0.6%) reported by Foresman (1986) who used a similar
method to calculate wound surface areas.
For results in detail see Appendix 3
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Main Study
Surface area was measured by placing an acetate sheet
(which had been previously cleaned with 70% alcohol) over
the wounds when they were first covered with the
split-skin graft without the dressing. Tracings were made
in indelible ink with a felt tip pen, the border between
the skin graft and the surrounding, normal skin lying on
the inner aspect of the line.
Measurements were made when the skin graft was applied and
when the animal was sacrificed and the skin graft
biopsied.
All measurements were stored on individual acetate sheets
labeled with the group name and each shape was also
labeled with its individual rat and wound number.
Surface Area Calculation
The acetate sheets were then photographed using a video
camera. This transferred the shapes to a computer monitor.
Using an electronic mouse, the inner edges of the shapes
were traced and the surface areas calculated by the
computer. The computerized results were expressed in
sguare millimeters to two decimal places.
When the results of the individual animals in the
sub-groups were added together for statistical analysis
the figures were rounded to the nearest whole number.
There were approximately a total of 1,600 surface area
measurements taken during this study.
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3.7 Myofibroblast Cell Estimation
This part of the study was carried out in the Department
of Experimental Dermatology, The London Hospital.
Myofibroblasts are identified morphologically or
immunocytochemically. Morphological analysis reguires
experience with electron microscopy both in specimen
preparation and in the identification of myofibroblasts in
the final image. This experience is not required when
immunocytochemistry is used. The technique used in this
experiment utilised the binding of anti-smooth muscle
actin antibody to the intracytoplasmic actin filaments of
the myofibrolast. This facilitated the accurate
identification and quantification of myofibroblasts using
light microscopy. Biopsy specimens were also larger so
increasing the likelihood of the cell density in the
specimen representing the population under the skin graft.
This technique has proved successful when used to quantify
myofibroblasts in open wounds in other studies (McGrath
1982).
Wound Biopsies
The rats were sacrificed and the skin grafts were biopsied
at times determined by the study protocol. Particular care
was taken to include the filamentous epimysium over the
muscle under the skin graft as according to Rudolph (1979)
it is in this area (immediately under the skin graft) that
myofibroblasts are to be found.
Biopsies of approximately 5x5mm. were taken from the
middle of the graft. This area was chosen as this part of
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the graft was closest to the area of the skin graft that
had been assessed for thickness. The biopsies were ori¬
ented on a cork disc the underside of which had been
previously marked with the wound and rat number. Orienta¬
tion was carried out with the aid of a glass cover slip so
that a transverse section of the graft and the underlying
structures were uppermost, lying parallel to the disc as





This would aid the sectioning procedure considerably. A
small blob of fixative gel was then applied, covering all
the tissue. The whole disc and attached tissue was then
cooled by immersing it in liguid nitrogen. The disc was
removed and the cover slip warmed. This allowed the cover
slip to be removed from the disc leaving the attached,
orientated specimen behind. The exposed portion of the
specimen was then covered with fixative and the disc was
returned to the liguid nitrogen.
All the biopsies from a sub-group were then collected and
placed in a labeled plastic bag. These bags were then
stored in the in-house -70°C refrigerator. They were then
transferred, in liguid nitrogen to the Dept. Experimental
Dermatology The London Hospital where they were placed in
plastic boxes labeled with the main group letter. All
boxes were then stored in a -70°C refrigerator until sec¬
tioning was undertaken.
Sectioning
This process involved controlled thawing of the biopsies
to —20°C and cutting eight sections per biopsy. This
number of sections were needed to allow both positive and
negative controls to be used at various stages of the
staining procedure. The labeled biopsies were sectioned
and at least 8 sections per biopsy were taken and placed
on a single glass slide. The glass slide was then labeled




Sections were recovered from the -70°C freezer and air
dried in a flow Calasef hood for 15 minutes.
The alpha-anti smooth muscle antibody was added to cover
the whole section. This preparation was then incubated for
one hour at room temperature in a humidification chamber.
The sections were then washed in physiologically buffered
saline three times (5 minutes each wash). The sections
were then incubated with Rabbit anti-mouse peroxidase
conjugated serum for a further hour. The washing procedure
was then repeated, with the last wash containing D.A.B..
The D.A.B. (3,3'-Di-aminobenzidine with 0.1% hydrogen
peroxide ) substrate was made up during the washing peri¬
ods and was thus fresh when applied to the sections. When
the tissue began to turn brown the sections were washed
and a counter stain of haematoxolin and eosin was applied
to assess tissue architecture. The section was then
mounted with a cover slip and the myofibroblast cell
clumps counted. Results are expressed as numbers of cell
clumps per unit surface area (of the skin graft).
Data from similar wounds treated in a similar way in each
group was accumulated. Mean values and 95% confidence
limits for the mean were then calculated. Paired Student's
"t" tests were then carried out comparing the results in













A failure was defined if the animal unexpectedly died at
any part of the study, or when the skin graft had been
damaged in any way other than in a superficial manner.
This was defined as there being enough trauma to the graft
to cause bleeding or serous ooze from the area of damage.
Perhaps surprisingly, in view of this animal's reputation
for disruption, there were fewer than anticipated fail¬
ures .
Failure rates are given under the following headlines;
Animal death both per and post operatively,
Animal interference and skin graft failures, and
Technical failures in the three experiments
ANIMAL DEATH
Per-Operative Deaths
Only three rats died per-operatively (1.5%). This ex¬
tremely low figure was achieved because of several
factors.
1) The considerable experience of the Animal house staff
in handling and anaesthetising rats
2) The devising of a new technique which allowed the rapid
harvesting and application of 4 skin grafts on one animal
3) Two pilot studies were carried out before the main
study to allow the operator to become experienced in the
necessary techniques. The first study involved dead
animals and the technique of harvesting skin grafts was
practised. Once proficiency had been gained the technique
was used on anaesthetised rats to work out exact drug dos¬
age, to increase the speed of the operation and to es-
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tablish the best dressing techniques.
The three animals were replaced on the days of the
wounding thus restoring the group numbers.
Post operative Deaths
Only one rat died (No.1283) in the post-operative period.
This animal lost weight in the immediate post-operative
period which was a normal occurance in all rats but failed
to gain weight over the following three weeks. It died
four weeks after the operation having been excluded from
the experiment ( and thus having all dressings removed )
two weeks beforehand. Its position in the study was not
replaced reducing the numbers in the sub-group (D15) to 7,
which still allowed statistical comparisons to be made.
Animal Interference and Skin Graft Failures
The ammount of grafts subsequently excluded from the study
ammounted to 57 grafts.
The reasons for exclusion were:
Operative Complications
One skin graft was applied to the wound incorrectly. The
outer aspect of the graft was applied to the wound instead
of the inner aspect, this resulted in total failure of the
graft. It was therefore excluded from the study.
Post-operative Complications
Out of 800 skin grafts applied there were only 3 instances
when a haematoma ( 1 graft ) or a seroma ( 2 grafts )
caused graft failure. This extremely low figure is even
more surprising when one considers that no formal method
of haemostasis was used when the grafts were harvested and
applied to the open wound.
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Rat Interference
The reason for the exclusion of the remainder of the
grafts (53 in total ) was animal interference. The rat in¬
terfered with the graft in usually one of two ways.
Gnawing
This only happened to the grafts over the hip flexor
crease as the anatomy of the rat dictated that it could
not reach its flank with its teeth. A protective vest was
placed around the cervical region to prevent the rat
damaging the dressings over the hip flexor area. Despite
this three rats were able to free themselves from the
collar and damage the (6) grafts on their hip flexor
creases.
Scratching
Following the removal of the tie over dressings the rat
was dressed with a toweling "waistcoat" to prevent it
scratching the skin graft on the flank. This dressing was
well tolerated by the animals but the tension reguired to
keep the vest on the animal was critical. If it was too
loose the animal was able to work its way out and subse¬
quently damaged the grafts, if it was too tight the animal
became distressed, which was unacceptable. Therefore the
dressings were applied to fit in a loose manner. This was
the main reason for the majority of exclusions (47 grafts)
from the experiment. This was felt to be an acceptable













Technical Failures in each Experiment
Moisture Vapour Transmission
There were 160 skin grafts studied (40 rats with 4 skin
grafts per animal ). There were four grafts not measured,
all on one rat which died (Gp.D15, Rat No.1283). The
failure rate on this part of the experiments therefore was
2.5%. No rats in these groups damaged any part of their
grafts.
Surface Areas
There was no additional failures associated with the
technical transfer of the wound surface areas from the
rats to the computer.
Myofibroblasts
There were no failures in this part of the study as the
technigues of sectioning, mounting and staining were
practiced beforehand. If any errors were made in the main
study there was enough spare biopsy material to refer to
for further processing. As a result of this, all specimens
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were processed giving results which are tabulated below.
OVERALL FAILURE RATE
A total of 61 grafts were excluded from the study [1 rat
death (4 grafts) and 57 grafts] of 800 grafts.
This gives an overall failure rate of 7.625%
4.2 Rat Weights
The surface area of the rat is related to it's weight
(Surface Area [mm2] = 10 x weight[grams]2/3 ) therefore
all rats were weighed prior to entry into, and at weekly
intervals throughout the study. This parameter was taken
as a measure of the general well being of the animal and
as a baseline measurement to indicate the similarity of
each group.
The rats were weighed using a mitsuyisu electronic
weighing machine which was standardised on a weekly basis.
Weights were expressed in grams and the values of each
group were tabulated. These tables were then statistically
evaluated and the mean weight and 95% Confidence Limits
for the mean were calculated for each group at weekly
intervals of the study. These tables can be found in
Appendix 3.
Data from the same post-operative dates was collected from
each table to give values for the rat population in the
main groups (A,B,C,D,and E.).
Mean group weight with 95% confidence limits (error bars)































I ■ 95% Confidence Limits
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Mean weight on entry to the study was 404g
(391-418g 95% Confidence Limit).
In the immediate post operative period all rats lost
weight. This phenomenon occurs after any animal experiment
of this magnitude (Personal Communication, S+N Research
Animal House Manager), but within 1-2 weeks the animal was
gaining weight. It usually took another three weeks
however for the animal to reach the pre-operative weight.
It is perhaps not surprising that all animals lost weight.
Before the operation the rats were housed together and had
no restraining dressings. After the skin grafting
procedure all rats were placed in a restraining vest with
an underlying tubigrip support and then housed in
individual cages. One week later ( under gaseous
anaesthesia ) all dressings were removed, the skin grafts
were checked, and lighter dressings applied allowing more
mobility. The restrictive dressings and the individual
housing of this social animal may have accounted for the
post operative weight loss.
Thereafter, all animals increased in weight to the end of
the study. Mean animal weight at 15 weeks was 573g (522 -
623g 95% Confidence Limits)
Summary
If weight is an indication of how stressed an animal is
then this baseline data suggests that all groups reacted
in a similar way to the trauma of the procedures. As
surface area is influenced by animal weight these figures
will be taken into account when the split skin graft
surface area results are presented.
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4.3 Moisture Vapour Transmission
Pilot Study - Baseline Measurements
To enable the results to be compared with published data,
readings were taken from shaved normal skin and open
wounds prior to covering them with the split skin grafts.
The mean value was found to be 7.59 grammes per meter
squared per hour for the shaved skin and 70.93 grammes per
meter squared per hour for open wounds on the flank and a
mean value of 6.87 G.M.H. for the shaved skin and 72.89
G.M.H for the open wounds on the hip flexor area. (Refer
to Appendix 3 for details of this pilot study )
These values are similar to published data detailing
evaporative water loss from normal skin (Lamke 1977,
Jonkman 1989) and open wounds (Foresman 1986).
Moisture Vapour Transmission - Flank Area
Group A
The control grafts in this group lost water initially at a
rate of 30g\m2\hr. Over the next 4 weeks the m.v.t. fell
to a value of 15g\m2\hr. It then slowly fell to a level of
12g\m2\hr at 15 weeks. Synthetically dressed skin grafts
lost water at a rate of 15g\m2\hr in the first week.
When the dressing was removed there was a massive surge in
the moisture vapour transmission rate. This surge peaked
at about 1 minute after dressing removal at 105g\m2\hr.
and thereafter fell over the next 30 minutes to a mean
level of 25g\m2\hr. At this time it was deemed unsafe to
further anaesthetise the rats so they were woken up. The
following day the same rats were anaesthetised and further
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readings were made. These readings were not statistically
different from the control grafts. Thereafter, skin graft
m.v.t. did not differ significantly in either group.
Groups B,C.D and E.
The skin grafts in these groups reacted in a similar way
to the grafts in Group A. The initial values in all
control skin grafts was approximately 30 g\m2\hr with the
opsite covered grafts having a m.v.t. of approximately 15
g\m2\hr. There was a similar m.v.t. surge when the
dressing was removed. The peak of this surge was similar
in all groups at between 100-110 g\m2\hr. Within 30
minutes of dressing removal the m.v.t. in all groups was
approaching that of the control group. Thereafter there
was little difference in the m.v.t. of both control and
opsite covered grafts to the end of the study.
The following graphs depict mean group moisture vapour
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Moisture Vapour Transmission - Hip Area
The following pages graphically illustrate the results of
the moisture vapour transmission rates from the split skin
grafts on the hip flexor region. The hip measurements were
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Mean water loss from the flank and hip open wounds in this
study is 72 +/- (95% Confidence Limits) 3 g/m2/hr. This is
similar to the values recorded by Foresman
( 58 +/- (Std.Dev.) 6 g/m2/hr).
The narrow 95% confidence limit bars are probably the
result of the environmental controls which stabalised the
light, temperature and humidity in all the rooms used
during the experiments (See Appendix 1).
Split Skin Grafted Wounds
Covering the wound with a split skin graft reduces the
Moisture Vapour Transmission (m.v.t.) to 30 g/m2/hr. Over
the next few weeks the m.v.t. slowly falls to a level of
about 15 g/m2/hr. Thereafter the m.v.t. remains constant
at this level to the end of the study.
Synthetic Dressings
When this split skin graft is covered with a synthetic
dressing the water loss is immediately reduced to a mean
value of 15 g/m2/hr. This is still higher than water loss
from normal, shaved skin, which in this experiment is
approximately 7 g/m2/hr. When the synthetic dressing is
removed, there is a surge in moisture vapour transmission
to over 100 g/m2/hr. Within 30 minutes the m.v.t. was
falling to control group values. A similar surge took
place when the dressing was removed from all the
synthetically dressed skin grafts in all groups. The peaks
were similar throughout indicating that the effect of the
dressing on wound humidity was maximal at one week.
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Leaving the skin graft covered with the dressing after one
week did not result in an increase in wound humidity.
Conclusion
The conclusion from this part of the study seems to be
that a synthetic dressing allows a split skin graft to
revascularise in an extremely moist environment. When this
dressing is removed there is a surge in water loss which
returns to the values of the control skin grafts within
one hour. Thereafter the skin graft looses water at a rate
which is similar to the control skin grafts. How this
affects the split skin graft's behaviour will be demon¬




This study was undertaken to familiarise the author with
the techniques involved in the accurate tracing of shapes
with an electronic mouse. The 2x2 cm. perspex block was
traced with a pen on to an acetate sheet. This was
repeated 50 times. The perspex block was then photographed
with the video camera and the image portrayed on the
monitor was traced with the electronic mouse. The areas
were then calculated by the computer.
The acetate tracings were then photographed with the same
apparatus. The images produced were then traced with the
mouse and the areas calculated.
The results showed that transferring the acetate tracing
of the shape to the computer with the electronic mouse
produced a mean surface area of 372 mm2 where as tracing
the actual shape with the electronic mouse produced a mean
surface area of 396 mm2. The error when tracing took place
was therefore 6%.
Surface Area - Flank
All the groups studied had at least 6 rats per group. This
meant that the data from each group could be analysed and
compared with data from other groups.
Tracings were made of all split skin grafts when they
were initially applied to the open wound at operation.
This initial figure would be considered the baseline and
allocated a value of 100%. The second tracing was made
when the animal was sacrificed. This value was then
expressed as a percentage of the first figure. This would
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standardise the results and allow the easier comparison of
change in surface area of skin grafts. All the sub group
results of one main group were then collected and
graphically presented. Group A therefore consisted of data
from sub groups A1,A2,A3,A4,A5,A10,A15. Group B consisted
of sub groups B2,B3,B4,B5,BIO,B15. Groups C, D and E were
similarly constructed.
The individual sub group data is collected in tabular form
in appendix 3.
Mean group surface area values with 95% confidence limits








0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Weeks
95% Confidence Limits
Student t test comparina Opsite with Controls
Degrees of Mean confidence
Freedom t P Difference interval
A2 6 1.494 0.1858 20.64 -6.51 49.
A3 7 2.531 0.0390 20.61 5.18 36.
A4 7 4.035 0.0050 30 . 85 16 .37 45.
A5 5 3 . 916 0.0112 33.52 16.27 50.
A10 7 5.621 0.0008 48.54 32.18 64.
A15 6 3 .775 0.0094 71. 66 34.58 108.
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Group B Flank
Mean Percentage Surface Area
Weeks
I = 95% Confidence Limits
Student t test comparincr Opsite with Controls
Degrees of Mean Confidence
Freedom t P Difference Interval
B2 6 0.332 0.7510 2.73 -13 .23 18.
B3 5 4.261 0.0084 20.39 10.64 30.
B4 6 3 . 213 0.0183 24.36 9.63 39.
B5 6 2.871 0.0284 24.87 8.04 41.
BIO 6 4.534 0.0040 31.27 17.87 44 .




Mean Percentage Surface Area
c
o to 3 4 5 6 7 8 9 10 11 12 13 14 15
Weeks
I - 95% Confidence Limits
Student t test comDarincr Oosite with Controls
Degrees of Mean Confidence
Freedom t p Difference Interval
C3 6 8.549 0.0001 33.74 26.07 41.41
C4 7 1. 402 0.2037 10.11 -3.55 23 .78
C5 6 5.552 0.0014 28.71 18 .66 38.76
CIO 6 2.167 0.0734 33.76 3.48 64 .03




Mean Percentage Surface Area
Opsite 4 Wks
Control




95% Confidence Limi ts
Student t test comoarina Oosite with Controls
Degrees of Mean Confidence
Freedom t p Difference Interval
D4 7 2.661 0.0234 26.77 7.71 45.84
D5 7 9.561 0.0000 15.15 12.15 18.15
D10 7 7.111 0.0002 35.97 26.39 45.56
D15 6 5.269 0.0019 16.14 10.19 22.10
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Group E Flank
Mean Percentage Surface Area
Weeks
95% Confidence Limits
Student t test comparincf Opsite with Controls
Degrees of Mean Confidence
Freedom t P Difference Interval
E5 6 3.474 0.0132 28 . 23 12.44 44.02
E10 6 4.651 0.0035 21.34 12.43 30.26
E15 7 4.629 0.0024 31.50 18.61 44.39
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Group A Hip
Mean Percentage Surface Area
Weeks
§ ■ 95% Confidence Limits
Student t test comparing Opsite with Controls
Degrees of Mean Confidence
Freedom t P Difference Interval
A2 6 1.894 0.1070 14.74 -0.38 29.87
A3 7 3.758 0.0071 14.91 7.39 22 . 43
A4 7 4.608 0.0025 29 . 46 17.35 41.58
A5 5 4 .145 0.0089 13.48 6.94 20 . 02
A10 7 2 . 791 0.0269 28 . 29 9.08 47 . 49
A15 5 2.002 0.1017 30. 28 -0.20 60 . 77
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Group B Hip
Mean Percentage Surface Area
Weeks
$ ■ 95% Confidence Limits
Student t test comparincr Opsite with Controls
Degrees of Mean Confidence
Freedom t P Difference Interval
B2 7 2.041 0.0806 18.96 1.36 36 . 56
B3 5 6.099 0.0017 30.97 20.74 41.20
B4 6 4 .335 0.0048 20.01 11.08 28 . 94
B5 5 5.930 0.0019 34 . 98 23 .10 46 . 87
BIO 6 5.806 0.0011 39.59 26 .34 52 . 83
B15 6 2.091 0.8150 26.03 1.84 50 . 22
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Group C Hip
Mean Percentage Surface Area
Weeks
£■ 95% Confidence Limits
Student t test comparing Opsite with Controls
Degrees of Mean Confidence
Freedom t P Difference Interval
C3 5 2.784 0.0387 24.75 6.83 42.67
C4 7 2.727 0.0295 17 .22 5.26 29.19
C5 6 1.639 0.1523 12.57 -2.33 27.47
CIO 6 4.337 0.0047 33 . 51 18.64 48.39




Mean Percentage Surface Area
Opsite 4 Wks
Control
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Weeks
§■ 95% Confidence Limits
Student t test comparinct Opsite with Controls
Degrees of Mean Confidence
Freedom t P Difference Interval
D4 7 3 . 258 0.0139 26.31 11.01 41. 62
D5 7 5.608 0.0008 14.50 9.60 19 . 40
D10 7 11.387 0.0000 35.25 29.38 41.12




Mean Percentage Surface Area
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Weeks
% • 95% Confidence Limits







E5 6 5.919 0.0010 31.81 21.37
E10 6 2.410 0.0526 17.69 3.43








During the first 3-4 weeks graft size fell to a mean of
56% its original size. This sharp fall in surface area is
not unique to this study. Although it is not commented
upon, this phenomenon occurs in published data on skin
graft contraction
(Rudolph 1979, Corps 1969). If one compares the weights of
the rats during this time in this study, then it may be
that the weight loss during this time has influenced graft
size as surface area is related to body weight (see page
118). This will be evaluated later.
After 4 weeks the skin grafts then went on to increase in
size and at the end of the study the grafts had reached
80-90% their original size. These figures are similar to
published animal work (Corps 1969, Rudolph 1979) and
compares with the clinical behaviour of human split skin
grafts (Padgett 1942, Grabb and Smith 1979).
Skin Grafts Synthetically Dressed
The split skin grafts covered with a synthetic dressing
behaved in a manner similar to the control skin grafts for
the first 3-4 weeks following wounding. After this time
the mean size of all the skin grafts synthetically dressed
increased at a rate greater than the control grafts.
Group A
The skin grafts in this group were covered with a
synthetic dressing for one week. The wounds shrank to a
mean of 68% their original size at 3 weeks. The wounds
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then increased in size until at 15 weeks they were 164%
their original size.
Groups B.C.D.and E.
The skin grafted wounds covered with the synthetic
dressing in these groups underwent an initial reduction in
size similar to the control grafts. However, the
contraction was always less in the synthetically dressed
group. The skin grafts in these groups then went on to
increase in size and at 15 weeks post wounding they were
all larger that their respective (in-animal) controls. The
optimum time for covering a skin graft with a synthetic
dressing was one week, grafts covered for longer periods
received no added benefit.
Surface Areas Hip
It is interesting that all grafts in this area undergo
contraction in the first 3-4 weeks following surgery. This
response is similar to the skin grafted wounds on a
non-flexor surface (flank area). After 4 weeks there is an
increase in size of all grafts; the size of the
synthetically dressed grafts being larger than the in
animal controls.
Discussion
The control skin grafts in this study contracted in a
manner similar to published data by never regaining their
original size (Rudolph 1979, Corps 1969, Padgett 1952).
Surface area is directly related to animal weight. Surface
area estimation was carried out on individual sub groups
at various points in the study when animal weight varied.
If mean group weight therefore is standardised to 414
grams the following charts allow direct comparison of
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surface areas within groups and between groups.
Weight Standardised (414g)
Group A Flank
Mean Percentage Surface Area
Weeks
Opsite 1 Week Control




Mean Percentage Surface Area
Weeks
Opsite 2 Wks —— Control




Mean Percentage Surface Area
Weeks
Opsite 3 Wks —— Control




Mean Percentage Surface Area
Weeks
Opsite 4 Wks -1— Control




Mean Percentage Surface Area
Weeks
Opsite 5 Wks —— Control
$ = 95% Confidence Limits
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Standardising rat weight reduces the magnitude of the
values but because in-animal controls were used the
difference between the control grafts and the opsite
covered grafts is similar.
Trends
Controls
The trend of the control grafted wounds was negative,
indicating the propensity of these grafts to reduce in
size. The slope of all the control graphs was similar
indicating their homogeneity.
Synthetic Dressings
All grafts synthetically dressed in groups A,B and C had a
positive or neutral trend. The grafts in these groups
therefore had a tendency to either increase in size in
keeping with their weight gain or to increase in size at a
rate greater than their weight gain. Grafts in groups D
and E had a negative trend. These grafts therefore did not
increase in size at the same rate as the rat gained
weight. Although the slope was less steep in the grafts
synthetically dressed compared to their control grafts, it
would appear that if the synthetic dressing remains in
situ for periods longer than three weeks the beneficial
effect on surface area is reduced.
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4.5 Myofibroblast Cell Population
These modified fibroblasts are difficult to assess
individually as they form clumps and each cell becomes
intimately associated with its neighbours. Previous
studies have identified myofibroblasts using the electron
microscope, Rudolph (1979) counted fibroblasts with a
"myofibroblast appearance". It is therefore accepted that
the assessment of cell numbers in this situation cannot be
100% accurate whichever method is used to first of all
identify then secondly to count these cells. Using an
immunoperoxidase stain linked to a specific monoclonal
antibody targeted to the intracellular actin moiety of the
myofibroblast would increase the accuracy and ease of
identification of these cells. Even this method is not
100% accurate. McGrath (1982) used this method when
identifying myofibroblasts with seguential slices of
tissue. She built up 2 dimentional maps of cell
distribution and statistically analysed this data.
However, on examination of the photomicrographs in this
paper, it would seem to be very difficult to identify
individual cells and it is possible that various sections
of one cell were counted as several cells.
Photomicrographs (overleaf) of the myofibroblasts
identified in this present study indicate the difficulty
in individual cell identification.
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The photograph below shows a low powered view of one
section of a skin grafted wound. Clumps of myofibroblasts
(stained brown) can be identified at the skin graft -
wound interface.
This high powered view gives an indication of the degree
of difficulty in individual cell identification. This %
would be regarded as one cell clump for simplicity.
This would then mean that the main innacuracy of this
method would be in the supposition that each clump
contained exactly the same number of cells. The likelyhood
of this being the case is remote but it is assumed that
the innacuracy of this method is the same throughout the
experiment thus allowing comparison within the study. This
method may be no more inaccurate than the time consuming
methods previously described.
The aim of the study was to compare the differences
between wounds covered with different dressings. Therefore
although data from this study could not be compared with
data from other studies an indication of the difference
induced in myofibroblast numbers by the different
dressings could be concluded.
Myofibroblast Cell Numbers - Flank
The following graphs represent the numbers of
myofibroblast cell clumps per high powered field per unit






% ■ 95% Confidence Limits
Student t test comparing Opsite with Controls
Weeks 1 2 3 4 5 10 15
Freedom 7 6 7 7 6 7 6
"t" 6.099 4.500 9.524 2.244 6.429 4.329 3.674
"p" 0.0005 0.0041 0.0000 0.0598 0.0006 0.0034 0.0104
Mean
Diff. 7.37 5.14 11.37 4.00 6.86 3.88 3.00
95%
Conf. 4.52 2.35 8.55 -0.22 4.27 1.76 1.00
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Myofibroblast Cell Numbers - Hip
The numbers of myofibroblast cell clumps were identified
and counted in the split skin grafts covering the hip
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Confidence 0.10 10.60 2.96 -0.02 -3.10 -2.47
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Weeks
% = 95% Confidence Limits
Student t test comparing Opsite with Controls
Weeks 3 4 5 10 15
°Freedom 6 7 6 6 5
"t" 7.747 4.681 2.238 2.414 2.739
"p" 0.000 0.002 0.067 0.052 0.041
Mean
Difference 8.43 6.00 3.14 1.86 1.00
95%
Confidence 5.77 2.97 -0.29 -0.03 0.06












2 3 4 5 6 7 8 9 10 11 12 13 14 15
Weeks
£ = 95% Confidence Limits
Student t test comparing Opsite with Controls
Weeks 4 5 10 15
°Freedom 7 6 7 6
3.444 0.862 1.598 0.725
»pM 0.011 0.422 0.154 0.496
Mean
Difference 6.38 1.29 3.25 1.00
95%
Confidence 2 . 00 -2.36 -1.56 -2.38











1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Weeks
S = 95% Confidence Limits
Student t test comparing Opsite with Controls
Weeks 5 10 15
°Freedom 567
"t" 2.236 4.221 0.323
"p" 0.076 0.006 0.756
Mean
Difference 2.00 3.43 0.25
95%
Confidence -0.30 1.44 -1.58
Limits 4.30 5.42 2.08
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Summary
The myofibroblast numbers in each sub group were counted.
The mean including 95% confidence intervals were
calculated. Further evaluation was carried out using the
paired student's t test.
Myofibroblasts Flank
Myofibroblast cells were always present in smaller numbers
under skin grafts covered with opsite. In both the control
and the synthetically dressed groups there was a peak
concentration at 3-4 weeks post wounding. The peak numbers
were larger in the control groups. At 5 weeks numbers of
myofibroblast cell clumps fell in both groups to small but
significant numbers. These numbers leveled out and at 15
weeks post skin grafting myofibroblasts were still present
in both groups. The numbers in the groups where the skin
grafts were synthetically dressed were smaller than the
control groups.
Control Groups
The numbers in the control groups were similarly
scattered. Groups A,B, and C, registered peaks of 17-20
cell clumps per high powered field per unit surface area
at 3,4,and 4 weeks respectively. Thereafter myofibroblast
cell numbers fell to between 6-10 cell clumps per high
powered field per unit surface area at 15 weeks.
Groups Synthetically Dressed
The mean cell count peaked in all groups at 4 weeks. The
cell numbers then fell to below 10 cells per high powered
field at 5 weeks and then to below 5 cells per high
powered field at 10 weeks.
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Myofibroblast Cell Numbers Hip
The myofibroblast numbers in the hip wounds vary in a
similar way to the flank myofibroblasts. The control
wounds have larger cell counts and peak at 3-4 weeks. They
then fall to approximately 10 cells per high powered field
at 5 weeks and remain at this level to 15 weeks. The
synthetically dressed wounds commence with fewer
myofibroblasts per high powered field. The peak at 4 weeks
in these groups is less than the corresponding control
peaks, but after 5 weeks the numbers in both groups are
statistically similar.
This technique only counted myofibroblasts with actin in
their cytoplasm. Therefore myofibroblasts without
intracellular actin would not be identified. This is
advantageous as Darby (1990) states that it is only those
cells with intracellular actin that actively participate
in wound contraction. This method therefore gives an
indication of the contraction potential within the wound.
It does not give the full answer however as the method
cannot quantify the amount of intracellular actin present
in each cell. It can be concluded that the numbers of
myofibroblasts identified give an indication of the
potential for wound contraction - the extent of such





This investigation was commenced to see if the occlusive
dressing that was used in the preceding animal experiments
had a similar effect on wound contraction in human wounds.
5.1 Experimental Design
This study was designed to investigate the effect of an
occlusive dressing on the contraction of wounds covered
with a split skin graft.
Twenty two patients with bilateral forearm tattoos were
entered into the study. The tattoos were of such a size
that, following their excision, a split skin graft would
be reguired to cover the defect.
Procedure
Under general anaesthesia the tattoo on each forearm was
removed with all aspects of the reticular dermis. This
left a wound with no macroscopic dermal contents. When
bleeding took place from the subcutaneous fat a sterile
paper towel was applied and held tightly to the wound for
a few seconds, the shape made was then carefully cut out
and applied to the wound to ensure that the template was
an accurate copy of the wound. This template was then
traced onto an sheet of paper and carefully stored for
later surface area measurement.
A split skin graft was then taken with a powered dermatome
from the inner aspect of the thigh. The dermatome was set
to harvest a split skin graft of similar thickness
throughout. The size of the split skin graft harvested
was intentionally made large enough to cover both wounds
and leave enough excess skin to allow thickness
measurements to be made. Graft thickness was measured
174
with a micrometer at three points, one measurement was
made from skin taken from each end of the skin graft
strip. The third measurement was taken from skin that was
between the two sections of the skin graft strip used to
cover both defects. The split skin grafts were carefully
applied with minimal tension and held in place with skin
staples. The grafts were dressed according to the regimen
allocated by opening an unmarked envelope which had the
options of occlusive or conventional dressings inside. The
occlusive dressing consisted of covering the split skin
graft with Opsite and then covering this dressing with one
layer of gauze dressings and securing these with a crepe
bandage. The conventional dressing consisted of one layer
of gauze dressings held with a crepe bandage. These
dressings remained intact for 24 hours. They were then
carefully removed (leaving the Opsite intact) and a check
was made to identify haematoma or seroma under the grafts.
If either of these two complications was detected in
either the Opsite or the Conventional group the patient
was removed from the study. Patients were reviewed
approximately 7-10 days later and all dressings were
removed. Further reviews were carried out at 1 month, 4-6
months and 12 months. During each occasion acetate
tracings were made of the skin grafts.
Surface Area Estimation
The wound templates were transferred to an acetate sheet
which was labelled. The surface area of the acetate
tracings of all grafts was measured using a computerised
digitising tablet. The edges were traced with a
computerised mouse. This digitised the irregular shape and
allowed the computer to calculate the surface area. The
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result was expressed in square millimeters.
Stastical Analysis
The results were calculated as percentages of the initial
wounding areas. The results were expressed as mean values
with 90% confidence limits. The surface areas of the skin
grafts in the Opsite groups were then compared to the




Twenty two patients with bilateral skin grafts entered the
trial. When the grafts were inspected at 24 hours there
was no sign of haematoma or seroma under any of the skin
grafts. However, when the patients were seen at 7-10 post
operative days six patients were excluded from the trial.
The reasons for this were:





Twenty patients were reviewed at 1 month. This number fell
to 12 patients presenting for review at 6 months and 11
patients at 12 months.
Skin Graft Thickness
The three measurements per sheet of split skin graft in
the 16 patients entering the trial were tabulated. The
mean graft thickness was 0.158 mm (90% confidence limits
0.149mm-0.168mm). These skin grafts would be classified as
thin split skin grafts (Grabb and Smith 1979) and as such
the wounds that they covered would be expected to contract
176
(Padgett 1942, Cronin 1961, Grabb and Smith 1979).
Surface Areas
The graph below illustrates the results.
The skin grafted wounds from both the conventional and the
Opsite covered group contracted to 81.8% and 76.5% their
respective original surface areas in the first 4 weeks.
There was no difference in the rate of contraction at this
time (p = 0.316). At 6 months the conventionally dressed
split skin grafts were 56.5% their original surface area
whereas the Opsite covered skin grafts were 82% their
original surface area. The mean difference between both
groups was statistically significant (p = 0.007).
The surface areas at 12 months were 59.8% original surface
area (conventional dressing) and 90.3% original surface
area (Opsite dressing).
This difference was statistically significant (p < 0.001).
Human Skin Graft Wound Contraction
Months
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Part Four - Discussion
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6.1 Discussion of Results
The studies in this thesis were designed to test the
hypothesis that wound contraction is reduced when wounds
are allowed to heal in a moist environment. Several
parameters of wound healing were investigated to see if
they were affected when the wound was covered with a
moisture retaining (occlusive) synthetic dressing.
Human Study-Open Wounds
To date there has been little work carried out
investigating the effects of a synthetic dressing on human
wound contraction. The variety of full thickness wounds
created make comparisons difficult and the ethical
objections to leaving these wounds to heal by secondary
intention are two main reasons for the paucity of such
studies. Hien et al (1988) used the wounds resulting from
Mohs micrographic surgery to study the effects of
occlusive dressings on wound healing. These wounds were of
mixed depth, size and shape and this made statistical
analysis difficult. Hein's results indicated that the
synthetic dressing was beneficial to epithelialisation and
collagen metabolism. This study however relied on a
subjective evaluation of the final scar and this
evaluation compared wounds of differing depths that took
different times to heal.
A study was therefore set up which would rely on an
objective evaluation of wound contraction (size) in
similar wounds from the same anatomical area. The wounds
used in this study were split skin graft donor sites and
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all wounds healed within 19 days, so standardising one
part of the study. Although these wounds all include a
portion of the dermis and epithelialisation is the major
mode of healing, Alvarez et al (1983) has shown that
collagen metabolism in superficial wounds is affected by
wound dressings.
If collagen metabolism is affected do superficial wounds
contract?
The findings of this study suggest that they do and if
healing takes place in a moist environment this
contraction is reduced. The study was designed to be a
double blind investigation with the dressings being
allocated after wounding and then removed (by another
person) before the second measurement was made. The aim
was to eliminate the need for biopsies to estimate wound
depth, this would reduce the assault on the patient and
eliminate the time consuming histological assessment. From
the fact that all wounds had healed by 19 days (with no
statistical difference between the two groups) and
dressings had been randomly allocated, it can be assumed
that both groups contained wounds of similar depth. This
point has been ratified by a professional statistician.
The perhaps surprisingly high figure of 20% contraction in
the conventionally dressed wounds is interesting. All
wounds in this study were surrounded by normal, lax skin.
Thus any physical force opposing wound contraction would
be minimal (Sawhney 1977).
If the dressings were reducing wound contraction by their
splintage action only, then one would expect the
conventional dressing group to contract less because these
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dressings become hard, are adherent to (and therefore
splint) the wound until complete epithelialisation takes
place. The synthetic dressing had minimal splintage so
some other factor must have been responsible for reducing
the wound contraction.
A reduction in moisture loss, an alteration in the wound
surface bacterial counts, an alteration in the surface
temperature or pizoelectric potentials have all been
postulated as reasons for the dressing's effect. It was
decided to investigate the effect on moisture loss to see
if this factor was influenced when split skin grafted
wounds were dressed with synthetic dressings.
Skin Grafted Wounds
In skin grafted wounds there is no exudate. Therefore, if
an occlusive dressing was to have an effect on underlying
wound contraction it must do so mainly by influencing the
wound via the skin graft. The most likely way of doing so
would be to reduce the dessicating stimulus by reducing
water loss from the skin graft so allowing the underlying
wound to heal in a moist environment.
Animal Study
Frank (1984,1985) and Foresman (1986) showed a reduction
in wound contraction when "Biobrane", a nylon\silicone
bilayer coated with porcine dermal polypeptides (Frank
1984) is used to dress the wound. In this study the
synthetic dressing used was Opsite (a polyurethane
membrane ) with a split skin graft replacing the porcine
dermal polypeptides. Full thickness wounds were created on
a flexor and a non-flexor aspect on both sides of a rat.
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This allowed in-animal controls so that paired results
could be subsequently analysed using the Student's t test.
Different groups of rats were studied with the Opsite
dressing covering the skin graft for 1, 2, 3, 4 and 5
weeks. This time scale was chosen as maximum wound
contraction occurs in rat skin grafted wounds during this
time (Corps 1969). Myofibroblast numbers also undergo
their biggest change before 5 weeks (Rudolph 1979, McGrath
1982, Darby et al 1990).
Moisture Vapour Transmission
The moisture vapour transmission (M.V.T.) of the open
wounds, skin grafted wounds, skin grafted wounds
synthetically dressed, and normal shaved skin was measured
in this study.
When the first 88 wounds (in groups A15, B15, C15, D15 and
E15) were created the M.V.T. was measured at a mean of
61.9 grams of water evaporated per square metre per hour
(g/m2/hr), standard deviation (S.D.) 5.04 , normal skin
had a M.V.T. of 5 g/m2/hr +/- S.D. 2. These results are
similar to that (58 g/m2/hr +/- S.D. 6 for open wounds and
8 g/m2/hr +/- S.D. 2 for normal skin) found when Foresman
(1986) carried out comparable studies in the rat with
similar equipment.
The open wounds were then covered with a split skin graft
taken from the skin removed in the creation of the
original wound. Skin graft thickness was measured and all
the skin grafts were similar. (Refer to appendix 2 for
details)
Control Grafts
The M.V.T. fell to a mean value of 30 g/m2/hr ( 95%
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confidence limit 29-31 g/m2/hr) when the grafts were
applied. This finding was similar in all groups tested.
(Appendix 3) The Moisture Vapour Transmission (M.V.T.) of
the control split skin grafts was therefore approximately
3 times that of normal skin indicating that these wounds
were being subjected to a continuing higher dessicating
stimulus. This may be one reason why wounds covered with
split skin grafts contract more than similar wounds
covered with full thickness skin grafts (Corps 1969).
Opsite Covered Grafts
When the skin grafts were covered with Opsite the M.V.T.
fell to approximately 15 g/m2/hr, about half that of the
control wounds. There was no significant difference
between the M.V.T. from the grafts on the flank compared
to the grafts on the hip.
Dressing Removal
When the opsite dressing was removed from the split skin
grafts there was a massive surge in M.V.T. to over 100
g/m2/hr. This value (equivalent to the M.V.T. of a partial
thickness wound (Jonkman 1989) and double the M.V.T. of a
freshly made full thickness wound) confirmed that the
split skin grafted wound had healed in a very moist
environment. The value guickly fell and at 30 minutes
following the removal of the dressing the M.V.T. was
similar to the values of the control grafts at the time of
application. The following day the M.V.T. was checked and
found to be similar to that of the opposite, control skin
graft.
M.V.T. readings were similar irrespective of how long the
skin graft had been covered with Opsite. The readings were
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similar in Groups B,C,D and E, indicating that Opsite kept
the wound healing environment very moist for as long as it
remained in situ. There was no fluid between the graft and
the dressing but the graft surface appeared very moist.
There was no macroscopic evidence of any parakeratosis
associated with normal graft revascularisation (Rudolph
1973) which was present on the opposite (control) grafts.
This appearance is similar to what Jonkman (1989) found
when superficial wounds re-epithelialised in extremely
moist conditions. This effect according to Jonkman lasted
for a few days, during which time the M.V.T. rate was
increased. One day after the dressings were removed there
was no statistical difference in M.V.T. between the
control grafts and those that had been dressed with Opsite
indicating that parakeratosis possibly influences moisture
loss less in skin grafts than superficial wounds. The
M.V.T. similarity between the control and the Opsite




The control wounds in all groups behaved like skin grafts
studied by other authors (Ragnell 1951, Corps 1969,
Rudolph 1976, Sawhney 1977, Rudolph 1979). In this study,
during the first 3-4 weeks the split skin grafts decreased
in size until they were approximately 50-60% their
original surface area. The initial rapid decrease in size
that occurred in the grafts was not related to weight
loss. All animals lost weight in the first post operative
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week. (See Results - Rat Weights) After two weeks all
animals in the study gained weight, and as surface area is
related to body weight in the rat, the animal's surface
area in general increased in size from 2-3 weeks onwards.
When the surface area results are presented with rat
weight standardized at 400g the initial reduction in size
still takes place. (See Appendix ?)
After 4 weeks the skin grafts then increased in size
reaching a value of 80-90% their original surface area at
15 weeks. There was no statistical evidence to suggest a
difference (Group A,p = 0.1017 ) in the surface areas of
the control groups in the flank and hip flexor area.
Therefore it can be concluded that this area cannot be
used as a model to study wound contraction in a flexor
crease. This will be discussed in the conclusions section.
Opsite Covered Groups
The grafts covered with Opsite all contracted in a similar
manner to the control grafts in the first 2-3 weeks after
wounding. This contraction was not related to animal
weight loss. When rat weight was standardized the initial
reduction in size remained. (See appendix 3)
After 3 weeks the difference in the mean surface area of
the synthetically dressed groups and the control groups
became statistically significant (p < 0.05). This
difference between the means persisted (with the exception
of group D ) with time to the end of the study. The
largest mean surface area at 15 weeks was measured in
group A15 at 164% the original wound's surface area. In
groups B15(Opsite on for 2 weeks), C15(Opsite on for 3
weeks), D15(Opsite on for 4 weeks) and E15(Opsite on for 5
185
weeks) the mean values were 128%, 132%, 105% and 121%
respectively. This indicates that if a split skin graft is
covered with Opsite for only one week the underlying wound
contraction process is altered, resulting in an increase
in surface area to approximately twice that of the control
group. Leaving the Opsite on the split skin graft for a
longer period of time does not result in a further
increase in size.
Although Frank (1985) showed that a wound covered with
Biobrane reacted in a similar manner to a wound covered
with a full thickness skin graft by reducing in size to
only 90% it's original size at 17 days, other workers have
shown varying degrees of wound contraction associated with
full thickness skin grafts. Ragnell (1953), Corps (1969)
and Sawhney (1971) found that wounds covered with a full
thickness skin graft contracted to 80%, 65-80% and 60%
respectively within 3-4 weeks of application. Therefore
although the full thickness skin graft is considered the
best clinical method for reducing wound contraction,
during the first 3-4 weeks following wounding in the rat
there is a reduction of wound size of between 20% and 40%
when full thickness skin grafts are used. After the
initial contraction phase of wound healing the wounds
covered with full thickness skin grafts increase in size
at a greater rate than those covered with split skin
grafts.
The most marked difference between the effect full
thickness skin grafts and split skin grafts have on wound
contraction takes place after 3-4 weeks. This indicates
that wound manipulation may not be able to fully reverse
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the forces influencing wound contraction during this time.
When the split skin grafts were covered with Opsite for
one week (Group A), wound contraction in the first week
was similar to that of the control wounds. When the
dressing was removed the wound had contracted to 94% its
original size. In the following three weeks the skin
grafted wounds that had been covered with Opsite
contracted at a slower rate than the in animal control
wounds. Three weeks after graft application, the wounds
had reduced to 68% their original size. This figure is
comparable to that of full thickness skin graft covered
wounds in other studies (see above). Thereafter, the skin
grafted wounds of the Opsite group increased in size so
that at the end of the study (15 weeks) the wounds were
164% their original size.
If one assumes that the period of wound healing after 4
weeks in the rat is predominantly the phase of collagen
remodeling (Corps 1969) then it would seem that Opsite
covered split skin grafts, like full thickness skin grafts
have their most marked effect on this phase of wound
contraction.
Hip Flexor Area
In order for this area to qualify as a model for wound
contraction split skin grafted wounds must contract more
that those on a non-flexor area. Evaluation of the surface
area results of the control skin grafts in all groups did
not show any significant difference from the control flank
grafts.
Further comparison of the difference between
control\Opsite grafts in the flank area and the difference
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between the control\Opsite grafts in the hip area showed
there to be no statistically significant difference
between the flank and the hip areas.
In other words the site chosen in the hip flexor area was
not a suitable model of a flexor crease.
Myofibroblast Cell Population
Evidence is continuing to accumulate to suggest that these
cells, if not responsible for wound contraction are
strongly associated with it. A recent review (Gown 1990)
indicates that these cells may be derived from either
fibroblasts or macrophages in the locality. These cells
exhibit the characteristics of myofibroblasts because a
smooth muscle phenotype has somehow been induced in them
by the wound environment. How this occurs remains unclear
but it would seem that the cytoplasmic constituents of
myofibroblasts are constantly in a state of change. For
example, in actively contracting wounds, the intermediate
filaments of these cells contain actin, when wound
contraction stops the intermediate filaments loose their
actin components (Darby et al 1990). A monoclonal antibody
was used to stain these cells by binding to the
intra-cellular actin moiety of the intermediate filaments
responsible for contraction. This has been shown to be
successful when used with light microscopy by several
authors (Gabbiani 1971, McGrath 1982). This technique
allows larger sections to be processed giving a more
accurate representation of myofibroblast numbers. However,
the anti-actin antibody also stains myoepithelial cells
(Franke et al 1980), vascular smooth muscle cells
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(Gabbiani 1971) and perivascular pericytes (Darby et al
1990). To try to minimize these cells being erroneously
counted as myofibroblasts the sections were counter
stained with Heamotoxylin and Eosin to assess tissue
architecture. If a cell that stained brown was not at the
skin graft/wound bed interface it was not counted. If a
cell was stained brown and it was in close approximation
to a blood vessel then it was assumed that it was either a
vascular smooth muscle cell or a perivascular pericyte and
was excluded from the count. This was similar to the
technique used by McGrath (1982) when she quantified
myofibroblasts in open wounds. Individual cells were also
not counted as they tended to clump together making single
cell identification impossible.
The results from this study indicate that myofibroblast
clumps peak when split skin graft surface area is at its
smallest both in the control and the Opsite covered
wounds. Although there is a statistical difference between
the dressed and the control groups (see individual graphs
for details) this difference remains constant from about 5
weeks onwards. Between 5 and 15 weeks the surface area in
the Opsite skin grafts changes from 100% to 160% its
original surface area. The myofibroblast clumps during
this time change from 5 clumps per high powered field per
unit surface area to approximately 1 clump per high
powered field per unit surface area. This indicates that
the myofibroblast numbers fall during the time the
overlying skin grafts increase in size.
The design of the study however only allows statistical
comparison between the Opsite covered grafts and the
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control grafts within individual groups so further studies
with greater numbers would be reguired to determine if
there was a statistical correlation between myofibroblast
numbers and change in wound size.
Human Split Skin Grafts
The results of this study indicate that dressing a split
skin graft with an occlusive dressing alters wound
contraction in a manner comparable to the reduction of
wound contraction in the rat. Wound contraction in the
control and the Opsite covered skin grafted wounds is
similar in both groups one month after skin grafting.
However, at 6 months after grafting, there is a
statistically significant difference of 25% (P = 0.007)
between the groups and at 12 months this difference is 30%
(P < 0.001). It is interesting to note that dressing a
split skin grafted wound during the first 7-10 days of
wound healing can have an effect which manifests several
months later, in the collagen remodeling phase of wound
healing. This is the phase when scars expand in both
animals and humans. The rate of expansion in this period
appears to be related to body growth (Peacock and Van
Winkle 1970) therefore one can expect the least expansion
to occur in adults, the participants in this experiment.
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Summary and Suggestions for Further Studies
The overriding aim of treatment of large burns is to
reduce mortality. Surgical intervention is planned to
convert the open burned area into a closed wound covered
with viable epithelium. In burn wounds where little or no
spontaneous reepithelialisation is anticipated, split skin
autografts are routinely used to cover the defect. The
major unfortunate conseguence of this technique is the
subsequent wound contraction which produces considerable
cosmetic and functional disability especially in children.
Attempts to reduce this contraction by late wound
manipulation are labour intensive, costly and only
partially successful.
Wound Contraction
Although wound contraction has been extensively studied in
open wounds it probably occurs to a varying degree in all
wounds. The human superficial wounds studied in this
thesis did in fact contract within 2-3 weeks. Wound
contraction is probably influenced by the amount of tissue
lost during wounding. Even when no tissue is lost, as in
incisional wounds, wound contraction still occurs in the
scar subsequently formed.
When all of the dermis and epidermis is replaced ( a full
thickness skin graft) wound contraction is present in a
reduced form. As one replaces less and less of the dermis
(ie using thinner and thinner split skin grafts) wound
contraction increases.
Therefore it would seem that the initial wounding events
trigger the wound contraction process and subsequent
treatment with current therapies can only reduce and not
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eliminate this phenomenon.
Wound contraction is a dynamic phenomenon. It usually
occurs when collagen is being laid down. In rats maximum
contraction of skin grafted wounds occurs within 3-4 weeks
following wounding. Thereafter the wounds increase in
size, the ones covered with full thickness skin grafts
enlarging more than those covered with split skin grafts.
This event coincides with the time when incisional scars
widen.
Wound Dressings
When an occlusive dressing was used to cover a superficial
wound in humans it was found that it reduced wound
contraction by a statistically significant amount in the
first 2-3 weeks. This indicated the effect these dressings
had on wound contraction could be repeated in humans.
The original papers by Frank indicated that a synthetic
dressing could reduce wound contraction to the same extent
as full thickness skin grafts.
When the split skin grafts in this thesis were covered
with an occlusive dressing for only one week several
findings were noted. The first was that the environment
under the dressing was very humid, and remained so for as
long as the dressing remained in situ. The surface area of
the split skin grafts only began to differ statistically
from the control grafts 3 weeks following wounding ie 2
weeks following dressing removal. The Opsite skin grafts
then began to increase in size and at 15 weeks following
wounding (14 weeks following dressing removal) the Opsite
grafts were almost twice the size of the control skin
grafts.
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Split skin grafts covered with the occlusive dressing for
longer than one week did not exhibit either a more marked
reduction in initial contraction or a further subsequent
increase in size indicating no benefit could be gained
from the prolonged coverage.
The area chosen to represent a flexor crease did not
differ from the non-flexor (flank) area with regards to
the contraction tendencies of the skin grafts. There was
no statistical difference between the sizes of the skin
grafts at either site. The reason for this site failing to
react like a flexor crease is probably because the wound
was made on the flank aspect of the rat's thigh.
Positioning the wound at the junctional area between the
side of the animal and the ventral aspect of the leg may
have resulted in greater success but this would have
required a more obtrusive harness being in situ longer to
prevent autocanabilisation. A dressing designed to protect
a skin graft on the ventral aspect of the rat would not
fully protect the skin graft on the flank area and may in
fact interfere with this graft. The decision was therefore
made to accept the lateral "flexor" wound site in the hope
that it would function as a flexor area. This would mean
no additional restrictions would be placed on the animal.
The results indicate that this area cannot be used as a
model of a flexor crease as wound contraction in this area
does not differ from that in the flank area.
Human Study
The study was then repeated in human split skin grafted
wounds with the graft covered with Opsite for only one
week. The results indicated that there was no difference
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between the grafts in the early phase of wound healing.
However, at 6 and 12 months after wounding there was a
statistically significant difference between both groups -
the Opsite covered skin grafts being the larger.
Moist Wound Healing Effects
How do these dressings work?
When a wound is created the tissue environment at the
surface of the wound has changed from being one which was
bathed in interstitial fluid to one subjected to the
dessicating stimulus of the outside atmosphere. The
reduction of this stimulus may influence wound contraction
by altering the processes of wound healing.
Little work has been done investigating the effects these
dressings have on wound contraction. The majority of work
has been carried out using open wounds as wound models. In
these experiments, wound fluid accumulates under the
dressing lifting it away from the wound surface. When
dermis is present in the wound the initial wound
contraction is reduced (eg. the superficial wounds studied
in this thesis). When no dermis is present, however, wound
contraction does not seem to be retarded when these
dressings are used.
It could be argued from the above findings that the
combination of moist wound healing with a portion of
intact dermis results in a reduction of wound contraction.
One occlusive dressing (Biobrane) adheres to the wound
surface via a membrane polypeptide-fibrin clot
interaction, and this dressing does reduce the contraction
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of full thickness wounds. In order for this dressing to
work wound adhesion is mandatory and this adhesion has
been likened to that of a skin graft. It would seem then
that this dressing is the (temporary) synthetic equivalent
of a full thickness skin graft with respect to reducing
wound contraction. It is possible that the polypeptide
layer on the undersurface of the dressing mimics dermal
collagen whilst the outer nylon\silicone layers induce the
moist environment.
A split skin autograft is a permanent source of dermal
collagen.
When a wound is covered with a split skin graft which is
then dressed with an occlusive dressing the wound healing
environment is altered. During the period the graft is
covered with the dressing the humidity at the skin graft
surface is greatly increased. Water loss from the graft
surface is therefore reduced so diminishing the
dessicating stimulus to the underlying wound. Following
the removal of the dressing the moisture vapour
transmission rates return to those of the control grafts
within 24 hours. This indicates that if these dressings
are to have any effect on wound healing as a result of
their influence on water loss they must do so only during
the time they cover the graft. In this study the shortest
period of time the skin grafts were covered with Opsite
was one week.
The skin grafted wounds that have been covered with Opsite
were always larger than their control equivalents. When
Biobrane was removed from open wounds, contraction
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continued albeit in a reduced form. The removal of Opsite
from the skin grafts resulted in a similar reduction of
wound contraction.
Skin grafted wounds that had been covered with Opsite
virtually never contracted to the same extent as their
controls. At the point of maximal contraction (3-4 weeks
in rats) there was on average a 26% difference in surface
area between the Grafts which had been covered with Opsite
and the controls. This figure is similar to that found
when other authors have compared the sizes of wounds
covered with full thickness and split skin grafts.
The most marked difference between the Opsite Groups and
the Control Groups occurs during the later stages of wound
healing. At the end of the study (15 weeks post wounding)
there was a mean difference of 42% between those grafts
that had been covered with Opsite and those that had not.
It is during this period of wound healing that the
differences between full thickness and split skin grafts
are most obvious.
From the data above it can be assumed that the early
manipulation of a split skin grafted wound results in a
reduction of wound contraction which manifests several
weeks following dressing removal.
The time span of a healing wound in a human is greater
than that of a rat. In burns patients many months may
elapse before a split skin grafted wound stops contracting
and enters the maturation phase of healing. It is
therefore not surprising to note that it took longer for
the differences between the skin grafted wounds covered
with Opsite to manifest. The mean difference between the
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Opsite covered grafts and the control grafts was 18% at 6
months and 23% at 12 months following surgery. The skin
grafts covered with Opsite were still only 89% their
original size at 1 year indicating that moist wound
healing does not totally eradicate the stimulus or the
effects of wound contraction.
Covering a split skin graft with an occlusive dressing
during the early stages of wound healing has a significant
effect on wound contraction. This effect persists when the
dressing is removed and manifests maximally several months
after its removal in rats as well as humans. It would seem
likely therefore that the early manipulation of the wound
environment may result in an alteration of the cells
associated with wound contraction.
During the two decades since their identification data has
continued to accumulate to suggest that myofibroblasts are
the cells responsible for wound contraction. Recent
studies suggest that smooth muscle actin manifests mainly
in myofibroblasts present in actively contracting wounds.
Therefore, the identification of these cells with an
anti-actin antibody should give an accurate picture of the
contracting capability of a wound.
The data collected for this work indicates that the
numbers of myofibroblasts under a split skin graft are
reduced when that graft is covered with an occlusive
dressing. These numbers remain lower than the control
wounds following dressing removal to the end of the study.
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If the surface area data is combined with the
myofibroblast data it would seem that:
A) myofibroblast numbers rise when wounds decrease in size
and fall when wounds increase in size
B) The skin grafted wounds that contract less and increase
in size to a greater degree contain a smaller numbers
of myofibroblasts.
Crude cell counts may not be the complete answer to the
guantification of the contractile force of the
myofibroblasts. Their identification with an anti-actin
antibody, although more accurate than pure morphological
identification, also does not give the full answer. The
immunocytochemical method does not differentiate between
cells with varying quantities of actin in their cytoplasm.
Myofibroblasts with different guantities of intracellular
actin, and therefore (presumably) different contractile
properties could not be differentiated with this method.
However, to date, no other method of identification exists
which is more accurate than the one used in this thesis.
An observed effect of Opsite dressings on open wound
healing is the reduction of the inflammatory phase of
wound healing. The human split skin grafts that had been
covered with Opsite appeared to be paler and more pliable
than the controls. The patients also commented that these
grafts were less painful and itched less than the control
grafts. These subjective findings do not contradict
histological findings of a reduction of inflammation in
wounds dressed with Opsite. One potential link between the
reduction of inflammation and the reduction of wound
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contraction via a reduction of myofibroblast numbers is
the cytokine TGF beta. This mediator has been found to
increase the inflammatory response, induce fibroplasia and
alter cultured fibroblast phenotype to that of a wound
healing fibroblast. It is possible that moist wound
healing results in an alteration of the cytokine profile
of a healing wound with perhaps a reduction in mediators
such as TGF beta or other similar polypeptides.
This results in a diminished inflammatory response and a
reduction of fibroplasia. When a wound is covered with a
skin graft this leads to reduction in wound contraction.
Wound contraction is only reduced and not eliminated when
early wound manipulation by occlusive dressings takes
place. This is not surprising as wound contraction takes
place when incisional wounds heal and when wounds are
covered with full thickness skin grafts.
Incisional wounds by definition have no tissue loss so all
events following wounding occur as a result of the initial
wounding trauma and the responses to it. It would be of
interest to investigate the m.v.t. rates of these wounds
to see if there is a difference between water loss from
traumatised skin and normal skin which may account for the
subsequent contraction of incisional wounds.
The contraction that occurs in incisional wounds could
therefore be regarded as "baseline wound contraction" and
any attempt to reduce this contraction would reguire more
active wound manipulation which may result in a disruption
of the other aspects of normal wound healing. A reduction
of this early wound contraction would be beneficial as
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burn contractures can develop in the first few weeks
following injury. This therefore occurs before the effect
of moist wound healing manifests.
Summary
Wound contraction is a dynamic phenomenon which occurs in
all wounds and can be reduced when the early wound healing
environment is altered by the judicious use of occlusive
dressings. Moist wound healing may be the initiating
factor which results in a reduction of the inflammatory
phase of wound healing one manifestation of which is a
reduction in wound contraction.
It would seem that the presence of dermis is required for
these dressings to work. Dermis is present in superficial
wounds and wounds covered with a skin graft. When these
wounds are covered with an occlusive dressing wound
contraction is reduced.
These dressings only reduce and do not eliminate wound
contraction. Their main effects manifest during the
collagen remodelling phase of wound healing. This phase
can occur late in human wound healing when contractures
secondary to wound contraction may already exist.
The quantification of the cytokine profile of healing
wounds of various types may provide baseline information
apon which the effects of moist wound healing could be
compared.
Wounds of differing types covered with different skin
grafts could therefore be compared to see if there is a
difference in cytokine concentrations accounting for the
differences in wound contraction. If such differences
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exist then specific cytokines could be neutralised by the
addition of antibodies perhaps in the dressing so
overcoming the fundemental tendency of the wound to










Lighting 12 hours light, 12 hours dark cycle
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Appendix 2 Split Skin Graft Thickness
A15
Rat No Flank hip
1249 0.320 0.244
1250 0.275 0 .161
1251 0.180 0. 307
1252 0.200 0.268
1253 0 . 264 0 .160
1317 0.145 0.256
1255 0.158 0.203











































































































38 Mean Difference 0.009
-0.577 95% Confidence -0.040
0.567 Limits 0.020
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Rat Weights (in grams )















Rat Weights (in grams )
Rat Weeks after Operation
No. Opn. 1 2
1372 430 382 410
1373 438 404 415
1376 435 400 407
1381 431 336 391
1382 463 423 436
1392 432 326 346
1397 461 425 430
1388 388 326 346
Mn.Wt. 435 378 398
95%
confidence 450 405 420
limits 420 350 375
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Group A3
Rat Weights (in grams )
Rat Weeks after
No. Opn 1 2 3
1552 434 361 407 420
1557 463 378 410 415
1559 408 339 388 401
1558 401 351 402 418
1561 464 371 434 440
1560 390 347 398 411
1562 371 297 356 379
1571 414 361 463 471
Mn.wt. 418 351 407 419
95%
Confidence 396 334 387 402
Limits 440 367 428 437
Group A4
Rat Weights (in grams )
Rat Weeks after operation
No. Opn 1 2 3 4
1334 422 381 405 450 479
1335 369 348 356 382 402
1336 425 377 384 421 450
1337 373 384 394 407 459
1338 394 330 357 383 438
1339 421 335 360 408 407
1340 423 382 394 440 475
1341 479 324 371 397 432
Mn.wt. 413 358 378 411 443
95%
Confidence 390 341 365 395 424
Limits 436 374 390 427 461
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Group A5
Rat Weights (in grams )
Rat Weeks after operation
No. Opn . 1 2 3 4 5
1495 464 405 420 457 487 487
1498 428 388 397 438 466 483
1500 434 371 383 460 490 508
1513 438 368 381 463 506 525
1512 440 406 423 497 533 551
1510 421 380 399 410 514 535
1515 468 411 430 470 492 499
1517 390 352 368 391 415 423
Mn.wt. 435 385 400 448 488 501
95%
Confidence 419 371 386 426 465 476
Limits 451 399 415 470 511 527
Group A10
Rat Weights (in grams )
Rat Weeks after operation
No. Opn . 1 2 3 4 5 6 7 8 9 10
1293 371 288 346 399 421 423 482 438 450 558 583
1294 403 358 401 438 463 480 509 504 522 539 560
1295 406 345 372 418 395 450 497 487 497 522 543
1296 416 363 393 447 469 488 503 508 515 536 562
1297 393 335 366 420 457 472 480 496 511 528 555
1298 407 364 389 434 457 477 478 498 511 531 549
1299 359 342 357 390 411 427 441 445 462 477 492
1300 367 316 335 374 402 422 437 455 463 480 501
Mn.Wt. 390 339 370 415 434 455 478 479 491 521 543
yo1©
Confidence 376 322 355 399 415 437 461 461 473 503 523




Rat Weight (in grams )
Weeks After Operation
No. Opn . 1 2 3 4 5 6 7 8 9
1249 346 315 364 400 446 472 491 503 527 530
1250 352 312 344 377 417 443 466 487 506 510
1251 384 356 396 436 475 502 537 560 586 599
1252 358 307 363 389 421 436 453 471 472 479
1253 341 306 344 375 410 431 444 464 472 478
1317 379 357 384 387 392 414 435 467 470 492
1255 347 322 369 400 432 446 460 482 469 481
1256 323 294 340 381 420 443 465 484 500 506




341 306 350 380 410 431 448 470 474 483
367 336 376 406 443 466 490 510 527 536
Rat Weeks After Operation
No. 10 11 12 13 14 15
1249 557 569 572 597 600 606
1250 530 543 547 562 572 582
1251 630 638 666 692 699 710
1252 495 504 501 510 510 522
1253 492 501 507 521 522 532
1317 509 521 540 555 564 575
1255 489 499 514 521 536 551
1256 520 531 541 562 562 578
Mean Wt. 528 538 549 565 571 582
95%
Confidence 497 508 514 527 532 544
Limits 558 569 583 603 609 620
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Group B2
Rat Weight (in grams )
Rat Weeks after
No. Opn. 1 2
1600 423 379 460
1601 455 416 400
1602 401 360 347
1603 455 407 410
1604 428 376 396
1605 450 405 406
1606 459 405 393
1511 412 373 403
Mn.Wt. 435 390 402
95%
Confidence 421 377 382
Limits 450 403 422
Group B3
Rat Weight (in grams )
Rat Weeks after
No. Opn 1 2 3
1572 455 402 400 410
1578 396 373 370 381
1579 361 344 392 400
1580 459 378 410 430
1581 393 331 355 567
1582 435 398 408 417
1583 464 410 421 439
1584 432 362 392 403
Mn.Wt. 424 375 394 431
95%
Confidence 400 356 379 393
Limits 448 393 408 468
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Group B4
Rat Weights (in grams )
Rat
No. Weeks after operation
Opn 1 2 3 4
1343 431 354 347 400 435
1344 424 363 354 400 428
1345 415 395 343 361 399
1346 422 409 390 407 424
1347 409 364 356 389 422
1348 394 370 357 392 421
1349 447 420 406 440 466
Mn.Wt. 420 382 365 398 428
95%
Confidence 409 365 348 382 414
Limits 432 400 381 415 442
Group B5
Rat Weight (in grams )
Rat Weeks after operatii
No. Opn . 1 2 3 4 5
1524 424 374 376 419 445 459
1608 457 390 401 445 490 514
1609 432 370 392 401 431 461
1610 440 358 373 429 471 492
1611 337 380 399 380 415 433
1613 437 341 363 406 451 472
1614 432 361 393 431 480 506
1615 466 382 418 465 504 514
Mn.Wt. 428 370 389 422 461 481
95%
Confidence 403 359 378 405 441 462
Limits 454 380 401 439 481 501
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Group BIO













Confidence 324 342 379 406 422 441 444 472 487 501 525
Limits 356 374 406 425 444 466 483 501 532 527 550
GROUP B15
Rat Weight (in grams )
Rat WEEKS AFTER OPERATION
No. Opn . 1 2 3 4 5 6 7 8 9
1257 357 279 333 382 426 454 482 503 527 543
1259 348 322 351 374 424 440 457 473 489 501
1260 342 324 374 400 431 456 482 502 506 517
1261 357 320 359 497 437 465 489 514 536 542
1263 358 336 371 395 436 461 480 500 501 519
1264 347 326 339 371 405 420 430 452 457 461
1265 368 340 376 410 448 476 495 513 522 539
1266 350 340 365 384 416 435 446 471 460 473
Mn.Wt. 353 323 359 402 428 451 470 491 500 512
95%
Confidence 348 311 348 375 419 439 455 476 481 492
Limits 359 336 369 428 437 463 485 506 519 532
Rat Weeks After Operation
No. 10 11 12 13 14 15
1257 561 573 577 578 579 591
1259 512 522 532 542 595 555
1260 560 581 549 563 569 575
1261 567 583 576 591 593 603
1263 530 543 550 554 560 565
1264 476 490 483 489 505 516
1265 553 572 587 610 616 631
1266 488 499 490 513 520 533
Mn.Wt. 531 545 543 555 567 571
95%
Confidence 508 521 518 529 542 547
Limits 554 570 568 581 592 595
212
Weeks after operation
Opn . 1 2 3 4 5 6 7 8 9 10
341 358 404 416 425 442 463 461 498 493 517
329 352 395 411 422 438 451 476 489 510 526
369 380 395 422 432 457 410 490 504 525 552
341 360 400 410 423 441 460 473 485 504 531
359 378 409 435 459 480 500 517 582 505 523
304 323 365 407 428 455 478 480 494 509 540
310 325 358 391 415 431 444 471 485 506 532
368 390 415 434 460 484 501 522 539 560 579
340 358 393 416 433 454 463 486 510 514 538
Group C3
Rat Weight (in grams )
Rat
No. Weeks after operation
Opn 1 2 3
1585 439 384 396 411
1586 411 361 376 391
1587 413 360 363 381
1590 434 390 366 391
1591 416 346 351 383
1593 374 312 361 374
1596 477 378 408 419
1598 413 390 424 441
Mn.Wt. 422 365 381 399
95%
Confidence 403 348 364 384
Limits 441 382 397 414
Group C4
Rat Weights (in grams )
Rat
No. Weeks after operation
Opn 1 2 3 4
1350 445 397 386 388 381
1351 464 424 426 441 453
1352 430 398 347 390 397
1353 377 357 382 359 374
1357 456 391 401 421 419
1358 406 363 352 396 417
1359 469 431 407 412 453
1360 449 420 376 374 408
Mn.Wt. 437 398 385 398 413
95%
Confidence 417 380 367 381 394
Limits 457 415 402 415 432
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Group C5
Rat Weight (in grams )
Rat Weeks after operation
No. Opn. 12345
1617 357 330 347 351 383 411
1618 473 426 435 459 484 508
1619 371 303 319 326 394 415
1620 446 388 400 427 457 430
1621 462 379 393 414 456 488
1563 461 439 449 356 469 478
1564 442 407 428 473 449 469
1569 442 398 403 446 475 499
Mn.Wt. 442 391 404 414 455 470
95%
Confidence 332 291 301 307 342 352
Limits 553 491 507 522 568 587
Group CIO
Rat Weight (in grams )
Rat Weeks after operation
No. Opn. 1 2 3 4 5 6 7 8 9 10
1309 406 368 375 393 405 431 460 466 471 484 500
1310 403 381 384 396 411 442 483 499 514 533 563
1311 388 363 340 353 373 397 413 418 446 465 482
1312 394 361 353 367 397 429 457 475 495 525 551
1312 382 350 340 376 381 404 442 437 447 463 473
1315 390 357 348 360 372 395 419 425 446 470 493
1316 412 379 320 377 388 430 487 478 495 517 533
Mn.Wt.
QC?.
398 368 353 378 393 421 451 458 475 495 515
Confidence 391 360 338 367 382 408 431 437 456 474 491
Limits 406 376 368 389 404 434 471 479 494 516 539
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GROUP CI5
Rat Weight (in grams )
Rat Weeks After Operation
No. Opn . 1 2 3 4 5 6 7 8 9
1267 356 324 333 358 387 403 420 449 442 450
1268 359 320 314 347 375 397 423 453 454 467
1269 321 271 316 342 351 373 387 402 404 406
1270 366 343 296 287 327 362 388 313 273 340
1271 373 356 349 355 390 415 434 470 470 474
1272 381 326 369 378 407 435 464 492 500 512
1273 345 302 243 266 306 355 387 430 426 430
1274 363 334 364 371 405 434 458 490 492 509
Mn Wt 358 322 323 338 369 397 420 437 433 449
95%
Confidence 346 305 296 312 345 377 400 399 386 412
Limits 370 339 350 364 392 417 440 475 479 485
Rat Weeks After Operation
No. 10 11 12 13 14 15
1267 466 475 485 508 510 513
1268 484 500 494 506 507 524
1269 406 446 418 428 430 449
1270 390 425 406 329 297 350
1271 494 515 521 535 537 582
1272 529 542 556 570 572 610
1273 449 476 466 484 484 517
1274 521 540 538 561 562 547
Mean Wt 467 490 486 490 487 512
95%
Confidence 435 462 451 439 430 459
Limits 500 517 520 541 545 564
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GROUP D4
Rat Weights (in grams )
Rat
No. Weeks after Operation
Opn 1 2 3 4
1361 406 408 381 366 363
1362 471 461 425 429 436
1363 450 410 380 401 412
1364 397 363 362 370 365
1365 454 422 412 414 441
1366 451 430 428 428 450
1367 437 393 416 439 438
1368 460 391 390 420 423
Mn.Wt. 441 410 399 408 416
95%
Confidence 424 391 384 391 394
Limits 458 429 415 426 438
Group D5
Rat Weight (in grams )
Rat Weeks; after <Operation
No. Opn . 1 2 3 4 5
1532 394 339 339 418 420 418
1533 335 295 306 327 351 396
1534 381 328 364 378 396 422
1535 393 350 352 368 384 392
1536 385 Died
1537 360 362 350 360 387 415
1539 389 362 385 340 350 421
1540 355 321 350 342 370 398
Mn.Wt. 374 337 349 362 380 409
95%
Confidence 360 320 333 341 363 400
Limits 388 353 366 383 397 418
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Group D10
Rat Weight (in grams )
Rat Weeks after wounding
No. Opn. 123456789 10
1318 378 319 355 370 357 389 423 442 465 481 479
1319 435 380 394 415 420 431 438 503 530 547 561
1320 380 337 396 419 417 422 456 469 495 523 514
1321 376 322 360 384 387 400 439 460 481 500 504
1322 353 320 344 357 360 387 400 417 437 451 453
1323 403 346 375 403 412 425 471 491 512 523 542
1324 430 322 371 410 424 437 472 494 507 533 539
1325 396 336 374 372 375 390 439 455 475 487 485
Mn.Wt. 398 368 353 378 393 421 451 458 475 495 515
95%
Confidence 380 355 341 363 375 408 435 439 456 474 491
Limits 417 381 365 393 411 434 467 477 494 516 539
GROUP D15
Rat Weight (in grams )
Rat Weeks After Operation
No. Opn.123456789
1275 365 344 346 372 380 381 419 459 479 500
1276 390 347 360 384 433 434 460 490 502 520
1278 345 334 328 359 372 391 462 455 471 483
1279 427 376 282 330 375 420 486 499 523 543
1281 406 376 368 385 411 444 456 525 504 568
1282 382 357 366 393 423 417 492 488 520 534
1284 392 371 395 421 434 432 453 482 565 584
Mn.Wt 387 358 349 378 404 417 461 485 509 533
95%
Confidence 368 346 325 358 385 401 445 469 488 509
Limits 405 369 374 397 423 433 478 502 531 558
Rat Weeks After Operation
No. 10 11 12 13 14 15
1275 523 547 550 568 570 590
1276 542 573 570 574 576 584
1278 512 539 539 555 559 571
1279 579 597 610 632 634 641
1281 596 607 629 630 648 678
1282 560 579 592 606 610 619
1284 612 623 630 667 681 696
Mn.Wt 561 581 589 605 611 626
95%
Confidence 535 560 563 577 580 592
Limits 586 602 614 633 642 659
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Group E5
Rat Weight (in grams )
Rat Weeks after wounding
No. Opn 1 2 3 4 5
1541 431 385 376 413 441 445
1544 369 339 339 350 342 403
1548 360 336 322 341 356 363
1549 361 318 331 349 349 387
1550 398 342 355 386 437 452
1556 402 372 373 411 446 455
Mn.Wt. 387 349 349 375 395 418
95%
Confidence 366 330 333 351 358 389
Limits 408 367 366 399 432 446
Group E10
Rat Weight (in grams )
Rat Weeks after wounding
No. Opn. 1 2 3 4 5 6 7 8 9 10
326 426 379 394 405 422 422 463 496 511 516
327 378 356 363 407 351 396 433 460 477 491
328 389 351 381 381 385 411 438 460 479 487
329 458 396 412 427 440 not 465 493 519 538 557
330 391 355 381 417 423 done465 484 514 534 542
332 445 399 388 412 396 437 470 497 511 528
333 438 384 361 393 392 433 446 473 487 502
Mn.Wt. 418 374 383 406 401 433 461 488 505 518
95%
Confidence 396 360 371 396 381 415 445 472 488 500
Limits 439 388 395 416 422 451 477 505 523 536
218
Group El5
Rat Weight (in grams )
Rat Weeks After Operation
No. Opn . 1 2 3 4 5 6 7 8 9
1324 389 325 367 406 415 409 441 503 529 558
1287 397 346 368 366 397 408 437 459 487 510
1288 368 327 361 375 376 378 400 430 477 473
1289 368 333 357 342 326 347 372 428 450 476
1290 373 313 297 358 372 374 400 448 470 495
1291 356 311 350 383 387 390 415 421 438 455
1292 344 303 329 335 318 320 360 391 410 431
1317 409 342 403 422 450 451 471 487 500 518
Av.Wt. 376 325 354 373 380 385 412 446 470 490
95%
Confidence 362 315 334 354 352 359 388 422 446 464
Limits 389 335 374 393 408 411 436 470 494 515
Rat Weeks After Operation
No. 10 11 12 13 14 15
1324 572 608 633 654 671 692
1287 530 550 566 570 582 601
1288 491 488 506 512 519 537
1289 492 530 544 562 576 590
1290 510 518 536 546 560 579
1291 469 462 446 458 492 515
1292 460 458 466 485 496 509
1317 531 538 543 547 554 570
Mn.Wt. 507 519 530 542 556 574
95%
Confidence 483 487 492 503 519 536
Limits 531 551 568 580 594 612
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PILOT STUDY
This study compared the results of 2 methods of measuring
the surface area of a 2x2cm acetate block.
The columns labelled shape contain the results of
photographing the shape through a video camera and
projecting that image on a computer screen. This image was
traced with an electronic mouse and the surface area of the
traced shape calculated by the computer.
The columns labelled tracing contain data resulting from the
initial tracing of the 2x2cm acetate block onto an acetate
sheet.The surface area of the traced shape was then
calculated using the above method.
The units used are mm2.
Tracing Shape Tracing Shape
396 400 384 395
400 415 356 391
378 392 358 371
321 389 381 408
350 416 387 406
368 387 369 412
357 394 375 400
325 378 374 387
349 409 388 381
410 410 397 392
369 420 392 379
378 387 384 388
375 375 364 396
381 377 366 407
395 398 356 393
378 406 368 422
365 408 372 431
369 403 384 378
369 379 395 385
370 386 367 399
372 381 352 386
365 389 361 405
352 392 365 406
367 394 391 385
369 399 400 402
378 420
Tracing Shape




%error 6.90 0 . 94
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Pilot Study - Moisture Vapour Transmission
M.V.T. RATES (g/m2/hr)
Rat No FLANK FLANK HIP HIP
skin wound skin wound
1249 5.30 59 . 30 5.20 69.00
1250 6.20 69. 30 4 . 60 58.90
1251 8 . 90 70.90 8.20 78.30
1252 5.10 78 . 60 9.10 69 . 20
1253 10.20 68 . 50 7 . 60 82 .10
1317 9 . 60 69 .10 7.50 83 . 60
1255 8.40 70 .10 6.20 56.10
1256 5.30 56.90 3.90 69.80
1257 5.90 69 . 00 7.10 74.40
1259 5.60 69.90 9 . 20 69 . 00
1260 8.10 59.30 4 . 80 75.60
1261 7 . 30 74 . 30 5.90 78.40
1263 7 . 20 68.90 6.10 80. 30
1264 6.80 68 .10 6.90 59 . 00
1265 5.50 85. 30 7.10 60 . 90
1266 4 .90 79.50 7 . 00 63 . 20
1267 8 . 90 81.10 5.00 94 . 00
1268 7.30 56 . 30 6.30 89 . 20
1269 9.50 69.20 6.90 75.60
1270 9.60 67 . 50 4.90 69 . 00
1271 8.10 64.90 7.00 80.10
1272 5.60 73 .10 8.10 78 . 20
1273 7 .60 82 .10 7 . 60 65.90
1274 5.90 78 . 50 5.90 65.80
1275 6.30 69 . 40 6.80 63 . 00
1276 9 .10 73 . 20 6.00 89 . 40
1278 9 . 90 65. 30 7.00 76 . 00
1279 10 . 50 89 . 00 7.50 68 . 00
1281 11. 20 62.90 7.90 59.90
1282 4.90 68 . 30 8.40 74 . 40
1284 8.30 74.20 8 .10 69.60
1285 7.80 79 . 60 6 . 00 96 . 20
1286 11.10 65. 30 8.50 58.30
1287 4.90 56. 30 7.30 67 . 90
1288 6.20 89.00 6.90 80.00
1289 9.50 78.60 9 . 00 78.30
1290 7.30 81. 50 9 . 80 65.00
1291 7 . 90 58 .10 5 . 80 71. 00
1292 8 . 40 65 . 90 3.90 80 .10
mean 7.59 70.93 6.85 72.89
95%
Confidence 7.01 68.24 6.40 69.81
Limits 8.17 73.62 7.29 75.97
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Moisture Vapour Transmission Results
The following tables are derived from measurements of
moisture vapour transmission measured with an evaporimeter.
M.V.T. is measured in grams of water per meter sguared per
hour (g\m2\Hr).
The time (in weeks) the measurements are made is indicated
in the row at the top of the table.
The letters after the numbers refer to the times immediately
following dressing removal
a 1 minute following Opsite removal
b 10 minutes following Opsite removal
c 20 minutes following Opsite removal
There is a column labelled Id in Group A15 comprising of
data recorded 24 hours following Opsite removal. The rats in
this group took a long time to recover from the anaesthetic
and a proportion required (temporary) ventilatory support.
As a result of this no further anaesthetics were given
within 24 hours of a lengthy anaesthetic.
The tables comprise of data from the flank wounds and the
hip wounds.
At the bottom of each section are 3 rows.
The mean values and 95% confidence limits for the mean
values are contained therein.
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GROUP A 15. Flank
Rat
No. Time ("Weeks 1
0 1 la lb lc Id 2 3
Control Wounds
1249 30 . 5 29.0 27 . 7 23 . 0 26.5 30 . 0 25.0 22
1250 31.9 29.7 25.7 23 . 6 25. 2 29.9 24 . 7 19
1251 23 . 0 32 . 3 25.5 24.2 29.9 22.1 25.9 21
1252 34.2 24 .1 26.6 25.6 25.0 23.0 27 .1 24
1253 28.6 25.7 26.1 20.7 25.0 26.7 27.8 18
1255 34.7 25.8 23 .1 22 . 9 24 . 9 31. 0 25.8 21
1256 21.5 28 . 6 22 . 0 21.0 21.8 23.6 24 . 8 23
mean 29.5 28 . 2 25.7 23 . 0 24.8 26.1 25.4 21
95% 26. 3 26.4 24.2 22 . 0 22.8 23.6 24.3 20
cl 32.7 29.9 27.2 24.0 26.7 28.5 26.5 22
Weeks
4 5 10 15
1249 17.0 15.0 14.0 13.0
1250 16.4 15.9 13 . 3 11.0
1251 19.9 12.9 19.0 17.1
1252 15.5 17 . 9 15. 3 16.3
1253 15.7 16.1 14.7 12.9
1255 15.0 14.5 13.1 11. 4
1256 16.0 17.1 14.4 13 . 7
mean 16 . 3 15.5 14 . 6 13 . 4
95% 15.2 14.5 13.3 12.0
cl 17.3 16.5 15.9 14.9
Time (Weeks
0 1 la lb lc Id 2
Opsite Wounds
1249 16.0 15.8 105.6 87.7 33.9 29 . 8 22.5 20
1250 15.9 14.9 110 . 4 89.5 37 . 7 25.1 23.1 20
1251 16.7 15.5 98 . 9 76. 9 29.4 27 . 9 24.9 24
1252 18.0 17.4 100.0 90 . 8 30.6 31.1 21.0 25
1253 14.7 12.9 104 . 5 85.3 35. 3 33.9 19. 3 17
1255 15.5 15. 3 103 . 8 91.1 40 . 0 27.0 24.0 20
1256 16 . 7 15.1 100.0 76.9 32 . 9 23.1 25.8 22
mean 16. 2 15.5 103 . 3 84.9 34.5 28.3 23.3 21
95% 15.6 14 . 6 100.9 81.0 32 . 2 26.1 21.8 19
cl 16.8 16.4 105.8 88.7 36 . 8 30.5 24.8 22
Weeks
4 5 10 15
1249 18.3 15.6 13 .7 12.2
1250 21.8 15.0 12.9 12 . 0
1251 17 . 9 18 . 0 12.1 11.9
1252 12.3 14.9 16.4 16.8
1253 18.1 13 . 3 15.8 12.5
1255 14 . 3 16 .1 15.9 11.1
1256 23 . 6 19 . 9 12.3 10 . 0
mean 17.7 16 .1 14 . 4 12 . 5
95% 15.2 14.7 13.2 11. 2

























0 1 la lb lc Id 2
Control Wounds
1249 34.7 23 . 5 24. 3 24 . 9 26.9 26.4 20.4 18
1250 32.2 24.8 23.6 25.0 27.1 26.3 23 . 2 19
1251 33 . 2 34.9 25.4 25.4 26.6 26.8 21.5 20
1252 35.4 32 .1 26 .1 26.8 26 . 2 25.1 24.9 17
1253 26.9 33 . 2 26.3 23.5 25.9 23.4 23.7 18
1255 32.9 29.8 23 . 4 24 . 3 21.9 21.4 22.2 17
1256 28.7 26.9 26 . 8 23 . 3 26.0 25.5 21. 8 17
mean 31.5 29. 3 25. 4 25.2 25.6 25.5 22.7 18
95% 29.4 26.6 24 . 4 24.1 24.5 24 . 0 21.7 17
cl 33.6 31.9 26.3 26.2 26.7 27.0 23.6 19
Weeks
4 5 10 15
1249 16.2 14 . 3 14 . 0 13.5
1250 15.0 15. 0 12.0 12 . 3
1251 17.8 15.5 13.6 15 . 6
1252 18.3 13.3 13 . 5 14.9
1253 16.6 14.4 13 . 9 15.8
1255 14.5 16.9 15.0 12.9
1256 16.3 15.3 11.1 13.6
mean 16 . 2 14 . 9 13.5 14 .0
95% 15.4 14 . 2 12 . 6 13.2
cl 17.1 15.6 14 . 3 14.8
Time (Weeks')
0 1 la lb lc Id 2 3
Opsite Wounds
1249 15. 3 16.1 100. 3 78.9 55.6 45.9 26 . 0 19
1250 16.1 15.4 105.3 85.2 61.2 32.2 23.5 18
1251 14. 3 15.7 104 . 9 83.3 67.7 36 .1 21.1 18
1252 14.9 14.7 105.5 84.9 63.0 38.0 22.2 19
1253 15.5 16.6 107 . 6 79 . 2 59.4 30 . 0 24 . 9 16
1255 16.5 16.5 110.2 81.3 69 .1 39.0 25.0 17
1256 18. 2 14.6 100 . 0 84.3 63.7 33 . 7 27.3 18
mean 15.8 15.6 104 .1 81.0 62 . 0 36.4 24.2 17
95% 15.0 15.0 101.4 78 . 0 58.9 33.3 22.9 17
cl 16.5 16.1 106 . 7 84.1 65.2 39.6 25.5 18
Weeks
4 5 10 15
1249 13 . 4 15.0 11.2 12.5
1250 16.0 16.5 13.6 12.6
1251 15.9 18.0 14.9 12 . 7
1252 17.8 13 . 6 14.4 11.3
1253 17.0 14.0 13.2 13 .9
1255 15.5 16.2 16.0 12.0
1256 16.1 18 . 6 12.7 15.9
mean 15.8 16 . 0 13.7 13.1
95% 14 . 9 14 . 8 12.7 12 . 2




































30.3 25.3 24.0 25.3 24.4 20.1 19.3 15.3 12.6 10.0






23.9 23.7 23.3 17.6 16.4 13.6 11.8
24.8 23.5 24.0 17.3 16.3 12.0 12.0
26.0 24.9 25.9 17.8 17.0 12.9 12.3
25.1 26.1 26.7 19.2 14.9 11.8 10.9
23.0 28.3 23.5 18.6 15.5 12.6 10.8
mean 30.1 25.9 24. 9 24.8 25.0 23 . 2 17 . 6 15.4 12.6 11.3
95% 28.8 25.1 23. 7 24.0 24.0 21.6 16.6 14.5 12.1 10 . 4
Cl 31.5 26.6 26. 1 25.6 26.0 24.8 18.6 16.3 13.1 12.2
Opsite Wounds
1257 16.2 15.8 100 .7 78 . 6 59.0 25.6 19.3 16.3 13 . 3 9.3
1259 15.6 12.9 105 . 3 79.2 63.4 28.3 15.9 15. 2 12.6 11. 2
1260 13 . 6 13.3 104 .0 69.1 65.1 23.1 17.7 19 . 0 15.6 9.6
1261 17.6 14.7 106 . 3 70.8 62.0 25.6 18.3 15.8 14.0 12.5
1263 16 . 0 14.4 104 .5 84.1 58.6 25.0 18.5 15.3 13 .9 13 . 0
1264 15.9 16.5 100 .9 80.6 59.1 24.9 18.6 16.7 13 .7 13.8
1265 15. 5 15.5 101 .5 81.1 66.0 28.9 17.3 16.0 14 .1 12.7
mean 15.6 14.8 103 .4 77 . 8 62.2 26.4 18.1 15.9 13 .8 11.8
95% 14.9 14.0 102.0 74.5 60 . 3 24.9 17.4 14.8 13.2 10.8
cl 16 . 4 15.6 104 . 7 81. 2 64 .1 28.0 18.8 17.0 14 .4 12.9
Hip
Control Wounds
1257 33 . 3 29.8 26.9 25.9 25.4 24.7 17.9 13.5 16.3 8 . 3
1259 31.0 25.3 25.8 26.8 30 . 6 21.6 17.3 16.9 18.9 12.6
1260 29.6 24.6 27.9 28.3 24.6 20 . 0 18 . 6 15.7 12.3 11.2
1261 28.9 24.5 23.2 26.4 28.1 19.9 19.3 15.4 15.6 10.2
1263 31. 2 23.1 26.8 27 . 3 27.6 19.1 19.1 14 . 3 17.6 13 . 5
1264 30.0 27.0 25.9 23.1 27.7 18.7 18.6 19.3 18.0 13.0




26.2 26.7 27.4 21.6 18.7 15.0 16.0 11.8
25.3 25.6 26.2 19.8 17.9 13.5 14.4 10.6
27.1 27.8 28.5 23.3 19.5 16.5 17.5 13.0
Opsite Wounds
1257 16. 3 15.9 106.1 64 . 3 45.0 25.6 25.6 14.5 12.0
1259 15.1 15.7 105.4 66.0 36.2 23.4 13.4 16.5 13.1
1260 18. 3 19.4 110.0 65. 3 39 .1 21.0 19.8 15.9 15.9
1261 16.4 13 .6 105.6 68 .1 37.9 29.4 17.0 16.4 13 . 8
1263 16.9 15.4 104 . 6 69.1 35.2 21.3 16.9 17.0 12.9
1264 15. 4 13 .8 107.7 75.3 43.1 24.8 17.9 16.8 13.7
1265 18.7 16.5 106.3 59.1 41.2 24.0 18.4 15.9 14.5
mean 16.8 15. 7 105.8 66.7 40 . 3 24.0 18.5 16.0 13 . 9
95% 15.9 14.5 104.1 63.7 37 . 8 22.2 16.3 15.4 13.1








1 2 3 3a 3b 3c 4 5 10 15
Rat Flank
No. Control Wounds
1268 31.2 26.3 19.5 15.8 15.5 15.9 13 .5 15. 3 11. 9 7.8
1269 32.9 28.7 20. 3 15.3 15.0 15.3 14.9 10.5 12.0 12.5
1270 29.6 29 . 0 26 . 0 15.2 14.9 15.0 12 . 0 11.6 13.1 10.9
1271 26.5 25.3 21.0 16.9 15.9 16.2 13.4 13 .9 12.8 11.1
1272 28.9 23.6 21.7 13.4 13 . 4 13.8 16.8 12.5 11.7 10. 2
1274 29.6 23.4 21.3 12.0 12.5 13.0 12.9 11.0 9.5 9.2
mean 30 . 0 25.7 21. 6 15.5 15.3 15.5 13.9 12.7 11.7 10.1
95% 28.7 24.2 20.1 14.1 14.1 14 . 4 13.0 11. 6 11. 0 9.1








15.9 14.9 14.2 110,






































mean 16.0 15.8 14.3 108.0 74.9 56.8 22.9 17.0 13.9 11.0
95% 15.2 14.7 13.7 105.6 72.1 52.4 21.4 15.8 12.9 9.5
cl 16.8 16.9 15.0 110.3 77.7 61.2 24.4 18.3 15.0 12.4
Control Wounds
Hip
1268 31.2 26.4 20.8 19.5 21.0 20.4 18.2 13.4 16.1 11.8
1269 33.5 24.3 23.0 22.5 22 . 6 22.0 21.6 14.9 13.5 12 . 9
1270 29.2 25.6 19.5 20.6 20.1 21. 3 15. 2 17.2 13.8 13.4
1271 28.7 29.4 17.9 18.9 16.8 17.3 18.0 15.6 11.4 13.6
1272 26.5 21.0 20.0 19.6 19.4 18.9 16.7 15.4 12.7 14.1
1274 32.1 25.2 23.9 22.5 23.4 21.9 19.5 14.1 12.8 10.7
mean 29.5 25.2 20.8 20.9
95% 27.4 23.6 19.5 20.0







20.9 20.5 18.5 15.3 13.3 12.5
19.4 19.1 17.2 14.5 12.4 11.7
22.3 21.8 19.8 16.0 14.1 13.3
Opsite Wounds
16.2 16.1 14.6 98.7 79.6
14.9 15.3 12.0 110.3 82.4
14.5 14.7 13.9 109.6 80.6
49.8 19.4 15.9 16.5 11.2
42.1 18.7 15.0 15.0 11.5
39.5 16.6 16.0 15.8 9.5
14.3 13.9 13.7 108.6 79.6 38.7 19.6 14.3 15.7 10.7
15.4 14.1 14.2 102.6 75.6 45.7 20.0 14.9 13.9 10.1
13.6 13.6 14.5 100.7 89.2 41.6 21.0 15.8 16.7 11.9
mean 15.0 15.0 14.0 104.8 79.5 43.6 20.3 15.6 15.2 10.9
95% 14.4 14.3 13.4 101.8 76.2 41.2 18.8 15.1 14.5 10.3











1275 33 . 2 25.3 23.5 18 . 9 18 . 6 18.7 19.0 17.0 14.9 10.6
1276 32.1 23.5 24.1 18.7 18.5 17.9 18 . 3 17.9 13.7 11.3
1278 30.6 23.7 24.5 20.6 17 . 9 19 . 3 18.5 20.6 15.0 11.4
1279 34 . 3 25.1 25.9 22.1 21.9 21.6 22.0 21.0 15.6 11.9
1281 32.9 25.6 26 .1 19.3 20.9 19.9 21.0 20.6 15 . 3 12 . 5
1282 30.0 24.9 22.6 18.3 19.8 19.5 19.9 19.2 13.9 13.1
1284 31.2 24.7 22.8 19.7 19. 3 18.5 19.3 17.9 12 . 9 13 . 6
mean 32.0 24.7 24.2 19.7
95% 31.0 24.1 23.3 18.8
cl 33.1 25.2 25.2 20.6
19.6 19.3 19.7 19.2 14.5 12.1
18.6 18.5 18.8 18.1 13.8 11.3
20.5 20.2 20.6 20.3 15.1 12.8
Opsite Wounds
1275 15.3 14.6 16.5 13.5 109.3 80.6 39.6 22.1 16.8 11.0
1276 15.6 15.3 13.6 14.6 106.9 81.3 34.9 22.5 18.3 11.9
1278 16.3 13.7 15.9 15.9 104.9 73.0 43.9 23.5 16.4 12.6
1279 16.9 15.8 15.1 15.2 105.2 76.9 41.2 19.6 19.3 14.3
1281 14.9 15.8 15.3 13.5 103.3 75.1 43.6 18.3 13.7 15.0
1282 15.9 16.3 14.6 14.9 107.8 79.3 44.4 22.3 14.6 15.9
1284 16.0 16.5 15.0 14.1 107.3 85.6 37.1 23.8 15.5 16.3
mean 15.8 15.4 15.1 14.5 106.4 78.8 40.7 21.7 16.4 13.9
95% 15.4 14.7 14.5 13.9 105.0 75.9 38.2 20.3 15.0 12.5


















28.7 25.9 21.8 25.5
25.6 25.4 24.3 24.9











20.8 21.5 18.6 16.8 12.0
19.3 21.0 14.9 15.9 12.9
25.0 24.1 17.4 15.3 13.8
24.3 19.0 14.6 14.1
23.6 18.0 13.9 14.5
24
27.6 19.5 18.7 13.2
30.1 25.6 21.8 20.0 19.6 20.3 19.1 19.5 17.7 13.9
mean 29.6 26.4 23.5 23.7
95% 28.0 25.1 22.5 21.4
cl 31.2 27.7 24.6 26.0
22.6 22.3 23.0 18.1 16.1 13.5
21.1 20.5 21.1 17.0 15.0 12.9
24.2 24.2 24.9 19.2 17.3 14.1
Opsite Wounds
1275 14.3 15.3 13.6 13.5 104.9 80.6 35.6 26.8 16.9 13.6
1276 15.6 14.9 13.7 13.1 106.7 79.1 39.4 23.4 19.4 10.3
1278 15.2 14.7 15.9 14.8 105.3 83.2 38.9 25.9 19.8 11.9
1279 15.9 16.3 15.2 14.3 103.8 76.1 45.8 27.3 18.3 13.5
1281 15.0 12.9 13.8 14.5 106.8 75.9 41.6 27.1 18.7 13.9
1282 19.1 17.3 14.6 13.7 105.9 77.8 32.9 25.8 16.4 13.9
1284 14.7 16.2 14.3 13.6 110.0 73.9 33.7 26.2 17.9 9.1
mean 15.7 15.4 14.4 13.9 106.2 78.1 38.3 26.1 18.2 12.3
95% 14.6 14.4 13.9 13.5 104.8 75.9 35.1 25.2 17.3 11.0




















































6 15.6 13.5 13.9 13.3
6 16.0 14.0 13.8 14.2
3 16.9 14.9 15.8 14.5
6 14.3 13.5 14.3 13.3
4 15.6 14.5 14.0 13.9
9 17.1 13.6 13.9 13.7
3 13.6 12.9 13.5 13.1


























mean 30.4 26.1 24.1 18.1 15.5
95% 29.0 25.2 23.4 17.5 14.6




















16.8 13.6 12.9 13











15.7 13.6 13.4 11.0 13
13.6 14.0 13.6 11.5 9.9
13.1 13.5 13.1 11.0 9.2






5 29.3 12.9 13.5
7 26.8 11.0 12.4
6 25.9 13.4 13.9
5 26.7 12.9 11.0
1 29.8 12.7 10.6
9
5
100.5 70.0 30.4 13.8 10
101.9 79.6 28.1 10.5 9
109.4 78.1 29.9 11.1 10.0
mean 16.0 15.0 13.9 13
95% 15.2 13.9 13.5 12

























4 13.8 105.0 73.3 28.4 12.3 11.5
5 13.3 102.9 70.7 27.2 11.5 10.4























18.6 17.9 17.5 13
18.9 18.0 18.6 13
18.3 18.6 19.0 14
18.5 17.3 16.7 18

















mean 31.5 25.0 22.1 19.0 17.0
95% 29.9 23.7 20.4 18.2 16.0
cl 33.0 26.3 23.7 19.7 17.9
17.3 17.2 16.7 13.9 12.1
16.3 16.4 15.7 12.6 11.1
























89.3 33.6 15.6 16.8
78.1 34.9 12.8 12.4
8
14.9 15.0 13.0 13.0 15.1 103.8 78





















mean 15.5 15.1 14.7 14.1 13.8 106.1 77.7 31.3 12.8 13.4
95% 14.8 14.3 14.2 13.7 13.1 104.2 73.7 28.7 11.8 11.9
cl 16.3 15.9 15.2 14.6 14.5 108.0 81.7 33.8 13.7 15.0
228
Statistical Analysis of M.V.T. Results
The following tables compare the Opsite covered skin grafts















-6.401 -10.307 52.013 28.609 4.507 0.821




































-2.93 -0.06 1.54 0.49 -0.67 -1.27
-5.94 -1.63 -2.09 -2.26 -3.58 -3.39







la lb lc Id
up ii
-10.951 -8.430 48.571 62.745 16.517 5.611





-16.17 -13.66 79.70 57.70
-19.78 -17.66 75.69 55.45



























0.43 1.03 0.41 -1.10
-1.77 -0.34 -1.08 -2.94
























-14.186 59.007 26.377 30.874 1.755
























































-7.314 124.022 17.423 6.676 2.642















































































































-15.38 -10.70 -7.03 84.48
-18.35 -13.72 -9.76 79.17









































3 4 4a 4b
UpH
■25.706 -25.358 -15.033 -11.688 76.171 31.626





16.20 -9.26 -9.07 -5.13 86.73 59.49
-17.74 -10.15 -10.55 -6.20 83.94 54.88









































3 4 4a 4b
Hp"
-12.022 -16.440 -14.689 -8.604 57.277 41.527





-13.87 -11.06 -9.10 -9.79 83.64 55.74
-16.69 -12.70 -10.62 -12.57 80.07 52.46



















































■15.111 -20.764 -13.105 -3.376 75.783















































-19.282 -11.675 -8.190 -9.510 -4.418 78.296 26.520
0.000 0.000 0.000 0.000 0.003 0.000 0.000
Mean
Difference -15.59 -9.85 -7.40
95% -17.91 -11.84 -9.54







5b 5c 10 15




























Rat Wd m Rat Wd.
No. No . Wnd Bx. % Diff No. No. Wnd Bx % Dif:
1382 1 445 342 76.9 1382 3 461 375 81.3
1372 1 314 423 134.7 1372 3 461 162 35.1
1376 1 420 305 72.6 1376 3 438 355 81.1
1381 3 412 340 82.5 1381 1 408 243 59.6
1388 3 455 249 54.7 1388 1 395 112 28.4
1397 1 440 238 54 .1 1397 3 451 296 65.6
1373 3 404 334 82.7 1373 1 401 223 55.6











No. No. Wnd Bx. % Diff
1382 2 420 317 75.5
1372 4 486 334 68 . 7
1376 2 487 370 76 . 0
1381 4 457 167 36.5
1388 2 515 307 59.6
1397 4 520 239 46.0







No. No. Wnd Bx % Diff
1293 4 433 166 38.3
1294 2 409 191 46.7
1295 4 515 173 33.6
1296 2 466 242 51. 9
1297 4 504 242 48.0
1298 2 497 228 45.9







Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1341 3 427 390 91.3 1293 1 394 300 76.1
1340 1 416 269 64.7 1294 3 401 134 33.4
1339 3 488 354 72.5 1295 1 398 159 39.9
1338 1 411 310 75.4 1296 3 426 300 70 . 4
1337 3 450 132 29 . 3 1297 1 349 187 53 .6
1336 1 415 295 71.1 1298 3 378 185 48 . 9
1335 3 312 180 57.7 1299 1 373 106 28.4
1334 3 432 357 82 . 6 1300 1 369 107 29 . 0
Mean Difference 68.1 Mean Difference 47.5
Confidence 56 Confidence 36
Limits (95%) 80 Limits (95% ) 59
Group A3 Hip
OPSITE CONTROL
Rat Wd. Rat Wd.
No. No. Wnd BX. % Diff No. No. Wnd Bx % Diff
1293 2 413 232 56.2 1293 4 466 142 30.5
1294 4 425 144 33.9 1294 2 378 60 15.9
1295 2 434 233 53 . 7 1295 4 379 192 50 . 7
1296 4 385 273 70.9 1296 2 412 150 36 . 4
1297 2 438 149 34.0 1297 4 469 117 24 . 9
1298 4 380 223 58.7 1298 2 407 173 42 . 5
1299 2 366 246 67.2 1299 4 404 266 65.8










Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd BX % Dif:
1552 1 398 309 77.6 1552 3 362 203 56.1
1557 3 383 328 85.6 1557 1 440 262 59.5
1559 1 462 299 64.7 1559 3 369 302 81.8
1558 3 384 376 97.9 1558 1 429 255 59.4
1561 1 507 398 78.5 1561 3 420 161 38.3
1560 3 416 562 135.1 1560 1 455 418 91. 9
1562 1 369 346 93.8 1562 3 417 178 42 . 7
1571 3 414 423 102 . 2 1571 1 428 252 58.9













No. No. Wnd Bx. % Diff No. No. Wnd Bx % Difj
1552 2 437 362 82 . 8 1552 4 392 181 46 . 2
1557 4 442 260 58.8 1557 2 432 167 38 . 7
1559 2 486 347 71.4 1559 4 486 292 60.1
1558 4 437 316 72 . 3 1558 2 415 272 65.5
1561 2 499 377 75. 6 1561 4 443 145 32 . 7
1560 4 468 433 92.5 1560 2 465 283 60.9
1562 2 486 253 52 .1 1562 4 379 107 28 . 2
1571 4 360 378 105.0 1571 2 494 210 42 . 5



























No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1 383 265 69.2 1495 3 362 207 57.2
1 392 410 104 . 6 1500 3 435 354 81.4
3 362 432 119.3 1510 1 356 312 87.6
1 370 360 97 . 3 1512 3 353 162 45.9
3 546 505 92 . 5 1511 1 495 373 75.4
1 370 401 108 . 4 1515 3 417 178 42 . 7











Wd. Wound Bx. % Diff Rat Wd. Wound Bx % Diff
No. No. No.
2 505 374 74 .1 1495 4 400 289 72.3
2 425 399 93.9 1500 4 366 298 81.4
4 397 397 100 . 0 1510 2 343 285 83 .1
2 427 302 70.7 1512 4 424 197 46.5
4 464 494 106 . 5 1511 2 478 424 88.7
2 487 449 92.2 1515 4 445 376 84 . 5













No. No. Wnd Bx.
1293 1 365 409
1294 3 378 484
1295 1 368 576
1296 3 329 325
1297 1 346 650
1298 3 346 529
1299 1 348 477











No. No. Wnd Bx
1293 3 367 305
1294 1 334 272
1295 3 309 357
1296 1 348 321
1297 3 328 394
1298 1 344 286
1299 3 354 194



















Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx
1293 2 467 471 100.9 1293 4 366 273
1294 4 365 332 91. 0 1294 2 386 257
1295 2 364 516 141.8 1295 4 280 351
1296 4 311 517 166 . 2 1296 2 337 306
1297 2 415 402 96.9 1297 4 368 372
1298 4 362 436 120 . 4 1298 2 283 316
1299 2 414 537 129.7 1299 4 360 220




















Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1249 1 413 564 136 . 6 1249 3 367 305 83.1
1250 3 230 262 113.9 1250 1 334 272 81.4
1251 1 282 613 217.4 1251 3 309 357 115.5
1252 3 283 484 171.0 1252 1 348 321 92 . 2
1253 1 237 382 161.2 1253 3 328 394 120 .1
1255 1 190 433 227 . 9 1255 1 344 286 83.1
1256 3 229 273 119.2 1256 3 354 194 54.8
Mean Difference 163 . 9 Mean Difference 90 .1
Confidence 133 Confidence 75
Limits (95%) 195 Limits (95% ) 105
Group A15 Hip
OPSITE CONTROL
Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx
1249 2 320 391 122.2 1249 4 469 214
1251 2 377 596 158.1 1251 4 294 390
1252 4 345 473 137.1 1252 2 396 352
1253 2 296 320 108 .1 1253 4 325 234
1255 2 352 280 79.5 1255 4 352 405
















Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1600 3 366 224 61.2 1600 1 363 320 88.2
1602 1 406 431 106 . 2 1602 3 345 365 105.8
1603 1 415 374 90.1 1603 3 380 409 107.6
1606 1 390 302 77.4 1606 3 403 312 77.4
1605 3 442 344 77.8 1605 1 394 270 68 . 5
1604 1 406 267 65.8 1604 3 400 205 51.3
1511 1 414 399 96.4 1511 3 421 240 57.0
Mean Difference 82.1 Mean Difference 79 . 4
Confidence 71 Confidence 64
Limits (95%) 93 Limits (95% ) 95
Group B2 Hip
OPSITE CONTROL
Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1600 4 383 308 80.4 1600 2 439 291 66. 3
1601 4 409 379 92.7 1601 2 457 234 51. 2
1602 2 428 315 73 .6 1602 4 401 197 49.1
1603 2 447 324 72.5 1603 4 499 397 79.6
1606 2 402 362 90.0 1606 4 414 278 67.1
1605 4 420 250 59 . 5 1605 2 466 383 82 . 2
1604 2 469 411 87 . 6 1604 4 382 271 70.9
1511 2 350 365 104.3 1511 4 468 199 42 . 5
Mean Difference 82.6 Mean Difference 63 . 6
Confidence 74 Confidence 54




Rat Wd. Rat Wd.
No. NO. Wnd Bx. % Diff No. No. Wnd Bx
1512 1 438 311 71.0 1512 3 403 287
1578 3 361 394 109.1 1578 1 315 279
1581 1 449 342 76.2 1581 3 389 233
1582 3 430 404 94 . 0 1582 1 445 312
1583 1 417 413 99.0 1583 3 469 302


















Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1512 2 473 366 77.4 1512 4 416 268 64.4
1578 4 341 341 100 . 0 1578 2 391 299 76 . 5
1581 2 482 356 73.9 1581 4 430 183 42.6
1582 4 378 314 83 .1 1582 2 402 212 52 . 7
1583 2 412 407 98.8 1583 4 438 216 49. 3
1584 4 371 357 96.2 1584 2 432 251 58.1










Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. NO. Wnd BX
1343 3 425 257 60.5 1343 1 397 200
1344 1 314 381 121. 3 1344 3 352 248
1345 3 410 294 71.7 1345 1 426 146
1346 1 369 293 79 . 4 1346 3 358 126
1347 3 443 409 92.3 1347 1 416 358
1348 1 354 276 78.0 1348 3 378 211



















Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1343 4 397 313 78.8 1343 2 477 378 79. 2
1344 2 407 387 95.1 1344 4 411 277 67.4
1345 4 406 234 57.6 1345 2 386 154 39.9
1346 2 371 262 70 . 6 1346 4 331 181 54.7
1347 4 432 439 101.6 1347 2 373 299 80.2
1348 2 462 402 87.0 1348 4 424 201 47.4
1349 4 428 208 48 . 6 1349 2 391 119 30.4










Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff NO. No. Wnd Bx % Dif:
1524 1 436 397 91.1 1524 3 376 275 73 .1
1610 3 370 277 74.9 1610 1 396 294 74 . 2
1611 1 409 284 69 . 4 1611 3 361 239 66 . 2
1614 3 419 405 96.7 1614 1 416 309 74.3
1608 1 393 540 137.4 1608 3 426 323 75.8
1613 3 383 368 96.1 1613 1 412 322 78.2
1615 1 398 369 92.7 1615 3 444 188 42 . 3
Mean Difference 94.0 Mean Difference 69 . 2
Confidence 79 Confidence 61
Limits (95%) 109 Limits (95% ) 78
Group B5 Hip
OPSITE CONTROL
Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1524 2 363 428 117 . 9 1524 4 464 331 71.3
1610 4 317 334 105.4 1610 2 246 216 87 . 8
1611 2 438 382 87. 2 1611 4 365 217 59 . 5
1614 4 392 486 124 . 0 1614 2 433 289 66.7
1608 2 370 412 111. 4 1608 4 365 305 83 . 6
1613 4 436 467 107.1 1613 2 422 313 74 . 2
Mean Difference 108 . 8 Mean Difference 73.8
Confidence 100 Confidence 66




Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1302 3 307 377 122.8 1302 1 335 312 93.1
1303 1 375 387 103.2 1303 3 347 371 106 . 9
1304 1 284 304 107.0 1304 3 306 241 78 . 8
1305 1 317 319 100.6 1305 3 361 192 53 . 2
1306 3 350 558 159.4 1306 1 355 421 118 . 6
1307 1 370 424 114 . 6 1307 3 370 236 63 . 8
1308 3 355 399 112.4 1308 1 324 281 86.7
Mean Difference 117.2 Mean Difference 85.9
Confidence 103 Confidence 70
Limits (95%) 131 Limits (95% ) 102
Group BIO Hip
OPSITE CONTROL
Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1302 4 376 377 100 . 3 1302 2 343 300 87 . 5
1303 2 333 393 118.0 1303 4 338 215 63.6
1304 2 318 318 100.0 1304 4 364 270 74.2
1305 2 263 327 124 . 3 1305 4 312 205 65.7
1306 4 310 539 173.9 1306 2 338 390 115. 4
1307 2 380 366 96.3 1307 4 404 270 66.8
1308 4 346 402 116.2 1308 2 305 240 78.7










Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd BX % Dif:
1257 1 358 293 81.8 1257 3 346 224 64.7
1259 3 407 645 158.5 1259 1 316 372 117 . 7
1260 1 317 530 167.2 1260 3 218 216 99.1
1261 3 276 372 134.8 1261 1 234 240 102 . 6
1263 3 320 457 142.8 1263 1 387 266 68 . 7
1264 1 288 299 103 . 8 1264 3 211 216 102.4
1265 1 301 330 109 . 6 1265 3 337 287 85.2
Mean Difference 128 . 4 Mean Difference 91. 5
Confidence 107 Confidence 78
Limits (95%) 150 Limits (95% ) 105
Group B15 Hip
OPSITE CONTROL
Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1257 2 319 465 145.8 1257 4 364 263 72.3
1259 4 434 405 93 . 3 1259 2 328 378 115. 2
1260 2 334 549 164 . 4 1260 4 283 334 118 . 0
1261 4 294 335 113 . 9 1261 2 275 230 83.6
1263 4 400 504 126.0 1263 2 386 511 132.4
1264 2 274 311 113 . 5 1264 4 359 246 68.5
1265 2 406 439 108.1 1265 4 321 298 92.8










Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Dif
1585 1 347 344 99.1 1585 3 366 243 66.4
1590 3 406 317 78 .1 1590 1 415 217 52.3
1591 1 404 337 83 . 4 1591 3 431 234 54.3
1587 1 379 281 74.1 1587 3 408 205 50.2
1586 3 412 329 79 . 9 1586 1 392 197 50 . 3
1598 1 338 385 113 . 9 1598 3 378 228 60. 3









Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1585 2 451 416 92 . 2 1585 4 393 235 59 . 8
1590 4 433 360 83.1 1590 2 383 257 67.1
1591 2 393 266 67.7 1591 4 378 164 43 . 4
1587 2 404 324 80 . 2 1587 4 426 158 37 .1
1586 4 422 547 129.6 1586 2 456 381 83.6
1598 2 428 238 55 . 6 1598 4 517 356 68 . 9













No. No. Wnd Bx. % Diff No. No . Wnd Bx
1350 1 404 208 51.5 1350 3 369 149
1351 3 385 274 71.2 1351 1 370 273
1352 1 401 149 37.2 1352 3 446 269
1353 3 421 316 75.1 1353 1 331 199
1357 1 429 414 96.5 1357 3 406 231
1358 3 350 311 88.9 1358 1 458 392
1359 1 385 332 86.2 1359 3 410 345
1360 3 402 364 90 . 5 1360 1 451 248
























Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Dif:
1350 2 467 266 57 . 0 1350 4 412 130 31.6
1351 4 400 306 76 . 5 1351 2 488 250 51.2
1352 2 480 353 73 . 5 1352 4 525 154 29.3
1353 4 390 255 65 . 4 1353 2 461 229 49.7
1357 2 473 363 76.7 1357 4 362 257 71. 0
1358 4 350 312 89 .1 1358 2 401 297 74.1
1359 2 420 355 84.5 1359 4 399 406 101.8
1360 4 392 361 92.1 1360 2 413 282 68 . 3










Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Dif:
1616 1 406 461 113 .5 1616 3 339 313 92 . 3
1621 3 358 401 112.0 1621 1 406 391 96.3
1618 1 299 359 120.1 1618 3 340 335 98.5
1620 3 312 287 92 . 0 1620 1 400 281 70.3
1617 1 232 234 100 . 9 1617 3 342 174 50 . 9
1569 3 339 368 108.6 1569 1 413 349 84.5
1619 1 401 481 120.0 1619 3 400 293 73 . 3









Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx
1616 2 382 402 105. 2 1616 4 364 300
1621 4 367 385 104.9 1621 2 411 360
1618 2 403 490 121. 6 1618 4 299 359
1620 4 446 257 57.6 1620 2 370 210
1617 2 384 405 105.5 1617 4 325 397
1569 4 385 379 98.4 1569 2 378 316

















Rat Wd. Rat Wd •
No. No. Wnd Bx. % Diff No. No . Wnd Bx % Diff
1309 1 328 573 174.7 1309 3 409 398 97 . 3
1310 3 388 513 132 . 2 1310 1 392 257 65.6
1311 1 391 545 139.4 1311 3 391 328 83 . 9
1312 3 377 397 105.3 1312 1 408 319 78 . 2
1313 1 348 352 101.1 1313 3 318 457 143 .7
1315 1 431 477 110 . 7 1315 3 305 317 103 . 9
1316 3 416 509 122.4 1316 1 441 339 76.9







Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx
1309 2 377 536 142 . 2 1309 4 447 386
1310 4 366 511 139.6 1310 2 414 528
1311 2 381 537 140.9 1311 4 408 432
1312 4 378 460 121.7 1312 2 422 341
1313 2 354 499 141.0 1313 4 394 358
1315 2 414 471 113 . 8 1315 4 427 312


















Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd BX % Diff
1268 1 300 301 100.3 1268 3 452 400 88.5
1269 1 386 441 114.2 1269 1 402 264 65.7
1270 1 341 353 103.5 1270 3 368 200 54.3
1271 1 308 466 151.3 1271 1 310 256 82.6
1272 3 287 439 153 . 0 1272 3 303 258 85.1
1274 3 275 468 170.2 1274 1 394 363 92.1
Mean Difference 132 .1 Mean Difference 78.1
Confidence 110 Confidence 67
Limits (95%) 154 Limits (95% ) 89
Group C15 Hip
OPSITE CONTROL
Rat Wd. Rat Wd.
No. NO. Wnd Bx. % Diff No. No. Wnd Bx
1268 2 389 458 117.7 1268 4 401 440
1269 2 315 490 155.6 1269 4 426 358
1270 2 446 328 73 . 5 1270 4 350 198
1271 2 308 466 151.3 1271 4 331 277
1272 4 288 439 152.4 1272 2 296 351
















Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd BX % Dif:
361 1 350 311 88.9 361 3 382 214 56 . 0
362 3 391 402 102 . 8 362 1 379 334 88.1
363 1 400 150 37.5 363 3 371 245 66 . 0
364 3 385 196 50 . 9 364 1 395 125 31.6
365 1 369 317 85.9 365 3 361 171 47 . 4
366 3 322 284 88 . 2 366 1 395 269 68.1
367 1 374 317 84 . 8 367 3 395 140 35.4
368 3 322 365 113.4 368 1 395 180 45.6












No. No. Wnd Bx. % Diff No. No. Wnd Bx % Dif:
361 2 367 297 80 . 9 361 4 333 154 46 . 2
362 4 365 375 102 . 7 362 2 382 321 84.0
363 2 365 202 55. 3 363 4 389 284 73 . 0
364 4 384 307 79 . 9 364 2 378 182 48 .1
365 2 393 311 79.1 365 4 379 269 71. 0
366 4 405 390 96 . 3 366 2 411 256 62.3
367 2 382 454 118.8 367 4 387 268 69 . 3
368 4 401 459 114.5 368 2 415 262 63 .1













No. NO. Wnd BX. % Diff No. No. Wnd Bx % Difl
1532 1 399 362 90.7 1532 3 387 287 74 . 2
1533 3 364 322 88.5 1533 1 434 351 80.9
1534 1 419 400 95.5 1534 3 393 324 82.4
1535 3 416 373 89.7 1535 1 374 250 66 . 8
1536 1 358 317 88.5 1536 3 335 247 73.7
1537 3 413 390 94 . 4 1537 1 434 357 82 . 3
1539 1 437 423 96.8 1539 3 415 333 80.2




















No. Wnd Bx Diff
1532 2 418 370 88.5 1532 4 385 250 64.9
1533 4 364 322 88.5 1533 2 452 310 68 . 6
1534 2 391 387 99.0 1534 4 381 300 78.7
1535 4 343 250 72.9 1535 2 443 313 70.7
1536 2 431 350 81. 2 1536 4 395 256 64 . 8
1537 4 387 350 90.4 1537 2 415 350 84.3
1539 2 407 373 91. 6 1539 4 392 301 76.8
1540 4 427 389 91.1 1540 2 422 331 78 . 4












Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx
1318 1 408 555 136.1 1318 3 387 463
1319 3 402 509 126.5 1319 1 373 250
1320 1 443 459 103 . 6 1320 3 381 231
1321 3 417 437 104 . 8 1321 1 446 293
1322 1 430 488 113 . 5 1322 3 403 294
1323 3 426 456 107.0 1323 1 522 365
1324 1 404 371 91. 8 1324 3 393 300



















Rat Wd. Rat Wd •
No. No. Wnd Bx. % Diff No. No . Wnd Bx % Diff
1318 2 424 531 125. 2 1318 4 418 360 86.1
1319 4 378 400 105.8 1319 2 386 348 90. 2
1320 2 443 459 103 . 6 1320 4 373 247 66.2
1321 4 350 430 122 . 9 1321 2 361 296 82.0
1322 2 371 438 118.1 1322 4 457 356 77.9
1323 4 436 452 103.7 1323 2 436 322 73.9
1324 2 448 403 90 . 0 1324 4 429 207 48 . 3
1325 4 450 464 103 .1 1325 2 482 317 65.8










Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Diff
1278 1 359 400 111.4 1278 3 401 364 90 . 8
1279 3 368 392 106.5 1279 1 379 337 88 . 9
1275 1 376 370 98 . 4 1275 3 412 390 94.7
1281 3 395 410 103.8 1281 1 383 301 78.6
1282 1 361 397 110 . 0 1282 3 403 365 90 . 6
1284 3 387 395 102.1 1284 1 394 379 96.2
1276 1 423 450 106.4 1276 3 379 325 85. 8
Mean Difference 105.5 Mean Difference 89 . 4
Confidence 102 Confidence 85
Limits (95 %) 109 Limits (95% ) 93
Group D15 Hip
OPSITE CONTROL
Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx
1278 2 374 385 102.9 1278 4 423 437
1279 4 401 429 107 . 0 1279 2 389 301
1275 2 334 341 102.1 1275 4 379 350
1281 4 374 380 101. 6 1281 2 423 358
1282 2 387 412 106.5 1282 4 382 331
1284 4 385 390 101. 3 1284 2 376 381



















Rat Wd. Rat Wd #
No. No. Wnd Bx. % Diff No. No . Wnd Bx % Diff
1544 3 391 302 77.2 1544 1 299 248 82 . 9
1548 3 303 282 93.1 1548 1 387 196 50.6
1549 1 418 301 72.0 1549 3 391 201 51.4
1550 3 304 337 110.9 1550 1 418 203 48 . 6
1541 1 453 401 88.5 1541 3 328 209 63 . 7
1564 3 370 367 99.2 1564 1 259 213 82 . 2
1556 3 399 368 92.2 1556 1 380 213 56.1









Rat Wd. Rat Wd
No. No. Wnd Bx. % Diff No. No . Wnd Bx % Diff
1544 4 366 302 82.5 1544 2 355 246 69. 3
1548 4 384 351 91.4 1548 2 371 217 58 . 5
1549 2 407 407 100.0 1549 4 403 260 64. 5
1550 4 413 391 94.7 1550 2 389 218 56 . 0
1541 2 445 383 86.1 1541 4 320 235 73 . 4
1564 4 412 441 107.0 1564 2 403 222 55.1
1556 4 490 441 90.0 1556 2 425 222 52 . 2










Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx
1326 1 379 402 106.1 1326 3 346 344
1327 3 429 539 125.6 1327 1 361 352
1328 1 399 418 104.8 1328 3 382 308
1329 3 481 340 70 . 7 1329 1 384 227
1330 1 346 402 116.2 1330 3 395 301
1332 1 430 337 78 . 4 1332 3 404 275
























Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx
1326 4 460 432 93 . 9 1326 2 445 293
1327 4 328 493 150 . 3 1327 2 377 421
1328 2 433 425 98 . 2 1328 4 474 339
1329 4 412 268 65.0 1329 2 340 276
1330 2 388 415 107 . 0 1330 4 426 350
1332 4 474 398 84.0 1332 2 503 302


















Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Dif:
1324 3 401 455 113 . 5 1324 3 290 220 75.9
1287 1 326 400 122 . 7 1287 1 273 303 111.0
1288 3 326 472 144 . 8 1288 3 320 315 98.4
1289 1 392 437 111.5 1289 1 352 302 85.8
1290 1 398 368 92.5 1290 3 327 291 89 . 0
1291 1 360 470 130.6 1291 1 321 328 102 . 2
1292 3 322 395 122.7 1292 3 260 231 88.8
1317 1 395 539 136.5 1317 1 367 263 71.7









Rat Wd. Rat Wd.
No. No. Wnd Bx. % Diff No. No. Wnd Bx % Dif:
1324 2 420 504 120 . 0 1324 4 379 344 90.8
1287 4 358 411 114.8 1287 2 393 270 68.7
1288 2 414 442 106.8 1288 4 350 327 93 . 4
1289 4 330 360 109 .1 1289 2 310 225 72.6
1290 2 317 320 100.9 1290 4 358 293 81. 8
1291 4 380 433 113.9 1291 2 285 336 117 . 9
1292 2 335 387 115.5 1292 4 415 295 71.1
1317 4 350 437 124 . 9 1317 2 360 266 73 . 9



















A2 6 1.494 0.1858 21.643 -6.51 49 . 80
A3 7 2.531 0.0390 20.613 5.18 36.04
A4 7 4.035 0 . 0050 30.850 16 . 37 45. 33
A5 5 3 . 916 0.0112 33.517 16 . 27 50.76
A10 7 5.621 0.0008 48.538 32 .18 64 . 90
A15 6 3 .775 0.0094 71.657 34.58 108.74
B2 6 0.332 0.7510 2.729 -13.23 18.69
B3 5 4 . 216 0.0084 20.386 10.64 30.13
B4 6 3 .213 0.0183 24.357 9.63 39.09
B5 6 2.871 0.0284 24.866 8.04 41. 73
BIO 6 4 . 534 0.0040 31.271 17.87 44 . 67
B15 6 3 .686 0.0103 36.871 17.43 56 . 31
C3 6 8 . 549 0.0001 33.743 26.07 41. 41
C4 7 1.402 0.2037 10.112 -3.55 23 . 78
C5 6 5.552 0 . 0014 28.714 18 . 66 38.76
CIO 6 2 .167 0.0734 33.757 3.48 64.03
C15 5 5.569 0.0026 54.033 34.48 73.58
D4 7 2.661 0.0324 26.775 7.71 45.84
D5 7 9.561 0.0000 15.150 12 .15 18.15
D10 7 7 . Ill 0.0002 35.975 26. 39 45.56
D15 6 5.269 0.0019 16.143 10.19 22.10
E5 6 3 .474 0.0132 28.229 12.44 44.02
E10 6 4.651 0.0035 21.343 12.43 30.26
E15 7 4 .629 0.0024 31.500 18.61 44 . 39
Hip Wounds
A2 6 1.894 0.1070 14.743 -0.38 29.87
A3 7 3.758 0.0071 14.913 7.39 22.43
A4 7 4 . 608 0.0025 29.463 17.35 41. 58
A5 5 4 .154 0.0089 13.483 6.94 20.02
A10 7 2.791 0.0269 28.288 9.08 47.49
A15 5 2 . 002 0.1017 30.283 -0.20 60.77
B2 7 2 .041 0.0806 18.963 1.36 36.56
B3 5 6 . 099 0.0017 30.967 20.74 41. 20
B4 6 4 .335 0.0048 20.014 11.08 28 . 94
B5 5 5.930 0.0019 34.983 23.10 46 . 87
BIO 6 5 . 806 0.0011 39.586 26.34 52 . 83
B15 6 2 . 091 0.8150 26.029 1.84 50 . 22
C3 5 2.784 0.0387 24.750 6.83 42 . 67
C4 7 2 . 727 0.0295 17.225 5.26 29 .19
C5 6 1. 639 0.1523 12.571 -2 .33 27 . 47
CIO 6 4.377 0.0047 33.514 18.64 48 . 39
C15 5 3 .191 0.0242 35.817 13.20 58 . 44
D4 7 3 . 258 0.0139 26.313 11.01 41.62
D5 7 5.608 0.0008 14.500 9.60 19.40
D10 7 11.387 0.0000 35.250 29.38 41.12
D15 6 2.898 0.0274 11.971 3.95 20 . 00
E5 6 5.919 0.0010 31.814 21. 37 42.26
E10 6 2.410 0.0526 17.686 3.43 31.94
E15 7 4 .411 0.0031 29.463 16.81 42.12
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Flank Wounds
The differences between the Opsite and the Control wounds
at








Flank Wound v Hip Wound
This table lists the results of the paired Student's "t"
tests comparing the differences between the Opsite and the
control wounds on the flank and hip areas. If the hip wound
is a true model of a flexor crease there should be a
significant difference between both sets of figures.
Mean 95%
°F t p Diff. Confidence Limits
A1
A2 6 0 . 406 0.6990 6 . 943 -34.93 48 . 82
A3 7 0 . 575 0.5832 5 . 687 -17.69 29.07
A4 7 0 .180 0.8619 1. 387 -16.80 19 . 57
A5 5 2 .374 0.0636 20.017 -1.66 41.69
A10 7 1.334 0.2240 20.213 15.62 56.04
A15 5 1.448 0.2074 48.150 -37.35 133.65
B2 6 -1.480 0.1894 -13.014 -34.53 8.50
B3 5 -5.266 0.0033 -10.567 -15.72 -5.41
B4 6 0 .533 0.6001 4 . 343 -14.87 23.55
B5 5 -1.425 0.2134 -14.383 -40.32 11.56
B10 6 -0.828 0.4392 -8.300 -32.82 16 .22
B15 6 0 . 570 0.5892 10.875 35.73 57.45
C3 5 0.620 0.5732 7.638 -25.11 40.47
C4 7 -0.643 0.5405 -7.150 -33.43 19 .13
C5 6 1.751 0.1305 16.144 -6. 40 38.63
C10 6 0.012 0.9910 0. 229 -47.34 47 . 80
C15 5 1. 492 0.1960 18.217 -13.18 49 . 61
D4 7 0.078 0.9402 0 . 425 -12.10 13 . 36
D5 7 0.179 0.8613 0.650 -7 . 94 9 . 24
D10 7 0.093 0.9289 0.700 -17.19 18.59
D15 6 0 . 987 0.3619 4 . 200 -6.22 14 .62
E5 6 -0.462 0.6600 -3.586 -22.56 15. 39
E10 6 0.463 0.6595 3.657 -15.66 22 . 97
E15 7 0.238 0.8190 2 .013 -18.01 22 . 04










Flank Flank Hip Hip
Rat No Bx Tme Opsite Control Opsite Cont]
(weeks)
565 1 3 10 5 10
566 1 2 12 3 8
567 1 5 11 4 12
568 1 3 14 6 8
570 1 3 8 3 6
573 1 2 13 3 9
574 1 1 9 3 12
575 1 8 9 4 11
Mean 3 11 4 10
Confidence 2 9 3 8
Limits (95%) 5 12 5 11
372 2 5 9 8 14
376 2 3 8 7 12
381 2 6 8 7 14
388 2 1 12 5 14
397 2 2 9 5 19
392 2 3 6 9 12
373 2 3 7 3 13
Mean 3 8 6 14
Confidence 2 7 5 12
Limits (95%) 4 10 8 16
341 3 11 21 15 30
340 3 9 26 16 17
339 3 9 23 18 21
338 3 13 20 6 25
337 3 10 20 9 26
336 3 11 19 14 25
335 3 12 23 12 25
334 3 8 22 12 27
Mean 10 22 13 25
Confidence 9 20 10 22
Limits (95%) 11 23 15 27
262
MEAN NUMBERS OF MFBS PER
UNIT SURFACE AREA
Flank Flank Hip Hip
gp Rat No Bx Tme Opsite Control Opsite Control
(weeks)
552 4 9 12 9 16
557 4 11 13 12 15
559 4 10 13 12 15
558 4 10 10 13 12
561 4 12 11 16 18
560 4 4 19 8 17
562 4 13 16 13 13
571 4 8 15 14 15
Mean 10 14 12 15
Confidence 8 12 10 14




495 5 2 10 12 17
498 5 2 13 13 18
500 5 5 12 14 16
510 5 6 8 11 12
512 5 4 9 10 9
511 5 3 11 11 19
515 5 3 10 16 20
Mean 4 10 12 16
Confidence 3 9 11 13
Limits (95%) 5 12 14 19
293 10 2 5 4 8
294 10 2 11 3 9
295 10 1 4 9 1
296 10 0 4 6 4
297 10 6 12 4 5
298 10 3 6 4 6
299 10 4 6 3 8
300 10 2 3 1 7
Mean 3 6 4 6
Confidence 1 4 3 4
Limits (95%) 4 9 6 8
249 15 0 4 6 7
250 15 0 3 4 8
251 15 1 3 9 2
252 15 2 1 9 5
253 15 2 8 2 6
255 15 2 5 3 4
256 15 1 5 7 9
Mean 1 4 6 6
Confidence 1 3 4 4
Limits (95 %) 2 6 8 8
263






Flank Flank Hip Hip
Rat No Bx Tme Opsite Control Opsite Conti
(weeks)
600 2 6 10 7 12
601 7 12 7 11
602 4 10 9 12
603 5 14 10 10
606 2 14 10 9
605 9 13 9 12
604 6 11 7 6
511 6 13 7 13
Mean 6 12 8 11
Confidence 4 11 7 9
Limits (95%) 7 13 9 12
572 3 10 20 8 19
578 12 18 8 20
581 9 15 7 22
582 7 17 9 23
583 9 17 8 22
584 6 16 8 18
Mean 9 17 8 21
Confidence 7 16 8 19
Limits (95%) 10 18 8 22
343 4 11 17 14 21
344 10 16 9 19
345 9 21 22 19
346 13 19 7 22
347 12 18 6 18
348 14 16 10 22
349 10 17 13 19
Mean 11 18 12 20
Confidence 10 16 8 19
Limits (95%) 13 19 15 21
264
MEAN NUMBERS OF MFBS PER
UNIT SURFACE AREA
Flank Flank Hip Hip
gp Rat No Bx Tme Opsite Control Opsite Control
(weeks)
524 5 0 9 7 10
610 2 12 8 10
611 5 13 8 9
614 9 13 8 8
608 4 10 9 8
613 3 11 6 11
615 1 12 6 11
Mean 3 11 7 10
Confidence 1 10 7 9
Limits (95%) 5 12 8 10
302 10 0 7 6 10
303 1 7 1 10
304 2 9 12 11
305 4 10 12 7
306 3 8 9 9
307 3 11 8 9
308 2 9 7 6
Mean 2 9 8 9
Confidence 1 8 5 8
Limits (95%) 3 10 10 10
257 15 1 6 7 2
259 0 7 9 7
260 1 5 10 12
261 2 6 7 11
263 1 6 9 9
264 1 7 9 10
265 2 5 9 11
Mean 1 6 9 9
Confidence 1 5 8 7
Limits (95%) 2 7 9 11
265
MEAN NUMBERS OF MFBS PER
UNIT SURFACE AREA
Flank Flank Hip Hip
gp Rat No Bx Tme Opsite Control Opsite Control
(weeks)
C3 585 3 11 13 12 22
590 9 13 12 23
591 10 15 11 23
596 9 17 13 20
586 9 14 12 21
587 10 14 13 19

































MEAN NUMBERS OF MFBS PER
UNIT SURFACE AREA
Flank Flank Hip Hip
Rat No Bx Tme Opsite Control Opsite Cont:
(weeks)
616 5 5 17 10 12
621 5 17 10 13
618 4 15 11 10
620 4 12 4 11
617 2 9 8 14
569 2 11 9 7
619 6 10 2 9
Mean 4 13 8 11
Confidence 3 11 5 9
Limits (95%) 5 15 10 13
309 10 2 5 4 10
310 2 5 7 7
311 1 1 6 8
312 1 2 6 6
313 1 6 6 7
315 2 7 5 7
316 1 6 5 7
Mean 1 5 6 7
Confidence 1 3 5 7
Limits (95%) 2 6 6 8
268 15 1 4 6 6
269 1 3 6 7
270 2 4 5 5
271 1 5 5 7
272 2 7 7 8
274 1 4 2 4
Mean 1 5 5 6
Confidence 1 3 4 5
Limits (95%) 2 6 6 7
267
MEAN NUMBERS OF MFBS PER
UNIT SURFACE AREA
Flank Flank Hip Hip
Rat No Bx Tme Opsite Control Opsite Cont:
(weeks)
361 4 16 25 19 22
362 16 25 19 22
363 17 20 20 27
364 12 13 15 27
365 22 19 15 18
366 19 22 17 27
367 17 21 11 25
368 15 21 19 18
Mean 17 21 17 23
Confidence 15 18 15 21
Limits (95%) 19 23 19 26
532 5 9 15 11 7
533 9 17 13 17
534 8 13 13 13
535 8 15 9 13
537 8 15 9 14
539 7 11 15 11
540 5 20 15 19
Mean 8 15 12 13
Confidence 7 13 10 11
Limits (95%) 9 17 14 16
D10
D15
318 10 3 7 10 11
319 3 7 4 19
320 3 8 6 13
321 1 8 7 10
322 1 8 10 10
323 1 8 9 9
324 1 8 7 3
325 3 7 8 12
Mean 2 8 8 11
Confidence 1 7 6 8
Limits (95%) 3 8 9 14
278 15 1 5 2 11
279 1 9 9 10
275 1 3 9 7
281 4 3 7 7
282 1 6 7 7
284 3 6 8 7
276 2 7 7 7
Mean 2 6 7 8
Confidence 1 4 5 7






MEAN NUMBERS OF MFBS PER
UNIT SURFACE AREA
Flank Flank Hip Hip
Rat No Bx Tme Opsite Control Opsite Cont:
(weeks)
544 5 7 10 9 10
548 4 10 9 13
549 4 9 8 13
550 3 9 11 12
541 1 14 10 9
556 5 7 9 11
Mean 4 10 9 11
Confidence 3 8 9 10
Limits (95%) 5 12 10 13
326 10 1 7 6 12
327 1 5 10 12
328 1 7 7 13
329 2 4 9 9
330 5 4 8 11
332 1 9 4 7
333 1 7 2 6
Mean 2 6 7 10
Confidence 1 5 5 8
Limits (95%) 3 7 9 12
324 15 1 3 9 12
287 0 3 9 7
288 0 1 9 10
289 2 4 7 6
290 3 1 7 4
291 3 3 5 6
292 2 1 3 6
317 3 4 3 3
Mean 2 3 7 7
Confidence 1 2 5 5
Limits (95%) 3 3 8 9
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Statistical Comparison of Myofibroblast Numbers under
the Control and the Opsite Skin Grafts
Groups were compared using the paired Student's "t" test.
Flank Wounds
Degrees of Mean 95% iConfidence
Freedom t P Diff. Limits
A1 7 6.009 0.0005 7 . 357 4 . 52 10 .23
A2 6 4.500 0.0041 5.143 2 . 35 7.94
A3 7 9.524 0.0000 11.375 8.55 14.20
A4 7 2.244 0.0598 4 . 000 -0 . 22 8 .22
A5 6 6.492 0.0006 6.857 4 . 27 9.44
A10 7 4.329 0.0034 3.875 1.76 5.99
A15 6 3.674 0.0104 3 . 000 1.00 5.00
B2 7 6.619 0.0003 6.500 4 .18 8 . 82
B3 5 10.38 0.0001 8 .333 6.27 10.40
B4 6 5.793 0.0012 6 .429 3 .71 9 .14
B5 6 8 . 892 0.0001 8.000 5.80 10.20
BIO 6 17.81 0.0000 6.571 5.67 7 . 47
B15 6 9.553 0.0001 4.875 3.61 6.10
C3 6 4 .833 0.0029 4 .143 2 . 05 6 .24
C4 7 6 . 906 0.0002 6 . 750 4 . 44 9.06
C5 6 8 . 088 0.0002 9 . 000 6 . 28 11.72
CIO 6 4.085 0.0065 3 .143 1. 26 5.03
C15 5 6.635 0.0012 3 .167 1. 94 4 .39
D4 7 2.804 0.0264 4 . 000 0.63 7 . 37
D5 6 5.461 0.0016 7.429 4 .10 10.76
D10 7 10.56 0.0000 5.625 4.37 6 . 88
D15 6 3.495 0.0129 3.714 1.11 6 .31
E5 5 3.693 0.0141 5.833 1. 77 9 .89
E10 6 3 . 845 0.0085 4 .429 1.61 7 . 25
E15 7 1.271 0.2443 0 . 750 -0.65 2 .15
Hip Wounds
A1 7 6.666 0.0003 5.6250 3 .63 7.62
A2 6 5.610 0.0014 7.714 4 . 35 11.48
A3 7 5.115 0.0014 11.750 6.32 17.18
A4 7 2.479 0.0423 3 .000 0 .14 5.86
A5 6 3 . 023 0.0230 3 .429 0 . 66 6.20
A10 7 1.030 0.3371 1.750 -2 . 27 5.77
A15 6 0 . 091 0.9302 0 .143 -3.69 3 . 97
B2 7 2.468 0.0430 2.375 0 .10 4 . 65
B3 5 15.779 0.0000 12.667 10 . 60 14.73
B4 6 3 . 772 0.0093 8.429 2.96 13 .90
B5 6 2 .423 0.0517 2.143 -0 .02 4.31
BIO 6 0.579 0.5726 1.000 -3 .10 5.10
B15 6 0. 253 0.8085 0.268 -2.47 3.05
C3 6 7.747 0.0002 8.429 5.77 11.09
C4 7 4.681 0.0023 6.000 2 . 97 9.03
C5 6 2 . 238 0.0666 3.143 -0 . 29 6.58
CIO 6 2 . 414 0.0523 1. 875 -0.03 3 .74
C15 5 2.739 0.0409 1. 000 0 . 06 1.94
D4 7 3.444 0.0108 6.375 2 . 00 10.75
D5 6 0.862 0.4218 1.286 -2.36 4.94
D10 7 1. 598 0.1540 3.250 -1.56 8.06
D15 6 0.725 0.4960 1. 000 -2 .38 4 .38
E5 5 2 . 236 0.0756 2 . 000 -0.30 4.30
E10 6 4.221 0.0056 3 . 429 1.44 5.42






CONVENTIONAL DRESSING SYNTHETIC DRESSING
Dressing Dressing
No. No.
day 0 day 15 % diff
(cm2) (cm2)
1 80.12 65.22 18.60
2 84 .36 69.35 17.79
3 89.51 80 .23 10.37
4 90 . 22 64.36 28 . 66
5 78.35 62.00 20.87
6 67.56 54.37 19.52
7 83 . 21 65. 39 21.42
8 89.78 77.01 14 . 22
9 79. 39 67.23 15.32
10 99.01 89.51 9.59
11 100.15 75.21 24 . 90
12 78 . 65 64.02 18.60
13 67.21 55.38 17.60
14 90.36 77.09 14.69
15 98.81 84 .10 14.89
16 95.64 57.38 40 . 00
17 80.64 59.71 25 . 95
18 81.48 60 . 09 26 . 25
19 87 .39 77.53 11.28
20 84 . 67 68.11 19 . 56
21 69 .20 50.39 27.18
22 90 . 57 71.58 20.97
23 81.57 65.98 19.11
24 89.37 69 . 44 22.30
25 78.00 65.05 16.60
mean 84.69 67.88 19.85
95%
Conf. 81.19 64.21 17.31
Lim. 88.18 71.55 22.39
day 0 day 17 % diff
(cm2) (cm2)
26 66 . 22 56.22 15.10
27 98.71 89. 35 9 . 48
28 97.33 91.28 6.22
29 78.22 75.09 4.00
30 84 .79 78.33 7 . 62
31 85.33 80.55 5.60
32 98.01 88 . 21 10 . 00
33 63.58 62.80 1.23
34 58 . 09 55.29 4 . 82
35 81.66 78.44 3 . 94
36 89.08 78.09 12 . 34
37 75.38 70.00 7.14
38 78 .21 73.66 5.82
39 88.59 75.98 14 . 23
40 99.33 91.56 7.82
41 56.05 50. 34 10.19
42 74.59 66.01 11.50
43 81.66 74.57 8 . 68
44 85.97 76.76 10 . 71
45 69.45 65.94 5.05
46 85.11 74.81 12 .10
47 64.77 60. 33 6 . 86
48 89.32 84.69 5.18
49 99.45 89.11 10. 40
50 94.67 90.00 4.93
80.41 73 . 84 8 . 04
75.37 69.26 6.70
85.46 78 . 42 9 . 38
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Statistical Analysis
Unpaired t test comparing initial wound size both groups
Conventional Occlusive












This indicates that the null hypothesis stating that there
is a difference between the initial sizes of both groups
is not proven.
Unpaired t test comparing the contraction

















The hypothesis stating that there is a difference
between dressing groups can be proved.
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Skin Graft Study
All measurements are in square millimeters
Size at Woundina Size at 1 Mth Size at 6 Mnths
Patient
Code Control Opsite Control Opsite Control Opsite
MB 8614 9863 7347 7721 4307 6115
LH1 1719 1975 1264 1368 859 1580
LH2 2265 3489 1870 2699 1271 2975
WJ 6470 4752 5662 4550 3558 3944
VO 6857 6442 4700 5080 4114 5417
SR 4072 3349 2850 2511 3123 2819
VS 1710 3318 1641 2564 923 2388
JM 3678 4070 2280 3418 1655 2017
PM 11920 6835 8940 5399 6198 6021
CM 4078 963 3592 595 3437 870
LM 10622 1965 9065 1806 6752 1627
CB 1547 3858 1178 3120 1105 2960
mean 5296 4239 4199 3402 3108 3227
95%
Confidence 3016 2673 2341 2140 1824 2098
Limits 7575 5807 6056 4664 4392 4357



































C = Control Wounds
O = Opsite Wounds


























































































The above data columns list wound size expressed
as a percentage of the original surface area
Paired t tests on Data columns
1 mth 6 mths 12 mths
t = -0.014 5.701 6 .121
p = 0.9888 0.0001 0.0001
md -0.055 18.330 23.039
cl -8.40 11. 25 14 . 75
cl 8.29 25.41 31.32
There is no significant difference between wound sizes at 1
month.
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Reduction of open wound contraction
in humans with a synthetic dressing
M.I. James and J.H. Stevenson
Department of Plastic Surgery, Dundee Royal Infirmary, Dundee, Scotland
Summary. Many articles have been written about wound
contraction. The majority of these use animals as these
experiments are impossible to repeat in humans for ethi¬
cal reasons. Skin graft donor sites have been used in
this study as repeatable controlled wounds. Wound con¬
traction does occur in these wounds and it can be re¬
duced by covering the wound with a synthetic dressing.
Key words: Skin graft donor sites - Contraction - Syn¬
thetic dressings
Covering a wound with a full thickness skin graft effec¬
tively stops it contracting [1, 7, 11, 13]. Animal studies
have shown that, in the short term, synthetic dressings
have the same effect on reducing wound contraction as
full thickness skin grafts [4, 5]. A study was therefore
set up to see if a synthetic dressing had the same effect
on open wounds in humans. If this were the case then
the temporary dressing of burn wounds with synthetic
dressings would reduce the stimulus to wound contrac¬
tion which would perphaps reduce the need for long-
term physiotherapy, splintage therapy and possibly the
need for secondary surgery.
Split skin graft donor sites were used as wound mod¬
els in this study as they are made in a repeatable con¬
trolled procedure, can be treated in a similar manner,
and healing is independent of the primary defect for
which the skin graft is being used. The dressing used
in this study (Transigen, Smith and Nephew) is a synthet¬
ic wound dressing designed to allow excess moisture to
evaporate in a controlled manner ensuring the wound
is always kept moist. It is a soft pliable dressing that
does not adhere to moist surfaces.
Excess fluid from the wound surface passes through
pores in the inner membrane to accumulate and then
evaporate through the outer membrane thus allowing
wound healing to take place in a moist environment
without excessive fluid accumulating under the dressing.
Materials and methods
Fifty-five donor sites on 55 patients were studied. All donor sites
were on the thigh as large donor sites (at least 10x5 cm) were
used to minimize experimental error. Patients with more than one
donor site per thigh were excluded so that all wounds studied
were surrounded by normal skin.
Donor site size was assessed in theatre by compressing a sterile
paper towel on to the area after allowing capillary bleeding to
take place. The mark made was carefully cut out and re-applied
to ensure accuracy. An acetate sheet tracing was later taken and
the initial towel discarded.
The dressing regimen was then chosen by a randomizing tech¬
nique allocating the donor site to be dressed conventionally or
with Transigen.
Conventional dressing consisted of covering the wound with
paraffin impregnated gauze then dressing swabs covered by cotton
wool held in place with a crepe bandage.
The transigen dressing regimen consisted of drying the sur¬
rounding skin with a gauze swab and then applying the dressing
and loosely covering this with a crepe bandage.
Both dressings were left undisturbed for two weeks. The dress¬
ings were taken down in either the outpatient or ward environment
by the nursing staff. Tracings were then taken by one of the authors
of the epithelialised areas without him knowing which dressing
had been used. The surface areas were then calculated and com¬
pared.
Results
Infection occurred in two donor sites covered with Tran¬
sigen and three conventionally dressed donor sites. These
were excluded from the study and responded to local
dressing treatment.
The composition of both groups was similar with
regards to age and sex (Table 1).
The mean time from graft harvesting to dressing re¬
moval was 15.3 days (standard error of the mean 1.9
days) in the conventionally dressed group and 17 days
(standard error of the mean 1.5 days) in the Transigen
group.
Mean wound contraction was 20% in the conven¬
tionally treated wound and 8% in the Transigen dressed
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Table I. See text
Number of patients Age range Mean age
Male (C) 10 39-61 49.5
Female (C) 15 50-67 59
Male (T) 14 43-64 53
Female (T) 11 45-69 59.4
C = Conventional dressing
T= Transigen dressing
■ Conventional —Transigen
Percentage total surface area
Days
J Standard error of the mean
Fig. 1. Donor site contraction when dressings are removed
group (Fig. 1). This difference was statistically signifi¬
cant (p<0.04).
Discussion
We did not measure the graft thickness and biopsy the
underlying dermis to ensure that all wounds were simi¬
lar. The study was designed so that:
1) skin graft harvesting was carried out before dressing
groups were allocated.
2) measurements were taken after dressing removal with¬
out knowing which dressing had been used.
Therefore, with the random allocation of dressings, and
measurements being taken without knowing which
dressing was used, it would seem most likely that the
composition of both groups would be stastically similar
with regards to donor site depth [8].
Frank [4, 5] and Foresman [6] have shown that, in
rats, a synthetic dressing has the same effect as a full
thickness skin graft in reducing open wound contraction
in the short term. Flow the synthetic dressing achieved
this remains unclear. It is possible that it acted as a
splint or it may be that, by allowing wound healing to
take place in a moist environment, the dressing reduced
the stimulus to wound contraction. We decided to see
if these dressings had a similar effect in humans. We
accept that split skin graft donor sites are not full thick¬
ness wounds but our study shows that these wounds
do, in fact, contract in the short term. Other workers
have noted that even in partial thickness wounds there
is increased dermal collagen metabolism which can be
influenced by locally produced growth factors [3, 10]
indicating that wound contraction (as in this study) is
possible in partial thickness wounds. The perhaps sur¬
prisingly high figure of a 20% contraction of the control
wounds is interesting. These donor sites were all sur¬
rounded by normal, lax skin and thus any physical forces
opposing contraction would be minimal [15]. This figure
may vary depending on the position of the donor site.
If the dressings were reducing wound contraction by
their splintage action only, then the conventionally
dressed donor sites should contract minimally as these
dressings become hard and remain adherent to the
wound until it epithelialises. The synthetic dressing used
in this study had a minimal splintage effect so the reduc¬
tion of contraction must have been a result of other
factors. Recent work in rats has shown that the wound
under a split skin graft overed with a synthetic dressing
reacts as though it is covered with a full thickness graft.
Preliminary work indicates that dressing a split skin
graft in this way (for only one week) reduces the underly¬
ing myofibroblast cell populations [9], It is possible that
the reduction of human donor site contraction may be
a result of the synthetic dressing's effect either on the
underlying myofibroblast cell population or its effect on
wound epithelialisation or both. The moist environment
produced by the synthetic dressing is not the whole
answer to how it reduces underlying wound contraction
[2, 6]. It may be that the synthetic dressing influences
the accumulation of factors in the locality of the wound
which, in turn, help to increase epithelialisation and re¬
duce wound contraction [2].
Maximum wound contraction occurs in rats at 2-4
weeks [13, 14], This coincided with the clinical practice
of removing donor site dressings so measurements were
taken at that time, it would have been interesting to
follow up these patients over a longer period of time
to see if this initial difference in contraction remains.
This was not possible as the majority of these patients
lived a considerable distance from the hospital and regu¬
lar follow-up was difficult.
It would seem that partial thickness wounds, in hu¬
mans, do contract. This contraction can be measured
as early as 14-17 days after wounding and can be in¬
fluenced in humans as it is in rats by the material used
to dress the wound. This ability would be useful in a
burns unit as burns of varying depths with and without
skin grafts could be covered with these dressings with
the hope of reducing the long-term contracture problems
associated with these injuries. Although synthetic dress-
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ings have been used as a temporary dressing in superfi¬
cial burns [12] no studies have been reported where their
long-term effect on wound contraction has been investi¬
gated. Such studies are currently in progress.
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A new experimental model of lymphedema in rats' hind lower legs
G.-K. Huang1 and J. Maekawa2
1 Department of Orthopaedic Surgery, Shanghai First People's Hospital, Shanghai, China
2 Department of Plastic Surgery, Yokohama City University Hospital, Yokohama, Japan
Summary. In this study, a simple and reliable experimen¬
tal model for lymphedema is described. In the middle
portion of albino rats' hind lower leg, leaving the sa¬
phenous vessels and the accompanying lymphatics in¬
tact, all other soft tissues are incised circularly. After
retraction of the cut ends of muscles, the skin edge of
the ventral side is sutured to that of the dorsal side
to envelope the muscles of both cut ends and the saphen¬
ous vessels and lymphatics. Resection of lymphatics or
circular strip of soft tissues is not performed. In 48 of
50 rats' legs, measurements were made of leg circumfer¬
ence and the diameter of the lymphatics; in addition
changes of lymphatic contractility were observed. These
measurements, observations and histopathological stu¬
dies showed a consistent picture of lymphedema. The
clinical implication of this observation is that a small
number of lymphaticovenous anastomoses will not cor¬
rect lymphedema and that the quality of the results will
correlate with the number of anastomoses. In studying
the findings of experimental lymphedema, some other
clinical phenomena are explained and modifications of
the operative procedure of microlymphaticovenous
anastomosis for treating lymphedema are suggested.
Key words: Lymphedema - Lymphaticovenous anasto¬
mosis - Experimental model
In order to study the mechanism of lymphedema forma¬
tion and its therapeutic implications make it desirable
to produce an experimental model for lymphedema. It
is very difficult to establish models of lymphedema be¬
cause of the regeneration of lymphatics, in this way se¬
vered lymphatic vessels are reconstituted to functional
or anatomic perfection in most instances. In 1968, Ols¬
zewski et al. [14] excised a 2 cm circular strip of skin
and subcutaneous tissue in the dog thigh and resected
Requests for reprints to: Prof. G.-K. Huang, M.D., Department
ofOrthopaedic Surgery, Shanghai First People's Hospital, 190 Bei-
suzhou Lu, Shanghai 200085, People's Republic of China
a 4 cm length of femoral lymphatics; a 1 cm strip of
periosteum was excised, and the popliteal lymph node
was removed. The skin was sutured to muscle and al¬
lowed to heal by granulation. This technique resulted
in temporary swelling in all dogs, but chronic lymphede¬
ma developed in only eight of 23 dogs. In 1974, Clodius
et al. [2] made an experimental dog model by a circular
excision of soft tissue including all lymphatics for a dis¬
tance of 4 cm in the thigh followed by insertion of a
synthetic implant (polyurethane foam - Etheron) to pre¬
vent lymphatic regeneration.
In this study, a new experimental model of lymphede¬
ma in rats' hind legs is described. In this model, resection
of lymphatics and a circular strip of soft tissues was
not performed. The technique is simple; the method is
inexpensive and has a high success rate. In 48 of 50 rats'
hind lower legs, lymphedema could be demonstrated
over six months of observation.
Material and methods
Fifty albino rats weighing 200 to 300 g were used. The rats were
anesthetized with an intraperitoneal injection of 3% pentobarbital
sodium (30 mg/kg). The left hind leg was operated on; the right
hind leg served as a control. For visualization of lymphatics, 1%
methylene blue (0.05 ml) was injected into the sole of the foot.
Due to the uptake of the dye, two to three major lymphatic chan¬
nels around the saphenous artery and vein in the middle portion
of the rat's lower leg could be clearly visualized. The saphenous
vessels along with the lymphatics were carefully dissected and pre¬
served. All other soft tissues in the middle portion of the lower
leg were incised circularly (Fig. 1). After retraction of the cut ends
of the muscles, the skin edge of the ventral side was sutured to
that of the dorsal side to wrap the muscles of both cut ends and
the continuing saphenous vessels and lymphatics (Fig. 2). No resec¬
tion of lymphatics or a circular strip of soft tissue was performed.
In the model, the major lymphatics around the saphenous vessels
were preserved, but the formation of lympholymphatic anasto¬
moses of other severed lymphatics and collateral lymph flow
through the gap between the cut ends were prevented, otherwise,
all wounds were closed and allowed to heal without inflammation
and granulation.
After the operation, two rats died of anesthesia. The surviving
Eur J Plast Surg (1989) 12:258-260




A Simple and Reliable Method
for Rapidly Harvesting Split Skin Grafts in Rats
M.I. James
Department of Plastic Surgery, St. Andrews Hospital, Billericay, Essex, UK
Summary. A technique is presented which allows
the rapid precise harvesting of split-skin grafts in
rats. This technique uses the skin which would
have been discarded in the formation of an open
wound as a donor site thus reducing the overall
assault on the animal.
Key words: Harvesting method - Split-skin grafts
- Rats
The rat is a good animal model regularly used in
wound healing studies. The presence of a pannicu-
lus carnosus, however allows considerable skin
mobility which makes split skin graft harvesting
difficult. The use of a battery or electric powered
dermatome allows repeatable precise graft harvest¬
ing but this must be used with an anchoring appli¬
ance. Previous reports have suggested the use of
a clamp, but the techniques described require an
assistant or genetically similar donor rats [2-7].
These methods are time consuming and can only
be used by a single operator with difficulty.
This paper presents a technique which:
a) requires no assistant
b) uses the skin to be excised in the formation of
an open wound as a donor site thus eliminating
the need for donor rats or separate wounds on
the same animal
c) requires one custom made sheet of metal which
takes a few seconds to position to allow easy graft
harvesting
d) allows rapid graft harvesting, on average the
harvesting and application of 4 grafts on one rat
took 20-30 min which negated the need for per-
operative top-up anaesthesia
e) is reproducable. This technique has been used
to harvest 800 similar skin grafts.
Method
The anaesthetised rat is shaved and depillated in the standard
manner. The area of skin to be harvested is marked with ink.
In this instance 2 x 2 cm open wounds were to be covered with
split skin grafts harvested from the excised skin. Two incisions
were made in the opposite sides of the square through the pan-
niculus carnosus. The plane under this structure was mobilised
with scissors and the flat steel plate inserted (Fig. 1).
Experience showed that if the plate was 50% longer than
the area to be harvested (in this case 3 cm) the correct amount
of tension could be easily applied to allow rapid precise graft
harvesting. The incisions could be minimally lengthened to per¬
mit easier plate insertion.
The skin immediately cranial and caudal to the plate is
grasped between the index finger and thumb of the non-domi¬
nant hand, and by approximating these digits sufficient tension
can be applied to flatten the skin against the metal block. This
tension usually resulted in the uncut marked sides of the square
moving to the edge of the plate (Fig. 2).
The skin is then lubricated with a little mineral oil and
harvested with an electric dermatome. If the cutting head is
50% longer than the width of the skin graft the side of the
blade does not impede or disrupt the harvesting process by
cutting into the skin (Fig. 3).
Once the predetermined amount of skin is harvested (to
the previously marked fourth side of the square in this case),
the dermatome is stopped and withdrawn. This reduces the
risk of the cutting head damaging the newly harvested graft.
When the skin is removed from the dermatome the attached
edge is cut freeing the graft (Fig. 4). The underlying dermis
is then excised allowing the easy removal of the metal plate,
revealing an open wound ready for skin grafting.
Eight hundred skin grafts were harvested using this tech¬
nique and sample measurements were made on 50 grafts using
an electric micrometer (Model Mitutoyo Digimatic Indicator
range 0.002-30 mm).
Of the 50 sample grafts, mean graft thickness was
0.229 mm with a standard error of the mean of 0.015 mm indi¬
cating the reliability of the technique to produce grafts of simi¬
lar thickness.
Discussion
Techniques described in the literature require ei¬
ther genetically similar donor rats or appliances
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Figs. 1-4
designed to anchor the skin of the rat with clamps
or stay sutures. These techniques are time consum¬
ing and/or require an assistant.
The technique presented allows the rapid, pre¬
cise harvesting of split skin grafts in the rat by
a solo operator. The skin to be discarded in the
formation of an open wound is used as the donor
site for the split skin graft. The thickness of the
split skin graft can be varied by altering the setting
on the electric dermatome. The tension on the skin
during the grafting process is controlled by align¬
ing the edges of the square with the edge of the
underlying metal plate thus ensuring all grafts are
harvested using the same amount of tension. The
technique was quickly mastered and there were
only 5 failures which were attributed to a blunt
knife chewing up the graft.
The increase in size produced by stretching the
skin was lost when the skin graft underwent prima¬
ry, physiological contraction [1] immediately after
harvesting, returning to its original size.
In summary this technique, which allows pre¬
cise skin grafts to be rapidly harvested by one oper¬
ator, is to be recomended when wounds deep to
the panniculus carnosus are being formed. As the
split skin grafts are being harvested from skin
which otherwise would have been discarded in the
formation of the open wound the need for donor
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rats is eliminated and the overall assault on the
animal is reduced.
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Alteration of split skin graft contraction
with a synthetic dressing
M.I. James
Department of Plastic Surgery, St. Andrew's Hospital, Billericay, Essex, UK
Summary. In a rat model, covering a split skin graft
with a synthetic dressing for only one week alters the
subsequent contraction characteristics of the underlying
wound so that the graft increases in size in a manner
similar to a full thickness skin graft.
Key words: Split skin grafts - Synthetic dressing - Graft
contraction alteration
In open wounds the normal healing process involves
wound contraction [14], the control of which would be
a useful weapon in the surgeon's armamentarium.
Covering a wound with a skin graft reduces contrac¬
tion. Clinically and experimentally, wounds covered with
full thickness skin grafts contract minimally but those
covered with split skin grafts can contract by up to 60%
[8, 12, 15]. The presence of dermis was felt to be impor¬
tant [3], but a synthetic dressing has been shown to
have the same effect, in the short term, as a full thickness
skin graft in reducing contraction in open wounds [6,
7]. Reduction of moisture loss and adherence of the
dressing may be important factors in reducing wound
contraction [5]. If a synthetic dressing has this effect
on contraction of open wounds, what effect, if any, does
it have on wounds covered with split skin grafts?
A study was therefore set up to observe both surface
area and moisture loss from split skin grafted wounds,
one on each flank in rats, one side covered with a syn¬
thetic dressing, the other side acting as control.
Materials and methods
Animal model
Forty immature male Sprague Dawley rats (mean weight 384.4 g +
5.3 g standard error of the mean) were used in this experiment.
All rats were individually housed in cages kept in an environment
whose temperature and humidity were carefully controlled.
One full thickness wound (2x2 cm including panniculus car-
nosus) was created on each flank after depilation. The excised
skin was used to harvest a split skin graft (mean thickness
0.229 mm; SEM 0.012 mm) with an electric dermatome (Servomcd
UK). Graft thickness was checked with an electric micrometer and
sample biopsies were taken of the grafts and underlying tissue
to histologically confirm graft thickness and the similarity of both
sides. The grafts were then applied to the defects and secured with
sutures. On one side the graft was covered with Opsite cut to
shape, the other side acting as a control. A protocol was devised
so that the rats would be studied in 5 groups of 8, each group
having Opsite in situ for 1, 2, 3, 4 or 5 weeks. Measurements were
then taken.
Water loss
Water loss or moisture vapour transmission (MVT) was measured
with an evaporimeter. Measurements were taken from normal skin
and open wounds to compare with published data [5], Readings
were also taken from the split skin grafts covered with Opsite
and those acting as controls. MVT was measured when the dressing
was applied, when it was removed, the day following removal and
thereafter at regular intervals up to the end of the study.
Surface area
Tracings on acetate sheets were made of each skin graft at opera¬
tion and at regular predetermined intervals up to 15 weeks postop¬
eratively. These tracings were transferred to a computer and the
surface area was measured and expressed in square millimeters.
The mean values and standard error of the mean (SEM) per group
were then calculated.
Dressings
Once a skin graft was covered with Opsite, both grafts on the
animal were treated identically. A cotton wool ball was held over
the grafts with 4 ties over sutures. The rat was then placed in
a protective towelling dressing and a restrictive vest applied to
the anterior aspect of the thorax [13], Regular inspection occurred
and any disturbance of the dressing repaired. This technique was
well tolerated by the animals and few repairs were necessary. After
1 week, under gaseous anaesthesia, the ties over dressings were
removed and wound measurements taken according to the proto¬
col. The rats were then redressed with the towelling dressing and
the protective vest. These dressings were later removed under an¬
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Fig. 2. Water loss groups 2, 3, 4 and 5. SEM excluded for clarity
Results
Growth
Mean rat weight fell by 13.8% in the first postoperative
week and thereafter weight gain took place at a mean
rate of 4.7% per week until the end of the study when
mean rat weight was 582.4 g.
Failures
The study was statistically designed to accommodate a
25% failure rate. In fact only 3 rats were excluded from
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Fig. 3. Change in surface area group 1
ciated with a seroma (1 rat), haematoma (1 rat), and
autocanabalisation (1 rat). This indicated how well the
dressings were tolerated by the animals.
Water loss
Moisture vapour transmission (MVT) from open
wounds and normal skin had respective values 60 g/m2/h
(GMH) and 5 GMH. This compared well with previous¬
ly published data [5].
Covering a split skin graft with a synthetic dressing
enormously increased the humidity of the wound healing
environment. When this dressing was removed there was
a massive surge in moisture vapour transmission which
returned to the control group values after 1 day (Fig. 1).
Readings taken the day following dressing removal were
not significantly different from values recorded before
dressing removal. This phenomenon occurred in all
groups and there was no statistical difference in the peak
readings recorded in the first few minutes following
dressing removal (Fig. 2).
Surface area
Controls. The split graft controls in this experiment be¬
haved in a manner similar to published data [1, 3, 12,
15]. There was an initial reduction to 56% of the original
size at week 7 and thereafter a slow increase in size to
90% at week 15 (Fig. 3).
Opsite. Covering a split skin graft with Opsite for only
1 week resulted in the greatest increase in surface area
(Fig. 3). In this group the difference between the control
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Fig. 4. Change in surface area; Opsite on for 2-5 weeks. SEM
excluded for clarity
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Fig. 5. Covered with Opsite for one week
Fig. 6. Control
grafts and the Opsite covered grafts became statistically
significant (no overlap in the standard error of mean
between the 2 populations) 2 weeks after Opsite remov¬
al. This difference increased until at week 15 there was
a 70% difference between the Opsite and control groups
(Figs. 5 and 6). Covering a graft with a synthetic dressing
for longer than 1 week did not result in any greater in¬
crease in subsequent surface area values (Fig. 4).
Discussion
Skin grafting is a routine technique used by plastic sur¬
geons to reconstruct defects resulting usually from trau¬
ma, skin tumour excision and burns. Split skin grafts
are used in preference to full thickness skin grafts for
many reasons [2, 8], Self healing donor sites allowing
large graft harvesting, and better take, are the main ad¬
vantages but one major disadvantage is that wounds
covered with split skin grafts contract to a greater degree
than wounds covered with full thickness skin grafts. In
order to counteract this tendency, regimes incorporating
extensive splintage, pressure garment use, physiotherapy
and perhaps even secondary corrective surgery are neces¬
sary. This study shows that in rats, the application of
a synthetic dressing to a split skin graft allows this phase
of wound healing to take place in a very moist environ¬
ment. Split skin grafts treated in this way contract less
and progress to a greater size than the untreated con¬
trols. How synthetic dressings achieve this is unclear,
but covered wounds appear to act as if they were covered
by full thickness skin grafts. Frank [6, 7] who noted
a similar temporary effect of synthetic dressings on open
wounds concluded that intimate dressing adherence is
necessary to achieve this effect. This observation is en¬
dorsed by Foresman, who showed different rates of
wound contraction between different dressings [5].
These dressings adhered to the wound in different ways,
the ones with greater adherence showing a greater reduc¬
tion in contraction of the open wounds.
In this study, the synthetic dressing was applied to
the epidermal aspect of a split skin graft and it was
thus easier to obtain more of an intimate adherence to
the skin graft than to an open wound. It can be assumed
that intimate adherence of a synthetic dressing not only
reduces water loss but allows gaseous exchange and it
is interesting to note that the synthetic dressing main¬
tains its contraction reducing effect even when a split
skin graft is sandwiched between the dressing and the
open wound. In this study, however, the effect the syn¬
thetic dressing had, only began to statistically manifest
on surface area figures several weeks after dressing re¬
moval whereas open wound contraction was affected
only when the dressing was in situ. When Opsite was
removed after 1 week, this group showed the largest sur¬
face area values at the end of the study, some 14 weeks
after the dressing was removed. This implies that the
effect the dressing has is in the first few hours [4] or
days of the wound healing process and in order for this
effect to continue after the dressing removal it would
seem logical that a cellular component of the wound
healing process is affected. Myofibroblasts are now con¬
sidered to be the cells responsible for wound contraction
[11] and Rudolph [9, 16] has shown that the myofibrob¬
last cell populations are different in wounds covered with
full thickness skin grafts compared to wounds covered
with split skin grafts. Further studies are in progress
to identify and quantify the myofibroblast populations
under split grafts with and without Opsite dressings. Pre¬
liminary findings [10] indicate that myofibroblast cell
orientation beneath the skin graft may play an important
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role in the different rates of contraction in both groups.
From this study it can be concluded that in the rat the
application of a synthetic dressing to a split skin graft
in the early phase of wound healing allows the split skin
graft to increase in size in a manner similar to a full
thickness skin graft.
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